Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,Cellular Response To Starvation R-HSA-9711097,-0.8140159924265769,-3.046171168658789,0.0,0.0,0.0,79/136,4.24%,RPL6;ATP6V0C;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;ATP6V1D;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;ATP6V1A;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;ATP6V1G2;RPL15;ATP6V0E2;RPS12;SESN1;RPL30;RPL39;RPL22L1;RPL26;LAMTOR2;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;ATP6V0B;RHEB;RPL32;ATP6V1F;RPL36A;RRAGA
gsea,Translation R-HSA-72766,-0.7054152282177789,-3.0010589110499395,0.0,0.0,0.0,133/253,13.00%,RPL6;RPS29;EEF1A1;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;EIF4A1;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;SRP14;RPS15A;RPS14;RPL15;RPS12;MRPS26;RPL30;RPL39;EEF1G;EEF1B2;RPL22L1;EEF1A2;SPCS2;EIF3C;EIF4A2;RPL26;EIF1AX;AURKAIP1;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;EEF2;EIF3H;MRPL52;MRPS24;MRPL41;MRPL36;RPL32;EIF3F;EIF4H;RPL36A;MRPL18;EIF3A;TRMT112;MRPL23;MRPS21;MRPL14;MRPL54;RPL36AL;EIF5B;MRPL44;CHCHD1;EIF2S2;EIF3I;DDOST;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;SEC61G;MRPL57;SSR3;MRPL11;MRPL39;SSR2;RPS13;EIF3K;RPL35;MRPS36;MRPS16;RPLP0;MRPL17;EIF5;PABPC1;MRPS5;RPS27L;MRPL19;RPL10A;MRPL12;SRP19;MTIF3;SPCS1;SRP72;MRPL43;MRPL20
gsea,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.7292234197129679,-2.977226727566539,0.0,0.0,0.0,76/170,7.37%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A;CSNK1E;PDCD11;SNU13;EMG1;RPL36AL;RPP21;C1D;NOC4L
gsea,Influenza Infection R-HSA-168255,-0.7743989690044146,-2.9666991681593484,0.0,0.0,0.0,73/141,4.17%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;HSP90AA1;RPL9;RPL8;RPS6;RPS27;RAN;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;CALR;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;CLTA;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A;CANX
gsea,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.7174969175514102,-2.95398055260261,0.0,0.0,0.0,79/180,7.37%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;THUMPD1;RPL36A;CSNK1E;PDCD11;TRMT112;SNU13;NOP10;EMG1;RPL36AL;RPP21;C1D;NOC4L
gsea,rRNA Processing R-HSA-72312,-0.7062122062713921,-2.9402004107584414,0.0,0.0,0.0,79/190,7.37%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;THUMPD1;RPL36A;CSNK1E;PDCD11;TRMT112;SNU13;NOP10;EMG1;RPL36AL;RPP21;C1D;NOC4L
gsea,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.8305914397988352,-2.93099793258654,0.0,0.0,0.0,72/105,6.21%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A;PPP2CA;PPP2R1A;RPL36AL;RBM8A
gsea,Selenoamino Acid Metabolism R-HSA-2408522,-0.8776692950574395,-2.9286136128367724,0.0,0.0,0.0,68/93,4.12%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A
gsea,Cap-dependent Translation Initiation R-HSA-72737,-0.8556978773155752,-2.923356128452321,0.0,0.0,0.0,76/106,4.53%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;EIF4A1;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;EIF3C;EIF4A2;RPL26;EIF1AX;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;EIF3H;RPL32;EIF3F;EIF4H;RPL36A;EIF3A
gsea,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.7821370439854337,-2.9193601073852067,0.0,0.0,0.0,69/126,4.12%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;HSP90AA1;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A
gsea,Viral mRNA Translation R-HSA-192823,-0.9074825222175754,-2.9118337096625564,0.0,0.0,0.0,68/83,4.12%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A
gsea,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.6435255922446651,-2.9062705885851314,0.0,0.0,0.0,113/271,13.63%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;SERINC1;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;PSMC3;PSMB5;PSMA7;RPL15;RPS12;CKB;RPL30;RPL39;RPL22L1;RPL26;OAZ1;RPL34;PSMC2;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;SEM1;RPL36A;PSMA5;PSMA4;PHGDH;GLUL;RPL36AL;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;ACAD8;DLAT;PSMB1;ALDH6A1;PSMB3;GOT2;PSMA1;RPS13;PSMC6;RPL35;RPLP0;PSMD6;ADO;CARNMT1;BBOX1;RPS27L;RPL10A;PSMC1;PAOX;CHGA;SERINC2;CRYM;PSME3;DIO2;ARG2;PSMC4;RPS19
gsea,Selenocysteine Synthesis R-HSA-2408557,-0.9061392048371066,-2.902329568353216,0.0,0.0,0.0,68/82,4.12%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A
gsea,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.8757710387669889,-2.898904365366248,0.0,0.0,0.0,76/99,4.53%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;EIF4A1;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;EIF3C;EIF4A2;RPL26;EIF1AX;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;EIF3H;RPL32;EIF3F;EIF4H;RPL36A;EIF3A
gsea,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.8869936401128082,-2.8923052043205564,0.0,0.0,0.0,68/87,4.12%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A
gsea,Eukaryotic Translation Elongation R-HSA-156842,-0.918089644430579,-2.887465572374308,0.0,0.0,0.0,73/83,4.12%,RPL6;RPS29;EEF1A1;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;EEF1G;EEF1B2;RPL22L1;EEF1A2;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;EEF2;RPL32;RPL36A
gsea,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.8892219732053371,-2.8822310646368887,0.0,0.0,0.0,73/90,4.53%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;EIF3C;RPL26;EIF1AX;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;EIF3H;RPL32;EIF3F;RPL36A;EIF3A
gsea,Eukaryotic Translation Termination R-HSA-72764,-0.8983390960855403,-2.8805135158957347,0.0,0.0,0.0,69/83,4.63%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A;TRMT112
gsea,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.8913479197530744,-2.8766325829252986,0.0,0.0,0.0,68/85,4.12%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A
gsea,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.8696940467287151,-2.8760647844096616,0.0,0.0,0.0,76/100,4.53%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;EIF4A1;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;EIF3C;EIF4A2;RPL26;EIF1AX;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;EIF3H;RPL32;EIF3F;EIF4H;RPL36A;EIF3A
gsea,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.8501510713303068,-2.858571270072384,0.0,0.0,0.0,70/99,4.12%,RPL6;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;SRP14;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;SPCS2;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;RPL36A
gsea,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.7456103982103458,-2.8585445428668055,0.0,0.0,0.0,100/152,12.10%,RPL6;UBB;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;PSMC3;PSMB5;PSMA7;RPL15;ELOB;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;PSMC2;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;RPL32;SEM1;RPL36A;PSMA5;PSMA4;RPL36AL;RBM8A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;MAGOH;PSMB1;PSMB3;PSMA1;RPS13;PSMC6;RPL35;RPLP0;PSMD6;PABPC1;COL4A5;RPS27L;RPL10A;MAGOHB;PSMC1
gsea,Peptide Chain Elongation R-HSA-156902,-0.9169591797842219,-2.847300615870635,0.0,0.0,0.0,70/79,4.12%,RPL6;RPS29;EEF1A1;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;RPL15;RPS12;RPL30;RPL39;RPL22L1;RPL26;RPL34;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;EEF2;RPL32;RPL36A
gsea,Signaling By ROBO Receptors R-HSA-376176,-0.6870323961313504,-2.830925191186407,0.0,0.0,0.0,106/188,12.10%,RPL6;UBB;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;PFN2;RPL11;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;RPL27;RPL22;RPL37A;RPL41;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;PSMC3;PSMB5;PSMA7;RPL15;ELOB;RPS12;RPL30;RPL39;RPL22L1;CDC42;RPL26;RPL34;PSMC2;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;NCK1;RPL32;SEM1;RPL36A;PSMA5;PSMA4;PPP3CB;RPL36AL;RBM8A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;MAGOH;PSMB1;NELL2;PFN1;PSMB3;PSMA1;RPS13;PSMC6;RPL35;RPLP0;PSMD6;PABPC1;COL4A5;RPS27L;RPL10A;MAGOHB;PSMC1
gsea,Translation Initiation Complex Formation R-HSA-72649,-0.8424834484891413,-2.7863862801956216,0.0,0.0,0.0,41/52,11.19%,RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;RPS11;RPS15;RPS21;RPS6;RPS27;RPS17;EIF4A1;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;EIF3C;EIF4A2;EIF1AX;RPS9;EIF3H;EIF3F;EIF4H;EIF3A;EIF2S2;EIF3I;RPS13;EIF3K;PABPC1;RPS27L
gsea,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.8424834484891413,-2.7863862801956216,0.0,0.0,0.0,41/52,11.19%,RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;RPS11;RPS15;RPS21;RPS6;RPS27;RPS17;EIF4A1;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;EIF3C;EIF4A2;EIF1AX;RPS9;EIF3H;EIF3F;EIF4H;EIF3A;EIF2S2;EIF3I;RPS13;EIF3K;PABPC1;RPS27L
gsea,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.8424852654041635,-2.778039915849781,0.0,0.0,0.0,41/52,11.19%,RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;RPS11;RPS15;RPS21;RPS6;RPS27;RPS17;EIF4A1;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;EIF3C;EIF4A2;EIF1AX;RPS9;EIF3H;EIF3F;EIF4H;EIF3A;EIF2S2;EIF3I;RPS13;EIF3K;EIF5;RPS27L
gsea,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.6445295766276798,-2.744391191274154,0.0,0.0,0.0,82/138,20.23%,COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;IDH3B;NDUFA1;MDH2;ATP5PB;COX4I1;COX5B;COX7C;VDAC1;COX6B1;BSG;COX6A1;UQCRB;COX7A2L;NDUFB1;NDUFS8;UQCR10;COX5A;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;COX7B;CYCS;GLO1;UQCR11;NDUFB8;DLAT;UQCRC2;NDUFC2;NDUFV2;LDHA;HAGH;NDUFA7;NDUFA8;COX14;COX20;LDHB;NDUFC1;NDUFV1;SCO2;NDUFB6;NDUFA5;IDH3A;SUCLG1;SDHD;SDHB;LDLR;COX19;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;LDHD;SLC16A1;NDUFAF2;NDUFB7;NDUFB2;FAHD1;SURF1;NDUFAB1;UQCRFS1;NDUFAF3;NDUFA10;NDUFA11;MPC2;UCP2;IDH3G;TMEM186;IDH2;NDUFAF5
gsea,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.8479106314763438,-2.6976144564550557,0.0,0.0,0.0,34/45,7.16%,RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;RPS11;RPS15;RPS21;RPS6;RPS27;RPS17;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;EIF3C;EIF1AX;RPS9;EIF3H;EIF3F;EIF3A;EIF2S2;EIF3I
gsea,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.6775525763695028,-2.66834919543501,0.0,0.0,0.0,64/94,20.23%,COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;ATP5PB;COX4I1;COX5B;COX7C;COX6B1;COX6A1;UQCRB;COX7A2L;NDUFB1;NDUFS8;UQCR10;COX5A;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;COX7B;CYCS;UQCR11;NDUFB8;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;COX14;COX20;NDUFC1;NDUFV1;SCO2;NDUFB6;NDUFA5;SDHD;SDHB;COX19;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFAF2;NDUFB7;NDUFB2;SURF1;NDUFAB1;UQCRFS1;NDUFAF3;NDUFA10;NDUFA11;UCP2;TMEM186;NDUFAF5
gsea,Respiratory Electron Transport R-HSA-611105,-0.6872213912873251,-2.6672469977883604,0.0,0.0,0.0,62/89,20.23%,COX6C;UQCRQ;NDUFA3;COX8A;NDUFS5;NDUFA1;COX4I1;COX5B;COX7C;COX6B1;COX6A1;UQCRB;COX7A2L;NDUFB1;NDUFS8;UQCR10;COX5A;NDUFS2;NDUFB3;UQCRH;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;UQCRC1;COX7B;CYCS;UQCR11;NDUFB8;UQCRC2;NDUFC2;NDUFV2;NDUFA7;NDUFA8;COX14;COX20;NDUFC1;NDUFV1;SCO2;NDUFB6;NDUFA5;SDHD;SDHB;COX19;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;SDHA;NDUFAF2;NDUFB7;NDUFB2;SURF1;NDUFAB1;UQCRFS1;NDUFAF3;NDUFA10;NDUFA11;TMEM186;NDUFAF5
gsea,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.8494266636764158,-2.6643370405152482,0.0,0.0,0.0,30/43,4.07%,RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;RPS11;RPS15;RPS21;RPS6;RPS27;RPS17;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;SNRPG;RPS9;SNRPF;SNRPD2
gsea,SARS-CoV-2-host Interactions R-HSA-9705683,-0.5826378933385044,-2.6321245505391833,0.0,0.0,0.0,58/145,15.27%,HSP90AB1;RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;YWHAG;RPS11;RPS15;RPS21;YWHAH;HSP90AA1;YWHAB;RPS6;RPS27;RPS17;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;CNBP;YWHAE;SNRPG;RPS9;SNRPF;SNRPD2;MAP1LC3B;YWHAZ;YWHAQ;UBE2N;MASP2;G3BP2;RPS13;NUP50;UBE2V1;RPS27L;GJA1;DDX20;GEMIN7;NUP37;NUP205;RPS19;SEH1L;SNRPE;SEC13;G3BP1;NUP107
gsea,Complex I Biogenesis R-HSA-6799198,-0.7069097342731306,-2.589955582424477,0.0,0.0,0.0,37/50,21.78%,NDUFA3;NDUFS5;NDUFA1;NDUFB1;NDUFS8;NDUFS2;NDUFB3;NDUFA2;NDUFS7;NDUFB10;NDUFA13;NDUFB11;NDUFB8;NDUFC2;NDUFV2;NDUFA7;NDUFA8;NDUFC1;NDUFV1;NDUFB6;NDUFA5;NDUFB9;NDUFA12;NDUFB5;NDUFS6;NDUFB4;NDUFAF2;NDUFB7;NDUFB2;NDUFAB1;NDUFAF3;NDUFA10;NDUFA11;TMEM186;NDUFAF5;NDUFAF7;NDUFAF4
gsea,Cellular Response To Chemical Stress R-HSA-9711123,-0.5486889020022706,-2.4483829917762896,0.0,4.4134546524473865e-05,0.001,57/147,13.64%,UBB;RPS27A;COX6C;COX8A;PRDX5;COX4I1;PSMC3;COX5B;PSMB5;PSMA7;COX7C;SESN1;COX6B1;COX6A1;COX7A2L;PSMC2;UBA52;COX5A;SQSTM1;SEM1;PSMA5;COX7B;SOD1;MAP1LC3B;PSMA4;CYCS;GSTP1;PHGDH;SIN3B;PSMD2;PSMD4;TBL1XR1;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;SRXN1;PSMB3;GCLM;COX14;PSMA1;PRDX1;COX20;PSMC6;CSNK2B;PSMD6;HMOX2;NCF2;SCO2;P4HB;GSK3B;PSMC1;COX19;PSME3;PSMC4;TBL1X
gsea,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.6126678543167444,-2.4451075661728985,0.0,4.290858689879403e-05,0.001,38/69,22.14%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SQSTM1;SEM1;PSMA5;PSMA4;PHGDH;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;SRXN1;PSMB3;GCLM;PSMA1;PRDX1;PSMC6;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC;TALDO1;TXNRD1;PSMB10;PSMD5
gsea,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.6735263709287599,-2.4403385136797886,0.0,4.174889536098879e-05,0.001,29/47,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;CDK4;PSMA1;PSMC6;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.6605474728646623,-2.4394714225100027,0.0,4.065024021991013e-05,0.001,28/49,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;CBFB;PSMB6;PSMB7;PSMA2;UBC
gsea,Cellular Response To Hypoxia R-HSA-1234174,-0.621842161734659,-2.4388036789742826,0.0,3.9607926368117566e-05,0.001,32/63,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;ELOB;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;CITED2;RBX1;HIGD1A;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;LIMD1;UBC
gsea,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.6689455796118223,-2.434024840083254,0.0,3.861772820891462e-05,0.001,29/51,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;CDK4;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;CDKN1B;PSMB7;PSMA2;UBC
gsea,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.6635320609556918,-2.427471037525311,0.0,3.76758323989411e-05,0.001,29/49,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.6756612630414252,-2.4227673502885647,0.0,3.677878877039488e-05,0.001,29/49,17.72%,HSP90AB1;UBB;RPS27A;HSP90AA1;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Stabilization Of P53 R-HSA-69541,-0.6494808972106111,-2.417677899541492,0.0,3.592346810131593e-05,0.001,28/49,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PHF20;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.6423835420596776,-2.4108673554200037,0.0,3.510702564446784e-05,0.001,29/53,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PHF20;PSMC1;PSME3;PSMC4;PSMB6;CDKN1B;PSMB7;PSMA2;UBC
gsea,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.6575478567225332,-2.4072958473176778,0.0,3.432686951903522e-05,0.001,28/49,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Regulation Of Apoptosis R-HSA-169911,-0.6548227430464613,-2.3986280966768865,0.0,3.358063322514315e-05,0.001,27/48,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.6592173812264672,-2.391894471644848,0.0,3.286615166716139e-05,0.001,29/49,17.72%,UBB;RPS27A;HSPA8;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PABPC1;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.6343688744713103,-2.3861755435669005,0.0,3.218144017409552e-05,0.001,30/56,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;ELOB;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;LIMD1;UBC
gsea,G1/S DNA Damage Checkpoints R-HSA-69615,-0.62797402999028,-2.3831617323285745,0.0,3.15246760889099e-05,0.001,29/55,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PHF20;PSMC1;PSME3;PSMC4;PSMB6;CDKN1B;PSMB7;PSMA2;UBC
gsea,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.6611506260857094,-2.3821424654694168,0.0,3.08941825671317e-05,0.001,27/45,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.6627508771899837,-2.3799619503332727,0.0,3.0288414281501667e-05,0.001,27/45,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.6547023373507046,-2.3780229655258065,0.0,2.9705944776088175e-05,0.001,30/50,19.15%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;YWHAZ;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC;FBXW7
gsea,Orc1 Removal From Chromatin R-HSA-68949,-0.6197420429456739,-2.3690046684250494,0.0,2.914545525201104e-05,0.001,28/57,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.6243370475741068,-2.367888002912856,0.0,5.721144919839204e-05,0.001,30/54,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PRKACB;PSMA2;UBC
gsea,SARS-CoV-2 Infection R-HSA-9694516,-0.5011976039339509,-2.3663470596516536,0.0,5.6171241031148546e-05,0.001,69/219,15.27%,HSP90AB1;UBB;DDX5;RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;YWHAG;RPS11;RPS15;RPS21;YWHAH;HSP90AA1;YWHAB;RPS6;RPS27;RPS17;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;CNBP;YWHAE;SNRPG;UBA52;RPS9;SNRPF;SNRPD2;CANX;MAP1LC3B;YWHAZ;ZCRB1;YWHAQ;DAD1;CHMP4B;UBE2N;DDOST;MASP2;G3BP2;RPS13;NUP50;CHMP2A;UBE2V1;CHMP6;RPS27L;GJA1;DDX20;GSK3B;GEMIN7;NUP37;NUP205;RPS19;SEH1L;SNRPE;SEC13;G3BP1;NUP107
gsea,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.6280163512170933,-2.362467106332432,0.0,5.516818315559233e-05,0.001,29/53,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PRKACB;PSMA2;UBC
gsea,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.6343237941162327,-2.359505946211192,0.0,5.420032029321351e-05,0.001,29/51,19.27%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC;VCP;OS9
gsea,SARS-CoV Infections R-HSA-9679506,-0.48568646433066076,-2.3589151708267284,0.0,5.326583201229604e-05,0.001,96/288,17.72%,ATP1B1;HSP90AB1;UBB;DDX5;RPS29;RPS2;RPS7;RPSA;RPS8;RPS23;RPS28;FAU;RPS25;RPS5;RPS24;RPS27A;YWHAG;RPS11;RPS15;RPS21;YWHAH;FKBP1A;HSP90AA1;YWHAB;RPS6;RPS27;RPS17;RPS3;RPS4X;RPS10;RPS20;RPS16;RPS15A;RPS14;RPS12;CNBP;ATP1A3;YWHAE;SNRPG;UBA52;RPS9;AP2M1;NCK1;SNRPF;SNRPD2;CANX;MAP1LC3B;SAP18;ATP1B2;YWHAZ;PTGES3;ZCRB1;YWHAQ;IFNGR2;DAD1;RBX1;CHMP4B;UBE2N;DDOST;MASP2;G3BP2;CHD3;COMT;HMG20B;RBBP7;RPS13;ATP1A2;NUP50;CHMP2A;S1PR1;UBE2V1;CHMP6;RPS27L;GJA1;DDX20;GSK3B;AP2B1;GEMIN7;NUP37;NUP205;RPS19;SEH1L;SNRPE;SEC13;G3BP1;NUP107;FXYD1;GPC1;IMPDH2;PARP16;CHMP4C;FKBP4;GEMIN6;AP2S1;CHMP7;UBC
gsea,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.6101232150581749,-2.357674199600941,0.0,5.236302130022322e-05,0.001,36/72,16.75%,CALM1;UBB;PPIA;RPS27A;PPP3CA;FKBP1A;RASGRP1;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;HRAS;NFKBIB;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;BCL10;PSMA2
gsea,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.6538217955316554,-2.3566451077508725,0.0,5.149030427855284e-05,0.001,29/48,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;ELOB;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Protein Localization R-HSA-9609507,-0.519569158315325,-2.3525891423789576,0.0,5.06462009297241e-05,0.001,54/139,21.12%,UBB;SLC25A4;PRNP;VAMP2;RPS27A;DNAJC19;COX17;TIMM8B;VDAC1;CHCHD2;CHCHD10;UBA52;TOMM5;ATAD1;TOMM7;VAPA;TIMM13;NDUFB8;MPV17;PAM16;SEC61G;EMD;TOMM20;BCS1L;TIMM22;TIMM23;TIMM10;PAOX;PEX12;COX19;SAMM50;CHCHD4;TIMM50;TIMM44;LDHD;HSPD1;ACOX1;NUDT19;GRPEL1;HSPA9;HSCB;ZFAND6;UBC;PEX19;FXN;NUDT7;TOMM22;IDH3G;TOMM6;PEX11B;CYB5A;PMPCA;MTX1;FIS1
gsea,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.6346862478936247,-2.35166369571222,0.0,4.982932672118017e-05,0.001,29/50,19.27%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC;VCP;OS9
gsea,G2/M Checkpoints R-HSA-69481,-0.5351075148106084,-2.3504849741520273,0.0,4.903838502719318e-05,0.001,49/107,23.08%,UBB;RPS27A;YWHAG;YWHAH;YWHAB;PSMC3;PSMB5;PSMA7;YWHAE;PSMC2;UBA52;SEM1;PSMA5;PSMA4;YWHAZ;H2BC4;YWHAQ;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;RPA3;RNF168;PSMC1;BABAM2;PSME3;PSMC4;PSMB6;CDC45;PSMB7;PSMA2;UBC;RFC3;H2AX;UIMC1;RAD50;PSMB10;RAD9B;PSMD5;MCM6;RBBP8;ORC4
gsea,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.6170581839490458,-2.3470771125243024,0.0,4.8272160261143286e-05,0.001,30/55,19.27%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;P4HB;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC;VCP;OS9
gsea,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.6409867767926266,-2.3468855717024417,0.0,4.7529511641741085e-05,0.001,27/49,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.6297057050216843,-2.3465143142085436,0.0,4.680936752595713e-05,0.001,36/54,24.75%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;RNF5;PSMC1;PSME3;PSMC4;PSMB6;RNF185;PSMB7;PSMA2;UBC;VCP;OS9;PSMB10;PSMD5;DERL1;DERL2;PSMD11
gsea,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.6203515083345897,-2.3453972475016807,0.0,4.61107202494503e-05,0.001,30/54,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PRKACB;PSMA2;UBC
gsea,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.5959129419925228,-2.345351694164672,0.0,4.5432621422252504e-05,0.001,35/61,22.14%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;STUB1;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;CBFB;PSMB6;PSMB7;PSMA2;UBC;FBXW7;PSMB10;ESRRA;PSMD5
gsea,Iron Uptake And Transport R-HSA-917937,-0.64093284205051,-2.34347475937546,0.0,4.4774177633524204e-05,0.001,20/46,17.72%,FTH1;UBB;ATP6V0C;ATP6V1D;RPS27A;ATP6V1A;ATP6V1G2;ATP6V0E2;SLC22A17;UBA52;ATP6V0B;ATP6V1F;NEDD8;ATP6V1E1;HMOX2;ATP6V1C1;ALAD;ATP6V1B2;ATP6V1G1;UBC
gsea,Mitochondrial Protein Import R-HSA-1268020,-0.5997981623825953,-2.3423552365011107,0.0,4.4134546524473865e-05,0.001,33/57,20.75%,SLC25A4;DNAJC19;COX17;TIMM8B;VDAC1;CHCHD2;CHCHD10;TOMM5;TOMM7;TIMM13;NDUFB8;PAM16;TOMM20;BCS1L;TIMM22;TIMM23;TIMM10;COX19;SAMM50;CHCHD4;TIMM50;TIMM44;LDHD;HSPD1;GRPEL1;HSPA9;HSCB;FXN;TOMM22;IDH3G;TOMM6;PMPCA;MTX1
gsea,Attenuation Phase R-HSA-3371568,-0.7744842109303549,-2.339625339956179,0.0,6.526939978971486e-05,0.001,9/21,5.34%,HSP90AB1;UBB;HSBP1;HSPA8;HSP90AA1;DNAJB6;HSPA2;MRPL18;PTGES3
gsea,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.6107641156835537,-2.339508306625844,0.0,6.436288034819104e-05,0.001,21/49,16.61%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;SESN1;LAMTOR2;ATP6V0B;RHEB;ATP6V1F;RRAGA;LAMTOR3;ATP6V1E1;RRAGD;ITFG2;ATP6V1C1;SEH1L;SEC13;KICS2;ATP6V1B2;ATP6V1G1
gsea,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.7452148792882183,2.338594167450141,0.0,0.0004211917248214064,0.001,10/21,7.92%,GRIA3;PTPRS;GRIN2A;GRIA1;GRIA4;PTPRD;PTPRF;MPP3;LRFN2;LRFN1
gsea,Degradation Of AXIN R-HSA-4641257,-0.6277989970986863,-2.3366499601201363,0.0,6.348119705575007e-05,0.001,27/50,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.591809664205596,-2.3352771939891572,0.0,6.262334304148317e-05,0.001,32/66,17.72%,UBB;RPS27A;H2AZ1;PSMC3;LMO1;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;H2BC4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;H2AJ;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;CBFB;PSMB6;PSMB7;PSMA2;UBC
gsea,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.6074808213916134,-2.3338787318540652,0.0,6.178836513426339e-05,0.001,29/57,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;FZD2;PSMB3;PSMA1;PSMC6;PSMD6;FZD4;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.6466847086815172,-2.3309279947342127,0.0,6.097536032986519e-05,0.001,27/46,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Activation Of BH3-only Proteins R-HSA-114452,-0.7346387056585745,-2.3238660540886427,0.0,6.018347253337343e-05,0.001,10/24,8.39%,DYNLL1;YWHAG;DYNLL2;YWHAH;YWHAB;YWHAE;PPP3R1;YWHAZ;YWHAQ;BAD
gsea,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.6399806939860718,-2.3228273299807296,0.0,5.9411889552176336e-05,0.001,27/47,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,ABC Transporter Disorders R-HSA-5619084,-0.5876413546288931,-2.3162975829946633,0.0,5.8659840317338664e-05,0.001,37/63,24.75%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;RNF5;PSMC1;PSME3;PSMC4;PSMB6;RNF185;PSMB7;PSMA2;UBC;VCP;OS9;ABCB6;PSMB10;PSMD5;DERL1;DERL2;PSMD11
gsea,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.5663912301081006,-2.3138767754006007,0.0,5.792659231337193e-05,0.001,41/93,16.75%,CALM1;UBB;PPIA;RPS27A;PPP3CA;FKBP1A;RASGRP1;PSMC3;PSMB5;PSMA7;ORAI2;PSMC2;UBA52;NCK1;SEM1;PSMA5;PSMA4;PPP3R1;CLSTN1;PPP3CB;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;HRAS;NFKBIB;PSMA1;PSMC6;PSMD6;PSMC1;LYN;PIK3R1;PSME3;PSMC4;PSMB6;PSMB7;BCL10;PSMA2
gsea,Axon Guidance R-HSA-422475,-0.46503813111500714,-2.3117515917538847,0.0,5.721144919839203e-05,0.001,119/444,7.78%,HSP90AB1;RPL6;UBB;EPHA5;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;PRNP;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;PFN2;RPL11;EPHA7;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;MYL6;ACTG1;RPL27;RPL22;RPL37A;HSPA8;RPL41;HSP90AA1;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;PSMC3;PSMB5;PSMA7;RPL15;ELOB;RPS12;CLTA;RPL30;RPL39;RPL22L1;CDC42;RPL26;RPL34;PSMC2;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;AP2M1;NCK1;ARPC5;WASL;SEMA5A;RPL32;SEM1;RPL36A;PSMA5;PSENEN;MYL12B;PSMA4;ARPC2;CLSTN1;DPYSL2;PPP3CB;ARPC1A;RPL36AL;RBM8A;ACTR2;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;ARPC3;RBX1;IRS2;MAGOH;PSMB1;NELL2;CDK5R1;PFN1;ITGAV;APH1A;PSMB3
gsea,Amyloid Fiber Formation R-HSA-977225,-0.6332442147681808,-2.3013545196596503,0.0,5.651374859841164e-05,0.001,13/39,7.69%,UBB;ITM2B;TTR;APOE;RPS27A;CST3;H2AZ1;UBA52;CALB1;PSENEN;H2BC4;SNCA;APH1A
gsea,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.5489421666943012,-2.2976793091736174,0.0,5.583286006108138e-05,0.001,49/88,26.65%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;SESN1;PSMC2;UBA52;SQSTM1;SEM1;PSMA5;MAP1LC3B;PSMA4;PHGDH;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;SRXN1;PSMB3;GCLM;PSMA1;PRDX1;PSMC6;CSNK2B;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;PSMB6;MUL1;PSMB7;PSMA2;UBC;VCP;TALDO1;TXNRD1;PSMB10;PSMD5;AKT1;PSMD11;KEAP1;SKP1;GSR;PSMD10
gsea,Degradation Of DVL R-HSA-4641258,-0.6175991761314815,-2.2939921411946926,0.0,7.355757754078976e-05,0.002,28/51,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.5436092482868088,-2.2927001463070305,0.0,7.2692194275604e-05,0.002,44/90,22.14%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;BAX;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PPM1D;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;CDK4;PSMA1;PSMC6;STUB1;PSMD6;SOX9;WWTR1;MAF;GSK3B;PSMC1;MAPK3;PSME3;PSMC4;CBFB;PSMB6;PSMB7;HEY1;PSMA2;UBC;FBXW7;MAPK1;PSMB10;ESRRA;PSMD5
gsea,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.6614709178936306,-2.290415934753101,0.0,7.184693620263186e-05,0.002,13/35,8.96%,HSP90AB1;DYNLL1;DYNLL2;HSPA8;HSP90AA1;DNAJA1;CAPZA2;DNAJA2;HSPA2;PTGES3;DCTN6;DCTN3;ACTR10
gsea,Interaction Between L1 And Ankyrins R-HSA-445095,0.7150636064174666,2.2903388492516688,0.0,0.0012635751744642194,0.004,13/22,14.11%,ANK3;SPTBN4;SCN1A;SCN8A;SPTB;KCNQ2;KCNQ3;NFASC;SPTAN1;SCN7A;L1CAM;SPTBN1;ANK2
gsea,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.5553609750354239,-2.2889152823116823,0.0,7.102110934972805e-05,0.002,36/87,17.72%,CALM1;UBB;RPS27A;PPP3CA;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;NFKB2;PSMA4;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;UBE2V1;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;BCL10;PSMA2;UBA3;UBC
gsea,Autophagy R-HSA-9612973,-0.5188961812304733,-2.2868938255805826,0.0,7.021405128893568e-05,0.002,36/119,11.48%,HSP90AB1;UBB;EEF1A1;GABARAPL1;DYNLL1;RPS27A;DYNLL2;HSPA8;HSP90AA1;PARK7;VDAC1;LAMTOR2;UBA52;TOMM5;GABARAPL2;RHEB;SQSTM1;GABARAP;RRAGA;TOMM7;MAP1LC3B;LAMTOR3;VPS28;CHMP4B;UBE2N;ATG12;PINK1;RRAGD;TOMM20;CSNK2B;GFAP;CHMP2A;TSG101;UBE2V1;CHMP6;MAP1LC3A
gsea,Mitochondrial Translation Initiation R-HSA-5368286,-0.5476715544498448,-2.2866608258249155,0.0,6.94251293643409e-05,0.002,40/82,21.13%,MRPS26;AURKAIP1;MRPL52;MRPS24;MRPL41;MRPL36;MRPL18;MRPL23;MRPS21;MRPL14;MRPL54;MRPL44;CHCHD1;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;MRPL57;MRPL11;MRPL39;MRPS36;MRPS16;MRPL17;MRPS5;MRPL19;MRPL12;MTIF3;MRPL43;MRPL20;MRPS2;MRPL48;OXA1L;MRPS31;MRPL16;MRPL42;GADD45GIP1;ERAL1;MRPL38;MRPL35
gsea,Nervous System Development R-HSA-9675108,-0.4565980972490331,-2.2860915182438926,0.0,6.865373903807044e-05,0.002,119/462,7.78%,HSP90AB1;RPL6;UBB;EPHA5;RPS29;RPL37;RPS2;RPL23;RPS7;RPL19;RPL5;RPL3;PRNP;RPLP2;RPL21;RPSA;RPS8;RPS23;RPS28;RPL18A;RPLP1;PFN2;RPL11;EPHA7;FAU;RPS25;RPS5;RPS24;RPS27A;RPL7;RPL28;RPS11;RPL14;RPL27A;RPS15;RPS21;RPL38;RPL29;MYL6;ACTG1;RPL27;RPL22;RPL37A;HSPA8;RPL41;HSP90AA1;RPL9;RPL8;RPS6;RPS27;RPL4;RPS17;RPL7A;RPS3;RPL23A;RPS4X;RPS10;RPL13A;RPS20;RPL12;RPS16;RPS15A;RPS14;PSMC3;PSMB5;PSMA7;RPL15;ELOB;RPS12;CLTA;RPL30;RPL39;RPL22L1;CDC42;RPL26;RPL34;PSMC2;RPL31;RPL36;RPL35A;UBA52;RPS9;RPL18;AP2M1;NCK1;ARPC5;WASL;SEMA5A;RPL32;SEM1;RPL36A;PSMA5;PSENEN;MYL12B;PSMA4;ARPC2;CLSTN1;DPYSL2;PPP3CB;ARPC1A;RPL36AL;RBM8A;ACTR2;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;ARPC3;RBX1;IRS2;MAGOH;PSMB1;NELL2;CDK5R1;PFN1;ITGAV;APH1A;PSMB3
gsea,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.5634195377095226,-2.2850370159953988,0.0,6.78993023453444e-05,0.002,36/79,17.72%,UBB;RPS27A;HSPA8;YWHAB;SET;ANP32A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;YWHAZ;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PABPC1;PSMC1;EXOSC4;EXOSC3;PSME3;ZFP36L1;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.6129406053567685,-2.284821892352137,0.0,6.71612664502863e-05,0.002,29/54,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;NFKB2;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBA3;UBC
gsea,Signaling By NOTCH4 R-HSA-9013694,-0.5604728963223006,-2.283207040195353,0.0,6.643910229490688e-05,0.002,36/76,19.61%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;SNW1;UBA52;SEM1;PSMA5;PSENEN;PSMA4;YWHAZ;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;APH1A;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;JAG1;PSMB6;PSMB7;HEY1;PSMA2;UBC;FBXW7;MAMLD1
gsea,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.5462496630518224,-2.2785006166168036,0.0,6.573230333432278e-05,0.002,37/79,22.14%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;SNW1;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;WWTR1;PSMC1;PSME3;PSMC4;CBFB;BRD2;JAG1;PSMB6;PSMB7;PSMA2;UBC;CXXC1;MAMLD1;PSMB10;NRAS;PSMD5
gsea,Mitochondrial Translation Elongation R-HSA-5389840,-0.5458435541421492,-2.2751739365943324,0.0,6.504038435185621e-05,0.002,46/82,26.62%,MRPS26;AURKAIP1;MRPL52;MRPS24;MRPL41;MRPL36;MRPL18;MRPL23;MRPS21;MRPL14;MRPL54;MRPL44;CHCHD1;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;MRPL57;MRPL11;MRPL39;MRPS36;MRPS16;MRPL17;MRPS5;MRPL19;MRPL12;MRPL43;MRPL20;MRPS2;MRPL48;OXA1L;MRPS31;MRPL16;MRPL42;GADD45GIP1;ERAL1;MRPL38;MRPL35;MRPL21;MRPL24;TUFM;MRPL53;TSFM;MRPS34;MRPL50
gsea,Regulated Necrosis R-HSA-5218859,-0.6455219160496435,-2.27454255439658,0.0,6.436288034819104e-05,0.002,20/38,22.07%,UBB;HMGB1;RPS27A;HSP90AA1;UBA52;BAX;CYCS;CDC37;IL18;CHMP4B;GSDME;STUB1;CHMP2A;CHMP6;CHMP4C;CHMP7;UBC;RRM1;CFLAR;FASN
gsea,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.6043742836089794,-2.2698319263529663,0.0,6.369934549924063e-05,0.002,29/55,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;NFKB2;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBA3;UBC
gsea,Mitochondrial Translation Termination R-HSA-5419276,-0.5393413928051364,-2.269415388274383,0.0,6.30493521778198e-05,0.002,39/82,21.13%,MRPS26;AURKAIP1;MRPL52;MRPS24;MRPL41;MRPL36;MRPL18;MRPL23;MRPS21;MRPL14;MRPL54;MRPL44;CHCHD1;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;MRPL57;MRPL11;MRPL39;MRPS36;MRPS16;MRPL17;MRPS5;MRPL19;MRPL12;MRPL43;MRPL20;MRPS2;MRPL48;OXA1L;MRPS31;MRPL16;MRPL42;GADD45GIP1;ERAL1;MRPL38;MRPL35
gsea,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.587485775078831,-2.269246729853025,0.0,6.24124900346095e-05,0.002,29/60,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.7633986374258599,-2.2683937829614043,0.0,6.17883651342634e-05,0.002,17/22,14.31%,TUBA4A;TUBB2A;TUBA1A;CCT2;CCT6A;TUBB2B;TUBB4A;TUBB4B;PFDN6;PFDN2;PFDN4;PFDN5;TUBA1B;CCT7;VBP1;CCT5;CCT8
gsea,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.5609263568344598,-2.266683158483603,0.0,6.117659914283505e-05,0.002,35/76,17.72%,UBB;RPS27A;TLE5;PSMC3;PSMB5;PSMA7;PSMC2;TLE4;UBA52;SEM1;PSMA5;PSMA4;PPP2CA;PPP2R1A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;GSK3B;PSMC1;PSME3;PSMC4;PPP2R5D;PSMB6;TLE1;PSMB7;PSMA2;UBC
gsea,Metabolism Of Polyamines R-HSA-351202,-0.6110725401549351,-2.2652466955303834,0.0,6.0576828563003334e-05,0.002,25/49,16.75%,PSMC3;PSMB5;PSMA7;OAZ1;PSMC2;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PAOX;PSME3;PSMC4;PSMB6;PSMB7;PSMA2
gsea,Antigen processing-Cross Presentation R-HSA-1236975,-0.5653989543943877,-2.2636325987157075,0.0,5.998870401384797e-05,0.002,35/75,17.72%,UBB;HMGB1;RPS27A;CALR;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;NDUFA2;SEM1;PSMA5;PSMA4;PDIA3;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;ITGAV;PSMB3;SEC61G;PSMA1;PSMC6;PSMD6;NCF2;PSMC1;PSME3;PSMC4;PSMB6;VAMP3;PSMB7;PSMA2;UBC
gsea,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.6263674405251107,-2.263095762891192,0.0,5.941188955217635e-05,0.002,24/44,16.75%,PSMC3;PSMB5;PSMA7;OAZ1;PSMC2;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2
gsea,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.569683239146957,-2.2591426621504107,0.0,7.355757754078976e-05,0.002,29/64,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.530557001646401,-2.2580367284119967,0.0,7.286363813002759e-05,0.002,39/101,17.72%,CALM1;UBB;RPS27A;PPP3CA;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;NFKB2;PSMA4;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;PSMB3;HRAS;PSMA1;PSMC6;PSMD6;UBE2V1;PSMC1;LYN;PSME3;PSMC4;PSMB6;PSMB7;PRKACB;BCL10;PSMA2;UBA3;UBC
gsea,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.6332433296041043,-2.2565500954994633,0.0,7.218266954937312e-05,0.002,23/41,16.75%,PSMC3;PSMB5;PSMA7;PSMC2;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2
gsea,ER-Phagosome Pathway R-HSA-1236974,-0.5813886237887186,-2.2563693726450564,0.0,7.151431149799003e-05,0.002,33/67,17.72%,UBB;HMGB1;RPS27A;CALR;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;NDUFA2;SEM1;PSMA5;PSMA4;PDIA3;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;SEC61G;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;VAMP3;PSMB7;PSMA2;UBC
gsea,UCH Proteinases R-HSA-5689603,-0.5436542756079816,-2.2529876676131484,0.0,7.085821689709105e-05,0.002,38/80,18.28%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;H2AC25;PSMA4;NEDD8;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;SENP8;PSMB1;PSMB3;ADRM1;PSMA1;PSMC6;PSMD6;RUVBL1;UCHL1;KDM1B;PSMC1;PSME3;PSMC4;PSMB6;SMAD7;PSMB7;HCFC1;PSMA2;YY1;UBC;FOXK1
gsea,Programmed Cell Death R-HSA-5357801,-0.49701232396286404,-2.252313892222064,0.0,7.021405128893568e-05,0.002,65/162,22.14%,UBB;HMGB1;DYNLL1;RPS27A;YWHAG;DYNLL2;YWHAH;HSP90AA1;YWHAB;PSMC3;PSMB5;PSMA7;MAGED1;YWHAE;PSMC2;UBA52;NDUFA2;SEM1;BAX;PSMA5;PSMA4;PPP3R1;CYCS;YWHAZ;CDC37;IL18;YWHAQ;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;CHMP4B;PSMB1;PSMB3;BAD;GSDME;PSMA1;PSMC6;C1QBP;STUB1;PSMD6;CHMP2A;CHMP6;PSMC1;MAPK3;PSME3;PSMC4;PSMB6;PSMB7;CHMP4C;PSMA2;NMT1;CHMP7;UBC;DFFB;UACA;MAPK1;RRM1;VIM;PSMB10;BBC3;CFLAR;FASN;PSMD5
gsea,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.5693811747752076,-2.249718672051192,0.0,6.958149226831464e-05,0.002,29/63,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.5750350109642876,-2.249160181882013,0.0,6.896022894449039e-05,0.002,29/61,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,PCP/CE Pathway R-HSA-4086400,-0.5497354993667991,-2.248011931760282,0.0,6.83499614317073e-05,0.002,40/79,22.14%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;CLTA;PSMC2;UBA52;AP2M1;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PFN1;FZD2;PSMB3;PSMA1;PSMC6;PSMD6;FZD4;PSMC1;AP2B1;PSME3;PSMC4;PSMB6;PSMB7;CLTB;PSMA2;AP2S1;UBC;AP2A2;RHOA;PSMB10;VANGL2;PSMD5
gsea,Chaperone Mediated Autophagy R-HSA-9613829,-0.8162020628409048,-2.2454919895875634,0.0,6.775040036651688e-05,0.002,8/16,3.17%,HSP90AB1;UBB;EEF1A1;RPS27A;HSPA8;HSP90AA1;PARK7;UBA52
gsea,Mitochondrial Translation R-HSA-5368287,-0.5251158652555853,-2.2400202338497865,0.0,6.71612664502863e-05,0.002,47/88,26.62%,MRPS26;AURKAIP1;MRPL52;MRPS24;MRPL41;MRPL36;MRPL18;MRPL23;MRPS21;MRPL14;MRPL54;MRPL44;CHCHD1;MRPL9;MRPL30;MRPL33;MRPS14;MRPS33;MRPL57;MRPL11;MRPL39;MRPS36;MRPS16;MRPL17;MRPS5;MRPL19;MRPL12;MTIF3;MRPL43;MRPL20;MRPS2;MRPL48;OXA1L;MRPS31;MRPL16;MRPL42;GADD45GIP1;ERAL1;MRPL38;MRPL35;MRPL21;MRPL24;TUFM;MRPL53;TSFM;MRPS34;MRPL50
gsea,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.7661160672372664,2.2378470577252045,0.0,0.0014039724160713547,0.005,10/17,12.58%,PRKG1;PDE2A;GUCY1A2;PDE1A;PDE9A;PDE10A;KCNMA1;KCNMB4;PRKG2;PDE11A
gsea,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.7597453777679211,-2.236676290911362,0.0,6.658229001537004e-05,0.002,16/21,14.31%,TUBA4A;TUBB2A;TUBA1A;CCT2;CCT6A;TUBB2B;TUBB4A;TUBB4B;PFDN6;PFDN2;PFDN4;PFDN5;CCT7;VBP1;CCT5;CCT8
gsea,HSF1 Activation R-HSA-3371511,-0.7331721180193713,-2.230968083908167,0.0,6.601321061352927e-05,0.002,9/24,5.34%,HSP90AB1;UBB;EEF1A1;HSBP1;HSP90AA1;YWHAE;DNAJB6;MRPL18;PTGES3
gsea,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.5497373745893891,-2.2205783100640843,0.0,6.545377662527902e-05,0.002,34/70,19.97%,UBB;RPS27A;RASGRP1;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;UBE2V1;PSMC1;LYN;PSME3;PSMC4;PSMB6;PSMB7;BCL10;PSMA2;UBC;RASGRP2;NFKBIA
gsea,Interleukin-1 Signaling R-HSA-9020702,-0.5185014102917551,-2.220143792232044,0.0,6.490374488893214e-05,0.002,41/97,19.97%,UBB;HMGB1;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SQSTM1;SEM1;PSMA5;NFKB2;PSMA4;USP14;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;UBE2N;PSMB1;PSMB3;NFKBIB;PSMA1;PSMC6;PSMD6;UBE2V1;PSMC1;PSME3;PSMC4;PSMB6;MAP3K8;PSMB7;IRAK4;PSMA2;UBC;NKIRAS1;IL1R2;PELI2;NFKBIA
gsea,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.5379528449279445,-2.217497634195056,0.0,6.436288034819104e-05,0.002,40/81,25.33%,UBB;RPS27A;H2AZ1;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;H2BC4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;H2AJ;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC;H2AX;PSMB10;PSMD5;MCM6;ORC4;PSMD11;CDC26;CDC16
gsea,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.539289770897072,-2.2173830703350346,0.0,6.383095571721425e-05,0.002,38/77,25.33%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC;PSMB10;PSMD5;MCM6;ORC4;PSMD11;CDC26;SKP1;CDC16
gsea,ABC-family Proteins Mediated Transport R-HSA-382556,-0.5280869192264576,-2.213951085654922,0.0,7.596930139458615e-05,0.003,36/82,19.70%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;EIF2S2;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;RNF5;PSMC1;PSME3;PSMC4;PSMB6;ABCB10;RNF185;PSMB7;PSMA2;UBC;ABCA6;PEX19;VCP;OS9;ABCB6
gsea,Host Interactions Of HIV Factors R-HSA-162909,-0.5130321840976689,-2.2130498291821863,0.0,0.00010046888639717627,0.005,49/114,17.85%,UBB;SLC25A4;PPIA;RPS27A;RAN;PSMC3;PSMB5;PSMA7;ELOB;SLC25A5;BANF1;PSMC2;PSIP1;UBA52;AP2M1;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;NPM1;RANBP1;PSMA1;PSMC6;NUP50;PSMD6;PSMC1;AP2B1;NUP37;PSME3;PSMC4;NUP205;SEH1L;PSMB6;SEC13;NUP107;PSMB7;HCK;PSMA2;CD247;AP2S1;UBC;DOCK2
gsea,Late Endosomal Microautophagy R-HSA-9615710,-0.6737819695129925,-2.212714864003335,0.0,9.965865344236033e-05,0.005,14/26,17.72%,UBB;RPS27A;HSPA8;PARK7;UBA52;VPS28;CHMP4B;CHMP2A;TSG101;CHMP6;UBAP1;CHMP4C;CHMP7;UBC
gsea,DNA Replication Pre-Initiation R-HSA-69002,-0.5215476129027079,-2.2104873794957474,0.0,9.886138421482144e-05,0.005,34/93,17.72%,UBB;RPS27A;H2AZ1;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;H2BC4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;H2AJ;PSMA1;PSMC6;PSMD6;RPA3;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;CDC45;PSMB7;PSMA2;UBC
gsea,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.5608251536888226,-2.2080912270994815,0.0,9.730451202246206e-05,0.005,29/64,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.5608251536888226,-2.2080912270994815,0.0,9.730451202246206e-05,0.005,29/64,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.5628834904384346,-2.206575078377515,0.0,9.579591493684249e-05,0.005,29/63,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.5628834904384346,-2.206575078377515,0.0,9.579591493684249e-05,0.005,29/63,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,G1/S Transition R-HSA-69206,-0.5041476333700601,-2.1987843920077514,0.0,0.00010694140119391743,0.006,44/105,25.29%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PPP2CA;PPP2R1A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PCNA;CDK4;DHFR;PSMA1;PSMC6;PSMD6;RPA3;PSMC1;PSME3;PSMC4;PSMB6;CDKN1B;CDC45;PSMB7;PSMA2;UBC;E2F4;PSMB10;PSMD5;MCM6;ORC4;AKT1;PSMD11;LIN9;SKP1
gsea,Platelet Degranulation R-HSA-114608,-0.5179454771007298,-2.1949748731738823,0.0,0.00010612505461991806,0.006,34/79,22.64%,CALM1;PPIA;TMSB4X;TUBA4A;TTR;APLP2;FAM3C;MANF;TIMP3;VEGFC;SOD1;PDGFA;PFN1;OLA1;VTI1B;CLU;SCCPDH;VEGFB;MAGED2;TAGLN2;SPARC;CD63;VCL;CAP1;LAMP2;CHID1;ITGA2B;TLN1;SCG3;PDGFB;SELENOP;ENDOD1;ITIH3;TGFB2
gsea,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.5621054678953562,-2.1932049304310093,0.0,0.00010532107693340354,0.006,30/62,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;CSNK2B;STUB1;PSMD6;PSMC1;MKRN1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Protein Methylation R-HSA-8876725,-0.75731795552768,-2.187512619558665,0.0,0.00011614354348545751,0.007,5/17,3.47%,CALM1;EEF1A1;RPS2;HSPA8;EEF2
gsea,Apoptosis R-HSA-109581,-0.4875802493463523,-2.184805035652694,0.0,0.00011527680062362574,0.007,55/142,22.14%,UBB;HMGB1;DYNLL1;RPS27A;YWHAG;DYNLL2;YWHAH;YWHAB;PSMC3;PSMB5;PSMA7;MAGED1;YWHAE;PSMC2;UBA52;NDUFA2;SEM1;BAX;PSMA5;PSMA4;PPP3R1;CYCS;YWHAZ;YWHAQ;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;BAD;GSDME;PSMA1;PSMC6;C1QBP;PSMD6;PSMC1;MAPK3;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;NMT1;UBC;DFFB;UACA;MAPK1;VIM;PSMB10;BBC3;CFLAR;FASN;PSMD5
gsea,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.544460291310854,-2.180777889706613,0.0,0.00013730747807614088,0.008,36/72,25.29%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;CDK4;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;CDKN1B;PSMB7;PSMA2;UBC;E2F4;PSMB10;PSMD5;AKT1;PSMD11;LIN9;SKP1
gsea,Interleukin-1 Family Signaling R-HSA-446652,-0.4798739089402113,-2.1690814363794124,0.0,0.00015901417497788374,0.01,44/116,20.26%,UBB;HMGB1;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SQSTM1;SEM1;PSMA5;NFKB2;PSMA4;IL18;USP14;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;UBE2N;PSMB1;PSMB3;NFKBIB;PSMA1;PSMC6;PSMD6;IL1RAPL1;UBE2V1;PSMC1;PSME3;PSMC4;PSMB6;MAP3K8;PSMB7;IRAK4;PSMA2;UBC;NKIRAS1;IL1R2;PELI2;NFKBIA;TBK1
gsea,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.5366454468646464,-2.165368216673107,0.0,0.00019167923490556166,0.012,36/74,25.29%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;CDK4;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;CDKN1B;PSMB7;PSMA2;UBC;E2F4;PSMB10;PSMD5;AKT1;PSMD11;LIN9;SKP1
gsea,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.5428749807240263,-2.1647829000511583,0.0,0.00019029025494247785,0.012,29/68,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Synthesis Of DNA R-HSA-69239,-0.49981428241601233,-2.163220429134729,0.0,0.00020003427561452182,0.013,45/104,25.33%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;UBE2S;PSMB3;PCNA;PSMA1;PSMC6;PSMD6;RPA3;GINS2;ANAPC11;PSMC1;PSME3;PSMC4;GINS4;PSMB6;CDC45;PSMB7;PSMA2;UBC;RFC3;LRIG1;PSMB10;PSMD5;MCM6;ORC4;PSMD11;CDC26;SKP1;CDC16
gsea,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.53324927483775,-2.1630592383366145,0.0,0.00019860545936013237,0.013,29/72,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;ANAPC11;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,Macroautophagy R-HSA-1632852,-0.4942698222530118,-2.1621436188126126,0.0,0.0001971969100029683,0.013,31/106,11.48%,UBB;GABARAPL1;DYNLL1;RPS27A;DYNLL2;HSPA8;HSP90AA1;PARK7;VDAC1;LAMTOR2;UBA52;TOMM5;GABARAPL2;RHEB;SQSTM1;GABARAP;RRAGA;TOMM7;MAP1LC3B;LAMTOR3;CHMP4B;UBE2N;ATG12;PINK1;RRAGD;TOMM20;CSNK2B;CHMP2A;UBE2V1;CHMP6;MAP1LC3A
gsea,DNA Replication R-HSA-69306,-0.4884900552426651,-2.160758484187321,0.0,0.0001958081993691446,0.013,49/117,25.33%,UBB;RPS27A;H2AZ1;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;H2BC4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;UBE2S;PSMB3;PCNA;H2AJ;PSMA1;PSMC6;PSMD6;RPA3;GINS2;ANAPC11;PSMC1;PSME3;PSMC4;GINS4;PSMB6;CDC45;PSMB7;PSMA2;UBC;RFC3;H2AX;LRIG1;PSMB10;PSMD5;MCM6;ORC4;PSMD11;CDC26;SKP1;CDC16
gsea,Cytoprotection By HMOX1 R-HSA-9707564,-0.5752644136027222,-2.1454251133098303,0.0,0.00025925188168222403,0.016,19/45,13.64%,COX6C;COX8A;COX4I1;COX5B;COX7C;COX6B1;COX6A1;COX7A2L;COX5A;COX7B;CYCS;SIN3B;TBL1XR1;COX14;COX20;HMOX2;SCO2;COX19;TBL1X
gsea,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.7680257369945633,-2.1449621296429906,0.0,0.00026817866811746266,0.017,8/15,8.39%,YWHAG;YWHAH;YWHAB;YWHAE;PPP3R1;YWHAZ;YWHAQ;BAD
gsea,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.5347005116632169,-2.143527417026454,0.0,0.0002663291600614802,0.017,20/59,14.82%,RPS2;RPS7;RPS6;RPS14;RPS9;THUMPD1;PDCD11;TRMT112;SNU13;NOP10;EMG1;NOC4L;GAR1;UTP3;FCF1;DKC1;UTP11;PNO1;NHP2;NOL11
gsea,Selective Autophagy R-HSA-9663891,-0.5498474181978921,-2.1391564933515497,0.0,0.0002750851872415836,0.018,20/56,11.48%,UBB;DYNLL1;RPS27A;DYNLL2;HSPA8;HSP90AA1;PARK7;VDAC1;UBA52;TOMM5;SQSTM1;TOMM7;MAP1LC3B;UBE2N;ATG12;PINK1;TOMM20;CSNK2B;UBE2V1;MAP1LC3A
gsea,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.5132626340125406,-2.134263320749542,0.0,0.0002837220848001891,0.019,34/73,17.77%,UBB;RPS27A;JUN;PSMC3;PSMB5;PSMA7;CDC42;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;SEPTIN7;PSMA1;PSMC6;PSMD6;PSMC1;MAPK6;PSME3;PSMC4;PSMB6;PSMB7;PRKACB;PSMA2;CCND3;UBC;MAPKAPK5
gsea,Plasma Lipoprotein Clearance R-HSA-8964043,-0.6899894446353269,-2.1309258253189665,0.0,0.00028180504368667433,0.019,7/22,3.29%,UBB;APOE;RPS27A;NCEH1;CLTA;UBA52;AP2M1
gsea,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.5496017384918644,-2.1306111247018658,0.0,0.00027991373466864294,0.019,29/60,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;NFKBIB;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;BCL10;PSMA2;UBC
gsea,Regulation Of RAS By GAPs R-HSA-5658442,-0.5511693874235457,-2.1283539747045017,0.0,0.00027804764310418526,0.019,30/59,17.72%,UBB;RPS27A;PSMC3;RASAL2;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;HRAS;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBC
gsea,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.5440103400334246,-2.1248269520999674,0.0,0.0002966659915386819,0.021,31/63,19.27%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;NFKB2;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;PSMB7;PSMA2;UBA3;UBC;CD27;TNFSF12
gsea,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.6908331392718967,-2.1239743350095273,0.0,0.00029471424159434843,0.021,12/22,16.61%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6V1E1;NCF2;ATP6V1C1;ATP6V1B2;ATP6V1G1
gsea,G2/M Transition R-HSA-69275,-0.46732985796112975,-2.1223699163606358,0.0,0.0003028841428150166,0.022,37/155,10.09%,HSP90AB1;UBB;TUBA4A;DYNLL1;RPS27A;YWHAG;TUBA1A;HSP90AA1;PSMC3;PSMB5;NME7;PSMA7;YWHAE;PSMC2;UBA52;CETN2;SEM1;CSNK1E;PSMA5;PSMA4;PPP2CA;PPP2R1A;PAFAH1B1;TUBB4A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;TUBB4B;PSMB1;DCTN3;PSMB3;PSMA1;PSMC6;PSMD6
gsea,Mitotic G2-G2/M Phases R-HSA-453274,-0.466344174741546,-2.121449455992862,0.0,0.0003009173626668672,0.022,37/156,10.09%,HSP90AB1;UBB;TUBA4A;DYNLL1;RPS27A;YWHAG;TUBA1A;HSP90AA1;PSMC3;PSMB5;NME7;PSMA7;YWHAE;PSMC2;UBA52;CETN2;SEM1;CSNK1E;PSMA5;PSMA4;PPP2CA;PPP2R1A;PAFAH1B1;TUBB4A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;TUBB4B;PSMB1;DCTN3;PSMB3;PSMA1;PSMC6;PSMD6
gsea,DARPP-32 Events R-HSA-180024,-0.6816150095857317,-2.1213581136903676,0.0,0.0002989759603270809,0.022,11/22,16.04%,CALM1;PPP3CA;PPP3R1;PPP1CA;PPP2CA;PPP3CB;PPP2R1A;PRKAR1B;PPP1R1B;PPP2R5D;PRKACB
gsea,Mitotic Anaphase R-HSA-68882,-0.4423205213316129,-2.1155862372259286,0.0,0.0003762753004971168,0.026,63/186,17.72%,UBB;TUBA4A;DYNLL1;TUBB2A;RPS27A;DYNLL2;TUBA1A;RPS27;RAN;PSMC3;PSMB5;PSMA7;BANF1;PSMC2;UBA52;SEM1;PSMA5;PSMA4;SMC1A;TUBB2B;PPP2CA;PPP2R1A;PAFAH1B1;TUBB4A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;CHMP4B;TUBB4B;PSMB1;UBE2S;PSMB3;RAD21;EMD;PSMA1;PSMC6;PSMD6;CHMP2A;ZWINT;TUBA1B;CHMP6;ANAPC11;PSMC1;NUP37;PSME3;PSMC4;NUP205;PPP2R5D;VPS4A;SEH1L;PSMB6;SEC13;NUDC;NUP107;PSMB7;PPP1CC;CENPP;CHMP4C;PSMA2;CHMP7;UBC
gsea,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.4418488714902893,-2.113058753118273,0.0,0.0004132342891145004,0.027,63/187,17.72%,UBB;TUBA4A;DYNLL1;TUBB2A;RPS27A;DYNLL2;TUBA1A;RPS27;RAN;PSMC3;PSMB5;PSMA7;BANF1;PSMC2;UBA52;SEM1;PSMA5;PSMA4;SMC1A;TUBB2B;PPP2CA;PPP2R1A;PAFAH1B1;TUBB4A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;CHMP4B;TUBB4B;PSMB1;UBE2S;PSMB3;RAD21;EMD;PSMA1;PSMC6;PSMD6;CHMP2A;ZWINT;TUBA1B;CHMP6;ANAPC11;PSMC1;NUP37;PSME3;PSMC4;NUP205;PPP2R5D;VPS4A;SEH1L;PSMB6;SEC13;NUDC;NUP107;PSMB7;PPP1CC;CENPP;CHMP4C;PSMA2;CHMP7;UBC
gsea,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.7699629877477377,-2.1113831718079834,0.0,0.0004301721623271502,0.027,12/16,14.31%,TUBA4A;TUBB2A;TUBA1A;CCT2;CCT6A;TUBB2B;TUBB4A;TUBB4B;TUBA1B;CCT7;CCT5;CCT8
gsea,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.49332210875340055,-2.11032790712404,0.0,0.0004274666770294952,0.027,34/83,22.64%,CALM1;PPIA;TMSB4X;TUBA4A;TTR;APLP2;FAM3C;MANF;TIMP3;VEGFC;SOD1;PDGFA;PFN1;OLA1;VTI1B;CLU;SCCPDH;VEGFB;MAGED2;TAGLN2;SPARC;CD63;VCL;CAP1;LAMP2;CHID1;ITGA2B;TLN1;SCG3;PDGFB;SELENOP;ENDOD1;ITIH3;TGFB2
gsea,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.5889896205351087,-2.1098427014701397,0.0,0.0004247950102980608,0.027,22/44,24.69%,DYNLL1;YWHAG;DYNLL2;YWHAH;YWHAB;YWHAE;BAX;PPP3R1;CYCS;YWHAZ;YWHAQ;BAD;GSDME;C1QBP;MAPK3;NMT1;UACA;MAPK1;BBC3;DIABLO;SEPTIN4;AKT1
gsea,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.5897577490836485,-2.1076821841168965,0.0,0.0004317509986089833,0.027,18/37,23.39%,UBB;PEBP1;RPS27A;YWHAB;UBA52;DUSP7;PPP2CA;PPP2R1A;HRAS;MAPK3;PPP2R5D;DUSP8;UBC;DUSP5;MAPK1;PPP2R5A;NRAS;DUSP16
gsea,HIV Infection R-HSA-162906,-0.4403941921324012,-2.107405342088596,0.0,0.0004290858689879402,0.027,91/205,25.29%,UBB;SLC25A4;PPIA;RPS27A;RAN;PSMC3;PSMB5;PSMA7;ELOB;SLC25A5;BANF1;PSMC2;PSIP1;UBA52;AP2M1;SEM1;PSMA5;PSMA4;POLR2F;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;VPS28;RBX1;CHMP4B;POLR2I;PSMB1;PSMB3;POLR2G;TAF10;NPM1;POLR2E;RANBP1;TCEA1;PSMA1;PSMC6;TAF11;NUP50;PSMD6;CHMP2A;TSG101;POLR2C;CHMP6;GTF2H5;PSMC1;AP2B1;NUP37;PSME3;PSMC4;NUP205;VPS4A;SEH1L;PSMB6;GTF2B;SEC13;UBAP1;NUP107;PSMB7;HCK;CHMP4C;PSMA2;NMT1;CD247;AP2S1;CHMP7;UBC;DOCK2;POLR2J;TAF5;ELOC;LRIG1;POLR2B;AP2A2;TAF7;PSMB10;NCBP2;PSMD5;NUP35;XRCC6;ERCC3;POLR2L;HMGA1;TAF7L;SSRP1;PSMD11;B2M;GTF2H4;NUP62;SKP1
gsea,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.48779314281760355,-2.104669267375121,0.0,0.0004548836697000986,0.028,39/111,16.75%,CALM1;UBB;RPS27A;PPP3CA;JUN;RASGRP1;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;PSMB3;HRAS;PSMA1;PSMC6;PSMD6;UBE2V1;PSMC1;LYN;PIK3R1;MAPK3;PSME3;PSMC4;PSMB6;PSMB7;BCL10;PSMA2
gsea,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.4705590963549536,-2.0990852416912604,0.0,0.0004897858211862342,0.029,37/117,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PPP2CA;PPP2R1A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PCNA;CDK4;DHFR;PSMA1;PSMC6;PSMD6;RPA3;PSMC1;LYN;PSME3;PSMC4;PSMB6;CDKN1B;CDC45;PSMB7;PSMA2;CCND3;UBC
gsea,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.6474699672902419,-2.096294698476319,0.0,0.0005055411692803369,0.031,6/26,7.56%,CALM1;HSP90AB1;VAMP2;HSP90AA1;EEF2;SNAP25
gsea,Neutrophil Degranulation R-HSA-6798695,-0.43101817225833644,-2.095607001629697,0.0,0.0005024957405497325,0.031,90/291,16.75%,FTH1;HSP90AB1;ATP6V0C;EEF1A1;HMGB1;PPIA;TTR;DYNLL1;RAB3A;ATP6V1D;CST3;PDAP1;HSPA8;HSP90AA1;PGRMC1;PRDX5;SRP14;PSMC3;PKM;RAP2B;ARL8A;NME2;LAMTOR2;ALDOC;PSMC2;ARPC5;EEF2;NDUFA2;CCT2;PSMA5;COMMD3;VAPA;CTSB;CD47;GSTP1;RAB14;RAB6A;LAMTOR3;ARSA;ACTR2;PSMD2;NIT2;LAMP1;PSMD7;ACTR1B;PDXK;TUBB4B;PSMB1;NDUFC2;DDOST;SNAP25;ITGAV;RAB24;ATP6AP2;FUCA1;APRT;ACTR10;RAB18;CSNK2B;PAFAH1B2;PSMD6;HMOX2;COTL1;AGA;YPEL5;RAB31;CSTB;PFKL;TRAPPC1;CYSTM1;CD63;ACLY;RAP1A;VCL;SURF4;GUSB;ALAD;CYB5R3;CCT8;VAT1;CPPED1;FAF2;SNAP29;CAP1;PSMB7;LAMP2;RCAN1;IMPDH2;CTSH;PSMA2
gsea,Hedgehog On State R-HSA-5632684,-0.5099643089357554,-2.094152242214414,0.0,0.000517986294538735,0.032,30/75,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;HHIP;PSMA1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;PSMB6;GAS8;PSMB7;PSMA2;UBC
gsea,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.5531758143648486,-2.0917936735006766,0.0,0.0005332924371707257,0.033,21/47,20.14%,IDH3B;MDH2;VDAC1;BSG;GLO1;DLAT;LDHA;HAGH;LDHB;IDH3A;SUCLG1;SDHD;SDHB;LDLR;SDHA;LDHD;SLC16A1;FAHD1;MPC2;IDH3G;IDH2
gsea,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.5125468672197723,-2.0916223884551894,0.0,0.0005301368606194196,0.033,27/77,9.50%,YWHAG;COX6C;YWHAH;YWHAB;COX8A;PRDX5;COX4I1;COX5B;COX7C;SESN1;COX6B1;COX6A1;COX7A2L;YWHAE;LAMTOR2;COX5A;RHEB;RRAGA;COX7B;CYCS;YWHAZ;YWHAQ;LAMTOR3;RRAGD;COX14;PRDX1;COX20
gsea,Budding And Maturation Of HIV Virion R-HSA-162588,-0.6249962161487576,-2.088168676856439,0.0,0.0005542779813514805,0.034,14/27,17.72%,UBB;PPIA;RPS27A;UBA52;VPS28;CHMP4B;CHMP2A;TSG101;CHMP6;VPS4A;UBAP1;CHMP4C;CHMP7;UBC
gsea,Chaperonin-mediated Protein Folding R-HSA-390466,-0.5039634951245497,-2.080052159397832,0.0,0.0006233036833719553,0.038,28/70,14.31%,TUBA4A;TUBB2A;TUBA1A;GNB2;GNG2;CCT2;CCT6A;TUBB2B;TUBB4A;GNG13;TUBB4B;FBXW2;PFDN6;PFDN2;GNG10;PDCL;PFDN4;CSNK2B;GNG3;PFDN5;FBXO6;TUBA1B;CCT7;FKBP9;GNA11;VBP1;CCT5;CCT8
gsea,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.6125753896436217,-2.0775710671925793,0.0,0.0006286606917730288,0.039,14/28,17.72%,UBB;RPS27A;UBA52;VPS28;CHMP4B;CHMP2A;TSG101;CHMP6;STAM2;VPS4A;UBAP1;CHMP4C;CHMP7;UBC
gsea,Protein-protein Interactions At Synapses R-HSA-6794362,0.48947549401975715,2.0773633774006464,0.0,0.008845026221249535,0.042,22/84,8.74%,DLGAP2;GRIA3;PTPRS;DLGAP1;GRIN2A;NLGN1;SHANK2;GRIA1;GRIA4;IL1RAPL2;NTRK3;PTPRD;EPB41L1;PTPRF;SHANK3;CASK;DLGAP3;SHANK1;MPP3;LRFN2;LRFN1;STX1A
gsea,Downstream TCR Signaling R-HSA-202424,-0.5091181643750555,-2.0625852440727557,0.0,0.0007053874054345099,0.044,32/75,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;UBE2V1;PSMC1;PIK3R1;PSME3;PSMC4;PSMB6;PSMB7;BCL10;PSMA2;CD247;UBC
gsea,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.5931916996881473,-2.0608645106340635,0.0,0.0007279663708347124,0.046,11/32,9.99%,DYNLL1;DYNLL2;CAPZA2;RAB6B;DCTN6;PAFAH1B1;RAB6A;DCTN3;ACTR10;RAB18;PAFAH1B2
gsea,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.6436747240819176,-2.0510253283955593,0.0,0.0008032487467454242,0.048,11/23,19.81%,HSP90AB1;ACTG1;HSP90AA1;CCT2;CCT6A;CDC37;TWF1;CCT7;HNRNPC;TXNL1;DDX39B
gsea,Insulin Receptor Recycling R-HSA-77387,-0.6870253534878394,-2.046802883187812,0.0,0.0008250151026449943,0.05,11/20,16.61%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6V1E1;ATP6V1C1;ATP6V1B2;ATP6V1G1
gsea,MET Promotes Cell Motility R-HSA-8875878,0.6342119899816414,2.045875134517678,0.0,0.010445554775570881,0.064,8/21,7.76%,DOCK7;LAMB1;TNS3;LAMC1;SOS1;PTK2;LAMB3;ITGA3
gsea,Protein Folding R-HSA-391251,-0.4853141284330481,-2.0389029350887986,0.0,0.0009163528727539063,0.057,30/76,14.31%,TUBA4A;TUBB2A;TUBA1A;GNB2;GNG2;CCT2;CCT6A;TUBB2B;TUBB4A;GNG13;TUBB4B;FBXW2;PFDN6;TBCC;PFDN2;GNG10;PDCL;PFDN4;CSNK2B;GNG3;PFDN5;FBXO6;TUBA1B;TBCA;CCT7;FKBP9;GNA11;VBP1;CCT5;CCT8
gsea,Ub-specific Processing Proteases R-HSA-5689880,-0.4413421584016755,-2.0247741643694863,0.0,0.0010413769404651134,0.068,49/143,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;VDAC1;PSMC2;UBA52;USP2;SEM1;PSMA5;H2AC25;PSMA4;H2BC4;USP14;MAT2B;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;USP22;PSMB3;TAF10;SNX3;ADRM1;PSMA1;TOMM20;PSMC6;OTUB1;PSMD6;RUVBL1;VDAC2;PSMC1;FOXO4;DDB2;PSME3;STAM2;PSMC4;TADA2B;PSMB6;MUL1;SMAD2;SMAD7;PSMB7;PSMA2;PTRH2;UBC
gsea,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.5015074251967035,-2.0210444270396457,0.0,0.0011218557915438883,0.075,23/60,17.53%,TUBA4A;TUBB2A;TUBA1A;RAN;BANF1;TUBB2B;PPP2CA;PPP2R1A;TUBB4A;CHMP4B;TUBB4B;EMD;CHMP2A;TUBA1B;CHMP6;NUP37;NUP205;VPS4A;SEH1L;SEC13;NUP107;CHMP4C;CHMP7
gsea,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.6719388023510862,-2.0184885324218196,0.002070393374741201,0.0011671135636471975,0.079,12/21,11.48%,UBB;RPS27A;VDAC1;UBA52;TOMM5;SQSTM1;TOMM7;MAP1LC3B;ATG12;PINK1;TOMM20;MAP1LC3A
gsea,Glucagon-type Ligand Receptors R-HSA-420092,-0.6728135189857413,-2.0165304233707415,0.0,0.0011862683361412447,0.082,7/17,9.69%,GNAS;GLP2R;GNB2;GNG2;GNG13;GNG10;GNG3
gsea,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.6852767713484962,-2.0159902357205626,0.0,0.0011797503782503588,0.082,13/19,17.53%,TUBA4A;TUBB2A;TUBA1A;TUBB2B;TUBB4A;CHMP4B;TUBB4B;CHMP2A;TUBA1B;CHMP6;VPS4A;CHMP4C;CHMP7
gsea,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.4772323890940424,-2.0144585389920358,0.0,0.0011901857218485161,0.082,16/80,7.31%,UBB;TUBA4A;DYNLL1;RPS27A;YWHAG;TUBA1A;HSP90AA1;YWHAE;UBA52;CETN2;CSNK1E;PPP2R1A;PAFAH1B1;TUBB4A;TUBB4B;DCTN3
gsea,Mitophagy R-HSA-5205647,-0.6169225913219362,-2.0103704309850636,0.0,0.0012256931127177248,0.086,17/27,20.68%,UBB;RPS27A;VDAC1;UBA52;TOMM5;SQSTM1;TOMM7;MAP1LC3B;ATG12;PINK1;TOMM20;CSNK2B;MAP1LC3A;UBC;TOMM22;TOMM6;FUNDC1
gsea,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.6252138907251537,-2.004644863415418,0.0,0.0012858659771184545,0.089,10/23,22.07%,UBB;RPS27A;HSP90AA1;UBA52;CDC37;STUB1;UBC;RRM1;CFLAR;FASN
gsea,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.6718092645014129,-2.001241681557977,0.0,0.0013287820458981374,0.091,8/17,12.01%,GNB2;GNG2;P2RY12;GNG13;GNG10;GNG3;GNAI1;GNAI2
gsea,TCR Signaling R-HSA-202403,-0.4747036724723781,-1.9991264478331414,0.0,0.0013712391192898027,0.093,34/90,17.72%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;NCK1;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;UBE2V1;PSMC1;PIK3R1;PSME3;PSMC4;PSMB6;VASP;PSMB7;BCL10;PSMA2;CD247;UBC
gsea,HSF1-dependent Transactivation R-HSA-3371571,-0.5958334975298457,-1.9987322114341481,0.0018975332068311196,0.0013639452941871973,0.093,14/30,16.59%,HSP90AB1;UBB;HSBP1;HSPA8;HSP90AA1;DNAJB6;HSPA2;MRPL18;PTGES3;CRYAB;HSPH1;AKT1S1;CAMK2B;FKBP4
gsea,S Phase R-HSA-69242,-0.4334454544738735,-1.9987102802321497,0.0,0.0013567286524190111,0.093,58/139,28.24%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;SMC1A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;UBE2S;PSMB3;PCNA;CDK4;RAD21;PSMA1;PSMC6;PSMD6;RPA3;GINS2;ANAPC11;GSK3B;PSMC1;PSME3;PSMC4;GINS4;PSMB6;CDKN1B;CDC45;PSMB7;PSMA2;UBC;RFC3;E2F4;LRIG1;PSMB10;PSMD5;MCM6;ORC4;AKT1;PSMD11;CDC26;LIN9;SKP1;CDC16;PSMD10;POLD4;SMC3;POLD2;AKT3
gsea,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.6383384730599251,-1.9933367157439403,0.0,0.0014634086479167645,0.102,6/21,9.90%,UBB;RPS27A;HSP90AA1;UBA52;CDC37;STUB1
gsea,Cellular Response To Heat Stress R-HSA-3371556,-0.478169357494415,-1.993164530478715,0.0,0.0014557468225350014,0.102,32/87,16.88%,HSP90AB1;UBB;EEF1A1;HSBP1;HSPA8;HSP90AA1;YWHAE;DNAJB6;HSPA2;MRPL18;ST13;PTGES3;BAG1;HIKESHI;BAG5;NUP50;BAG4;RPA3;GSK3B;CRYAB;HSPH1;NUP37;MAPK3;NUP205;SEH1L;SEC13;NUP107;AKT1S1;HSPA9;CAMK2B;FKBP4;RPS19BP1
gsea,Transferrin Endocytosis And Recycling R-HSA-917977,-0.6260433075005022,-1.9875524658804278,0.0,0.0015688452084871567,0.11,11/24,16.61%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP6V0B;ATP6V1F;ATP6V1E1;ATP6V1C1;ATP6V1B2;ATP6V1G1
gsea,Cell Cycle Checkpoints R-HSA-69620,-0.41242744959077077,-1.9870613641280719,0.0,0.0015607164768369642,0.11,72/199,23.25%,UBB;DYNLL1;RPS27A;YWHAG;DYNLL2;YWHAH;YWHAB;RPS27;PSMC3;PSMB5;PSMA7;YWHAE;PSMC2;UBA52;SEM1;PSMA5;PSMA4;YWHAZ;H2BC4;PPP2CA;PPP2R1A;YWHAQ;PAFAH1B1;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;UBE2N;PSMB1;UBE2S;PSMB3;PSMA1;PSMC6;PSMD6;RPA3;PHF20;ZWINT;ANAPC11;RNF168;PSMC1;BABAM2;NUP37;PSME3;PSMC4;PPP2R5D;SEH1L;PSMB6;SEC13;CDKN1B;NUDC;NUP107;CDC45;PSMB7;PPP1CC;CENPP;PSMA2;UBC;RFC3;H2AX;UIMC1;PPP2R5A;RAD50;ITGB3BP;PSMB10;RCC2;RAD9B;PSMD5;MCM6;RBBP8;ORC4;NDE1
gsea,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.5323313936772215,-1.9837541536027774,0.0,0.0015685963829188002,0.111,16/41,17.72%,UBB;APOE;RPS27A;NCEH1;CLTA;UBA52;AP2M1;LCAT;P4HB;AP2B1;LDLR;PLTP;ANGPTL3;PRKACB;AP2S1;UBC
gsea,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.5754160139790093,1.981958745998322,0.0020833333333333333,0.015303299335177769,0.125,8/30,10.90%,TJP2;ROCK1;SATB1;MAPT;TJP1;SPTAN1;PTK2;STK26
gsea,Separation Of Sister Chromatids R-HSA-2467813,-0.42435185895897926,-1.9707722900779792,0.0,0.0017744351012916667,0.126,45/139,16.75%,UBB;DYNLL1;RPS27A;DYNLL2;RPS27;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;SMC1A;PPP2CA;PPP2R1A;PAFAH1B1;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;UBE2S;PSMB3;RAD21;PSMA1;PSMC6;PSMD6;ZWINT;ANAPC11;PSMC1;NUP37;PSME3;PSMC4;PPP2R5D;SEH1L;PSMB6;SEC13;NUDC;NUP107;PSMB7;PPP1CC;CENPP;PSMA2
gsea,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.44623260576106466,-1.9693937079979853,0.0,0.0017969065370678642,0.13,44/119,17.72%,CALM1;UBB;RPS27A;PPP3CA;PSMC3;PSMB5;PSMA7;GNB2;CLTA;GNG2;PSMC2;UBA52;AP2M1;SEM1;PSMA5;PSMA4;PPP3R1;PPP3CB;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;GNG13;PSMB1;PFN1;FZD2;PSMB3;GNG10;PSMA1;PSMC6;GNG3;PSMD6;FZD4;PSMC1;AP2B1;PSME3;PSMC4;PSMB6;PSMB7;CLTB;PSMA2;AP2S1;UBC
gsea,NRAGE Signals Death Thru JNK R-HSA-193648,0.522327037996242,1.9651752030260239,0.0,0.01612562603601956,0.153,16/46,10.47%,KALRN;PLEKHG5;TRIO;FGD4;ABR;ITSN1;ARHGEF33;RASGRF2;SOS1;TIAM1;PRPF38B;FGD1;ARHGEF17;ARHGEF7;ARHGEF18;ARHGEF3
gsea,Aggrephagy R-HSA-9646399,-0.6158081851805955,-1.9623641474458495,0.001968503937007874,0.001913243793497496,0.141,8/22,7.06%,UBB;DYNLL1;RPS27A;DYNLL2;HSP90AA1;PARK7;UBA52;UBE2N
gsea,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.6283602676717286,-1.9590378698213449,0.0,0.0020206043648704824,0.149,7/21,5.59%,UBB;RPS27A;UBA52;SPRY2;FGF13;PPP2CA;PPP2R1A
gsea,Pyroptosis R-HSA-5620971,-0.7146048163272852,-1.9556016002670835,0.0,0.002095836505810442,0.152,10/15,17.53%,HMGB1;BAX;CYCS;IL18;CHMP4B;GSDME;CHMP2A;CHMP6;CHMP4C;CHMP7
gsea,SARS-CoV-1 Infection R-HSA-9678108,-0.5297608753552223,-1.9495683015892562,0.0,0.002232104690475265,0.162,18/43,20.74%,UBB;DDX5;RPS27A;UBA52;CANX;MAP1LC3B;ZCRB1;CHMP4B;CHMP2A;CHMP6;GSK3B;PARP16;CHMP4C;CHMP7;UBC;VCP;PARP4;ST6GAL1
gsea,Pyruvate Metabolism R-HSA-70268,-0.6095451903908888,-1.9491697040848093,0.0,0.0022363699320983397,0.163,10/24,19.40%,VDAC1;BSG;GLO1;DLAT;LDHA;HAGH;LDHB;LDHD;SLC16A1;MPC2
gsea,Gluconeogenesis R-HSA-70263,-0.6324332164777148,-1.940548130385926,0.0,0.002477652265284819,0.183,9/22,10.62%,MDH2;ALDOC;MDH1;TPI1;PGK1;ENO2;GOT2;G6PC3;PGAM2
gsea,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.5202073385621296,-1.9396817129975803,0.0,0.0025111035091510987,0.185,13/51,6.68%,HSP90AB1;ACTG1;HSP90AA1;BRK1;CDC42;NCK1;ARPC5;WASL;ARPC2;ARPC1A;ACTR2;ARPC3;ABI1
gsea,Glutathione Conjugation R-HSA-156590,-0.6072807055051626,-1.9335232584523285,0.0,0.0026805246639128974,0.198,8/21,17.39%,PRNP;GSTM5;GSTM1;GSTP1;HPGDS;GCLM;AKR1A1;GSTO1
gsea,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.5681190304423294,-1.9331593198093167,0.006211180124223602,0.002674984100324818,0.199,12/28,19.64%,UBB;RPS27A;SNW1;UBA52;SKIL;PARP1;WWTR1;MAPK3;SMAD2;SMAD7;UBC;MAPK1
gsea,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.6498749878110605,-1.9292664126590677,0.0,0.002766978972638737,0.208,6/16,9.69%,GNB2;CDC42;GNG2;GNG13;GNG10;GNG3
gsea,Translesion Synthesis By REV1 R-HSA-110312,-0.6688447184788604,-1.9278556284391857,0.0019083969465648854,0.0028282355538509453,0.211,8/16,22.65%,UBB;RPS27A;UBA52;PCNA;RPA3;UBC;RFC3;MAD2L2
gsea,M Phase R-HSA-68886,-0.38437376703917714,-1.9252901790465595,0.0,0.0028889031294745747,0.216,84/301,17.72%,UBB;TUBA4A;DYNLL1;TUBB2A;RPS27A;YWHAG;DYNLL2;TUBA1A;HSP90AA1;RPS27;RAN;SET;RAB2A;H2AZ1;PSMC3;PSMB5;NME7;PSMA7;YWHAE;BANF1;PSMC2;UBA52;CETN2;SEM1;CSNK1E;PSMA5;PSMA4;SMC1A;TUBB2B;H2BC4;PPP2CA;PPP2R1A;PAFAH1B1;TUBB4A;PSMD2;PSMD4;PSMA3;PSMC5;ENSA;PSMD7;CHMP4B;TUBB4B;PSMB1;DCTN3;UBE2S;PSMB3;RAD21;H2AJ;RAB1B;EMD;PSMA1;PSMC6;CSNK2B;NUP50;PSMD6;CHMP2A;ZWINT;TUBA1B;CHMP6;NCAPH2;ANAPC11;PSMC1;NUP37;MAPK3;PSME3;PSMC4;NUP205;PPP2R5D;VPS4A;SEH1L;CTDNEP1;PSMB6;SEC13;NUDC;NUP107;PSMB7;PPP1CC;CENPP;HAUS2;CHMP4C;PSMA2;NEK6;CHMP7;UBC
gsea,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.5928997449229814,-1.9247024618909003,0.002012072434607646,0.0028824715792299914,0.216,8/24,5.59%,UBB;RPS27A;FGFR2;UBA52;SPRY2;FGF13;PPP2CA;PPP2R1A
gsea,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.6026342497480052,-1.9215877158320323,0.00202020202020202,0.0029128800706152745,0.217,7/23,5.59%,UBB;RPS27A;UBA52;SPRY2;FGF13;PPP2CA;PPP2R1A
gsea,mTORC1-mediated Signaling R-HSA-166208,-0.6001492279682893,-1.9056763088659705,0.003883495145631068,0.003550634726317269,0.258,8/23,7.76%,FKBP1A;YWHAB;RPS6;LAMTOR2;RHEB;RRAGA;LAMTOR3;RRAGD
gsea,Translesion Synthesis By POLI R-HSA-5656121,-0.6427457346121794,-1.8991463264119295,0.0,0.00380348191038744,0.272,8/17,22.65%,UBB;RPS27A;UBA52;PCNA;RPA3;UBC;RFC3;MAD2L2
gsea,Netrin-1 Signaling R-HSA-373752,0.519137243050364,1.896550730769871,0.001949317738791423,0.030483751083949292,0.283,18/43,12.07%,DSCAML1;SLIT3;TRIO;ABLIM3;ABLIM2;MAPK14;DSCAM;TRPC5;DCC;TRPC6;TRPC3;PTK2;UNC5A;FYN;NEO1;MAPK12;PLCG1;TRPC1
gsea,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.5646329279836353,-1.8938708691037482,0.001953125,0.00401769416483356,0.285,11/32,6.68%,ACTG1;BRK1;CDC42;NCK1;ARPC5;WASL;ARPC2;ARPC1A;ACTR2;ARPC3;ABI1
gsea,Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.5567387585155684,-1.8924456851670424,0.0,0.004042229494764895,0.287,10/27,19.92%,UBB;RPS27A;UBA52;LCT;G6PC3;GUSB;DCXR;UBC;PPP1R3C;TALDO1
gsea,RHO GTPases Activate PKNs R-HSA-5625740,-0.5661147641680315,-1.8914603329350075,0.004032258064516129,0.004066536589068963,0.289,14/33,16.18%,YWHAG;YWHAH;MYL6;YWHAB;H2AZ1;YWHAE;MYL12B;YWHAZ;H2BC4;YWHAQ;H2AJ;RHOB;MYH14;MYL9
gsea,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.4991895695073257,-1.8908551695641265,0.0,0.004097770048834829,0.291,9/47,8.96%,HSP90AB1;UBB;HMGB1;RPS27A;HSP90AA1;UBA52;NFKB2;ATG12;NFKBIB
gsea,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.4131490478066536,-1.888575963062072,0.0,0.004192781919825016,0.296,51/123,24.96%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;BSG;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;SLC3A1;PSMA1;PSMC6;SLC24A5;NUP50;PSMD6;RNF5;PSMC1;NUP37;PSME3;PSMC4;NUP205;SLC35A1;SEH1L;PSMB6;SLC16A1;SEC13;NUP107;RNF185;PSMB7;PSMA2;UBC;VCP;OS9;ABCB6;SLC1A3;PSMB10;PSMD5;NUP35;DERL1;DERL2;PSMD11;NUP62
gsea,Neddylation R-HSA-8951664,-0.3901618736964459,-1.8881328403456914,0.0,0.004208978083687209,0.299,64/203,19.40%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;ELOB;PSMC2;UBA52;SQSTM1;SEM1;FBXL16;PSMA5;COMMD3;KLHL9;PSMA4;COPS6;NEDD8;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;SENP8;FBXW2;PSMB1;COMMD4;PSMB3;FBXO9;ASB13;RNF7;RBBP7;PSMA1;PSMC6;PSMD6;FBXO6;GPS1;FBXO32;PSMC1;DDB2;PSME3;COPS8;ASB5;PSMC4;WSB2;COMMD6;BTBD6;PSMB6;MUL1;DDA1;COMMD1;PSMB7;COMMD10;COMMD5;COMMD7;PSMA2;UBA3;UBC;COMMD8;COMMD2;VCP;FBXW7;FBXL3;ELOC
gsea,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.495089330704845,-1.888049053378993,0.0,0.00420386593835856,0.299,10/47,7.40%,CALM1;VAMP2;YWHAG;YWHAH;YWHAB;YWHAE;YWHAZ;YWHAQ;RAB14;RAB11A
gsea,O-linked Glycosylation R-HSA-5173105,0.4622421621010072,1.8877483951543745,0.0,0.03023220602606984,0.31,20/65,14.42%,ST6GALNAC3;ADAMTS17;SEMA5B;GALNT18;SPON1;GALNT14;ADAMTS20;ADAMTS3;GALNTL6;GALNT10;ST3GAL3;ADAMTS18;LARGE1;GALNT9;CFP;B3GALNT2;GALNT3;THSD7B;ADAMTS2;ADAMTS16
gsea,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.46529884151118917,-1.8867797471296013,0.0,0.004233907292722821,0.3,25/70,16.88%,UBB;HSBP1;HSPA8;YWHAE;DNAJB6;HSPA2;MRPL18;ST13;BAG1;HIKESHI;BAG5;NUP50;BAG4;RPA3;GSK3B;HSPH1;NUP37;MAPK3;NUP205;SEH1L;SEC13;NUP107;HSPA9;FKBP4;RPS19BP1
gsea,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.5940155010419813,-1.8846363477561956,0.002008032128514056,0.004319593852146469,0.306,8/24,17.72%,UBB;RPS27A;UBA52;PSENEN;APH1A;YBX1;JAG1;UBC
gsea,Signaling By Interleukins R-HSA-449147,-0.38162943512796593,-1.8845331757828332,0.0,0.0043140525206355074,0.308,110/283,26.84%,UBB;HMGB1;PPIA;VAMP2;RPS27A;HSPA8;HSP90AA1;JUN;PSMC3;PSMB5;PSMA7;CEBPD;NDN;CDC42;DUSP3;AURKAIP1;PSMC2;UBA52;MEF2C;SQSTM1;HNRNPA2B1;SEM1;CANX;PSMA5;DUSP7;NFKB2;SOD1;FGF13;PSMA4;CLSTN1;YWHAZ;IL18;PPP2CA;USP14;PPP2R1A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;IRS2;UBE2N;PSMB1;SNAP25;PSMB3;NFKBIB;HNRNPF;PSMA1;PSMC6;RPLP0;PSMD6;S1PR1;IL1RAPL1;RALA;UBE2V1;P4HB;PSMC1;LYN;PIK3R1;MAPK3;PSME3;PSMC4;PPP2R5D;PSMB6;MAP3K8;PSMB7;IL17RB;IL27;HSPA9;IRAK4;HCK;PSMA2;COL1A2;OPRM1;GSTO1;CSF1R;UBC;NKIRAS1;IL1R2;CREB1;MAPK1;PELI2;TALDO1;CRLF2;NFKBIA;TBK1;VIM;PSMB10;PSMD5;IL10RA;IL10RB;IL13RA1;LONP1;JAK1;PTPN11;MTAP;HSP90B1;AKT1;PSMD11;OPRD1;SKP1;FOXO3;RELA;INPPL1;PIK3CB;FSCN1;PSMD10;RNASEH2A;RAP1B
gsea,Hedgehog Off State R-HSA-5610787,-0.43858375420451906,-1.8819349208513583,0.0,0.004412465088623967,0.314,33/89,17.72%,UBB;GNAS;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;PSMA1;PSMC6;PSMD6;GSK3B;PRKAR1B;PSMC1;ADCY10;PSME3;PSMC4;PSMB6;PSMB7;PRKACB;PSMA2;UBC
gsea,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.5698852643239195,-1.8800150353566882,0.001996007984031936,0.0045375830645474685,0.321,11/25,19.92%,PPIA;CDC42;AURKAIP1;HNRNPA2B1;SOD1;HNRNPF;RPLP0;RALA;HSPA9;GSTO1;TALDO1
gsea,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.6279794171668706,-1.879371201585701,0.0019083969465648854,0.004531146776512649,0.322,10/19,23.39%,UBB;RPS27A;UBA52;PGK1;MAPK3;ENO1;UBC;MAPK1;RAB5A;DUSP16
gsea,Signaling By FGFR4 R-HSA-5654743,-0.5306400733110648,-1.8774062066257242,0.0019801980198019802,0.004620457392783413,0.325,10/30,13.02%,UBB;RPS27A;UBA52;SPRY2;FGF13;PPP2CA;PPP2R1A;HRAS;PIK3R1;MAPK3
gsea,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.6187593143451073,-1.871017709050419,0.003816793893129771,0.004933542370301868,0.339,11/20,24.78%,UBB;RPS27A;UBA52;PGK1;MAPK3;ENO1;UBC;MAPK1;RAB5A;DUSP16;B2M
gsea,Translesion Synthesis By POLH R-HSA-110320,-0.6076859352893751,-1.86934459710282,0.0,0.004966104346865688,0.34,8/19,18.97%,UBB;RPS27A;UBA52;PCNA;RPA3;UBC;RFC3;VCP
gsea,Interleukin-12 Family Signaling R-HSA-447115,-0.5102267182664721,-1.8642541996800859,0.003898635477582846,0.005301927401258846,0.351,16/37,24.26%,PPIA;CDC42;AURKAIP1;HNRNPA2B1;CANX;SOD1;HNRNPF;RPLP0;RALA;P4HB;IL27;HSPA9;GSTO1;TALDO1;JAK1;MTAP
gsea,Spry Regulation Of FGF Signaling R-HSA-1295596,-0.6390262402310678,-1.8520997874965486,0.00199203187250996,0.005970636587430453,0.374,6/16,5.59%,UBB;RPS27A;UBA52;SPRY2;PPP2CA;PPP2R1A
gsea,RAS Processing R-HSA-9648002,-0.6368003353269632,-1.8519573393987854,0.0,0.00595816378080397,0.375,7/17,22.54%,CALM1;ABHD17A;HRAS;LYPLA1;ARL2;NRAS;ABHD17C
gsea,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.5162379584350172,-1.851222882027119,0.0,0.005985747872381766,0.376,9/36,10.68%,UBB;HMGB1;RPS27A;UBA52;NFKB2;USP14;UBE2N;NFKBIB;UBE2V1
gsea,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.5430749410749058,-1.8490632604528485,0.002,0.006165577207603536,0.384,13/29,14.31%,GNB2;GNG2;CCT2;CCT6A;GNG13;GNG10;PDCL;CSNK2B;GNG3;CCT7;GNA11;CCT5;CCT8
gsea,Potential Therapeutics For SARS R-HSA-9679191,-0.44739673229920834,-1.8432171194281375,0.0,0.006574915777107515,0.405,18/78,10.48%,ATP1B1;HSP90AB1;FKBP1A;HSP90AA1;ATP1A3;AP2M1;NCK1;SAP18;ATP1B2;PTGES3;IFNGR2;RBX1;CHD3;COMT;HMG20B;RBBP7;ATP1A2;S1PR1
gsea,mRNA Splicing R-HSA-72172,-0.38449668903151585,-1.8424867809050143,0.0,0.006573230333432277,0.405,88/188,30.44%,DDX5;HSPA8;SNRPG;SNW1;HNRNPA2B1;WBP11;SNRPF;SNRPD2;SNRNP27;SF3B2;WBP4;CPSF2;POLR2F;SNU13;SF3B4;TFIP11;ZCRB1;RBM42;RBM8A;HNRNPA1;PCBP1;POLR2I;ZRSR2;MAGOH;RBM22;LSM7;BUD31;POLR2G;POLR2E;LSM4;LSM2;HNRNPF;PUF60;YBX1;U2AF1;CTNNBL1;POLR2C;HNRNPK;SNRNP200;MAGOHB;SRSF3;LSM8;TXNL4A;SNRPE;SYF2;PDCD7;U2AF1L4;HNRNPC;PHF5A;SF3B6;U2AF2;SNRPN;CDC40;PRPF19;SLU7;PQBP1;POLR2J;LSM5;SNRPC;CWC15;POLR2B;SART1;NCBP2;SNRPB;PPIE;HNRNPA3;PRPF38A;BCAS2;DNAJC8;POLR2L;GPKOW;HNRNPUL1;USP39;SNRPA;SNRPB2;CSTF1;RBM17;ELAVL2;PRPF6;DHX16;HNRNPD;XAB2;LSM3;PPIL4;PPIL6;PPIH;SNRPA1;HNRNPM
gsea,Assembly Of HIV Virion R-HSA-175474,-0.6234256812948711,-1.8414574357562015,0.0020242914979757085,0.0065977406838281264,0.407,8/17,17.72%,UBB;PPIA;RPS27A;UBA52;VPS28;TSG101;UBAP1;UBC
gsea,PTEN Regulation R-HSA-6807070,-0.4036798329304136,-1.8402983321253015,0.0,0.0066415974759297895,0.412,39/127,13.41%,UBB;RPS27A;JUN;PSMC3;PSMB5;PSMA7;LAMTOR2;PSMC2;UBA52;RHEB;SEM1;RRAGA;PSMA5;VAPA;PSMA4;EGR1;LAMTOR3;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;RRAGD;PSMB3;CHD3;PML;RBBP7;PSMA1;PSMC6;CSNK2B;STUB1;PSMD6;CBX6;PSMC1;MKRN1;MAPK3;PSME3;PSMC4
gsea,Signaling By NOTCH R-HSA-157118,-0.38499994901041473,-1.838775537179131,0.0,0.0067045568470266905,0.419,52/163,19.90%,UBB;RPS27A;JUN;H2AZ1;PSMC3;PSMB5;PSMA7;PSMC2;TLE4;SNW1;UBA52;SEM1;PSMA5;PSENEN;TMED2;PSMA4;YWHAZ;H2BC4;RAB6A;PSMD2;PSMD4;TBL1XR1;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;APH1A;PSMB3;H2AJ;PSMA1;YBX1;PSMC6;PSMD6;PSMC1;PSME3;PSMC4;TBL1X;JAG1;PSMB6;TLE1;FABP7;PSMB7;SIRT6;HEY1;PSMA2;UBC;H2AX;FBXW7;CREB1;MAMLD1;PBX1
gsea,Centrosome Maturation R-HSA-380287,-0.4402883369157307,-1.8379181040357542,0.0,0.006702357180358906,0.419,14/74,7.31%,TUBA4A;DYNLL1;YWHAG;TUBA1A;HSP90AA1;NME7;YWHAE;CETN2;CSNK1E;PPP2R1A;PAFAH1B1;TUBB4A;TUBB4B;DCTN3
gsea,mRNA Splicing - Major Pathway R-HSA-72163,-0.3858622352678278,-1.8329524562058461,0.0,0.007015553957952823,0.433,85/180,30.44%,DDX5;HSPA8;SNRPG;SNW1;HNRNPA2B1;WBP11;SNRPF;SNRPD2;SNRNP27;SF3B2;WBP4;CPSF2;POLR2F;SNU13;SF3B4;TFIP11;RBM42;RBM8A;HNRNPA1;PCBP1;POLR2I;MAGOH;RBM22;LSM7;BUD31;POLR2G;POLR2E;LSM4;LSM2;HNRNPF;PUF60;YBX1;U2AF1;CTNNBL1;POLR2C;HNRNPK;SNRNP200;MAGOHB;SRSF3;LSM8;TXNL4A;SNRPE;SYF2;U2AF1L4;HNRNPC;PHF5A;SF3B6;U2AF2;SNRPN;CDC40;PRPF19;SLU7;PQBP1;POLR2J;LSM5;SNRPC;CWC15;POLR2B;SART1;NCBP2;SNRPB;PPIE;HNRNPA3;PRPF38A;BCAS2;DNAJC8;POLR2L;GPKOW;HNRNPUL1;USP39;SNRPA;SNRPB2;CSTF1;RBM17;ELAVL2;PRPF6;DHX16;HNRNPD;XAB2;LSM3;PPIL4;PPIL6;PPIH;SNRPA1;HNRNPM
gsea,Translesion Synthesis By POLK R-HSA-5655862,-0.6276555272889318,-1.8321082721935453,0.003875968992248062,0.0070120821013365305,0.436,8/17,22.65%,UBB;RPS27A;UBA52;PCNA;RPA3;UBC;RFC3;MAD2L2
gsea,Biological Oxidations R-HSA-211859,-0.4289910757887797,-1.8313371458449452,0.0,0.007046937511180454,0.438,41/93,32.32%,HSP90AB1;PRNP;GSTM5;AURKAIP1;GSTM1;TRMT112;GSTP1;PTGES3;MAT2B;HPGDS;GCLM;COMT;FDX2;VDAC2;PAOX;SLC35B3;CYB5R3;N6AMT1;ADH5;AKR1A1;ALDH1A1;GSTO1;ARNT2;MAOB;SULT4A1;FDX1;CYB5B;MIA3;TBXAS1;ALDH2;SMOX;BPHL;CYP46A1;MTRR;ESD;GSTO2;SLC26A2;PTGIS;PODXL2;GCLC;CYP27A1
gsea,AURKA Activation By TPX2 R-HSA-8854518,-0.450976291064279,-1.8278415841393372,0.0,0.007217083632485684,0.448,13/65,7.31%,TUBA4A;DYNLL1;YWHAG;TUBA1A;HSP90AA1;YWHAE;CETN2;CSNK1E;PPP2R1A;PAFAH1B1;TUBB4A;TUBB4B;DCTN3
gsea,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.450976291064279,-1.8278415841393372,0.0,0.007217083632485684,0.448,13/65,7.31%,TUBA4A;DYNLL1;YWHAG;TUBA1A;HSP90AA1;YWHAE;CETN2;CSNK1E;PPP2R1A;PAFAH1B1;TUBB4A;TUBB4B;DCTN3
gsea,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.6373553773603087,-1.8266952987207798,0.0019646365422396855,0.0072569804356670585,0.451,5/15,10.68%,UBB;RPS27A;UBA52;UBE2N;UBE2V1
gsea,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.6248169214071748,-1.8227759785536986,0.0,0.007510049258188925,0.462,6/17,10.68%,UBB;RPS27A;UBA52;NDUFA2;UBE2N;UBE2V1
gsea,Cyclin D Associated Events In G1 R-HSA-69231,-0.5052788541149859,-1.8220304061528676,0.0,0.007573452447124796,0.465,11/36,19.18%,UBB;RPS27A;UBA52;PPP2CA;PPP2R1A;CDK4;LYN;CDKN1B;CCND3;UBC;E2F4
gsea,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6131212669753354,-1.8216240788812623,0.01171875,0.007567828995779236,0.465,9/19,19.40%,UBB;RPS27A;ELOB;UBA52;RNF7;LYN;HCK;UBC;ELOC
gsea,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.5207207651549491,-1.820260329113982,0.003929273084479371,0.00761808357277866,0.466,21/35,30.18%,UBB;RPS27A;CALR;UBA52;CANX;PDIA3;UBXN1;RNF5;PSMC1;RNF185;UBC;VCP;OS9;RNF139;DERL1;DERL2;RNF103;UGGT1;EDEM3;MOGS;EDEM1
gsea,Signaling By EGFR In Cancer R-HSA-1643713,-0.570722128909512,-1.818418482250288,0.001996007984031936,0.007711187968756072,0.474,7/20,12.71%,UBB;RPS27A;HSP90AA1;UBA52;CDC37;HRAS;PIK3R1
gsea,Interleukin-12 Signaling R-HSA-9020591,-0.5239482891357614,-1.8170875865281468,0.0038535645472061657,0.007760470959592246,0.476,14/30,24.26%,PPIA;CDC42;AURKAIP1;HNRNPA2B1;SOD1;HNRNPF;RPLP0;RALA;P4HB;HSPA9;GSTO1;TALDO1;JAK1;MTAP
gsea,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.4749006051714278,-1.816479908615057,0.004024144869215292,0.007778713824938517,0.476,15/46,19.64%,UBB;RPS27A;SNW1;UBA52;SKIL;YBX1;PARP1;WWTR1;MAPK3;SMAD2;SMAD7;COL1A2;UBC;E2F4;MAPK1
gsea,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.43658327515655476,-1.8164592567136362,0.0,0.007754073490169419,0.476,14/74,7.31%,TUBA4A;DYNLL1;YWHAG;TUBA1A;HSP90AA1;NME7;YWHAE;CETN2;CSNK1E;PPP2R1A;PAFAH1B1;TUBB4A;TUBB4B;DCTN3
gsea,mRNA Splicing - Minor Pathway R-HSA-72165,-0.46302997693437664,-1.809232085745857,0.0018450184501845018,0.008222231265898043,0.493,22/49,21.67%,SNRPG;SNRPF;SNRPD2;SF3B2;POLR2F;SF3B4;ZCRB1;POLR2I;ZRSR2;POLR2G;POLR2E;YBX1;POLR2C;SNRNP200;TXNL4A;SNRPE;PDCD7;SF3B6;POLR2J;POLR2B;NCBP2;SNRPB
gsea,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.4160633836278969,-1.8087459734037175,0.0,0.008244506367424752,0.496,27/94,17.43%,DYNLL1;DYNLL2;TMED9;CAPZA2;ARF4;RAB6B;TMED2;DCTN6;PAFAH1B1;RAB6A;ARF3;DCTN3;NAPG;ARF5;RAB1B;ACTR10;RAB18;PAFAH1B2;TMED7;SURF4;UBE2Z;COPG2;ARFGAP2;COPG1;COPB2;NSF;DCTN5
gsea,"Cell Cycle, Mitotic R-HSA-69278",-0.34709213152108115,-1.8078523487796574,0.0,0.008308845584949287,0.499,98/407,17.72%,HSP90AB1;UBB;TUBA4A;DYNLL1;TUBB2A;RPS27A;YWHAG;DYNLL2;TUBA1A;HSP90AA1;RPS27;RAN;SET;RAB2A;H2AZ1;PSMC3;PSMB5;NME7;PSMA7;YWHAE;BANF1;PSMC2;UBA52;CETN2;SEM1;CSNK1E;PSMA5;PSMA4;SMC1A;TUBB2B;H2BC4;PPP2CA;PPP2R1A;PAFAH1B1;TUBB4A;PSMD2;PSMD4;PSMA3;PSMC5;ENSA;PSMD7;RBX1;CHMP4B;TUBB4B;PSMB1;DCTN3;UBE2S;PSMB3;PCNA;CDK4;RAD21;H2AJ;RAB1B;DHFR;EMD;PSMA1;PSMC6;CSNK2B;NUP50;PSMD6;CHMP2A;RPA3;ZWINT;TUBA1B;CHMP6;NCAPH2;GINS2;ANAPC11;GSK3B;PSMC1;LYN;NUP37;MAPK3;PSME3;PSMC4;NUP205;PPP2R5D;VPS4A;SEH1L;LCMT1;GINS4;CTDNEP1;PSMB6;SEC13;CDKN1B;NUDC;NUP107;CDC45;PSMB7;PPP1CC;CENPP;HAUS2;CHMP4C;PSMA2;NEK6;CHMP7;CCND3;UBC
gsea,Defective B3GALTL Causes PpS R-HSA-5083635,0.5360577267812333,1.8073374957680919,0.002257336343115124,0.06162034934137177,0.544,11/27,16.50%,ADAMTS17;SEMA5B;SPON1;ADAMTS20;ADAMTS3;ADAMTS18;CFP;THSD7B;ADAMTS2;ADAMTS16;THSD1
gsea,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.5265424139518597,-1.8057427141221565,0.009823182711198428,0.00843278952172875,0.507,5/29,7.69%,UBB;RPS27A;UBA52;PSENEN;APH1A
gsea,Phase II - Conjugation Of Compounds R-HSA-156580,-0.46321887044355986,-1.8046567915302878,0.0,0.008483925716594114,0.511,13/50,17.39%,PRNP;GSTM5;GSTM1;TRMT112;GSTP1;MAT2B;HPGDS;GCLM;COMT;SLC35B3;N6AMT1;AKR1A1;GSTO1
gsea,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.5896285579673032,-1.8042071585990518,0.008032128514056224,0.008510810525733,0.514,5/20,7.69%,UBB;RPS27A;UBA52;PSENEN;APH1A
gsea,Neuronal System R-HSA-112316,0.35220469958924167,1.803261297094871,0.0,0.05800958755494825,0.552,72/312,9.46%,GRIK4;DLGAP2;GRIA3;PTPRS;DLGAP1;NBEA;GRIN2A;NLGN1;CACNA1E;SHANK2;GRIA1;CACNA1A;LRRC7;CACNA2D3;GABRA2;CACNB2;GRIA4;GABRG3;RPS6KA2;PRKAG2;GABBR2;IL1RAPL2;KCNAB1;ADCY8;KCND3;KCNN3;CACNA1B;KCNK9;NRG1;CHRNA4;NTRK3;UNC13B;KCNK13;ADCY2;KCNJ6;PTPRD;PPM1E;KCNH1;ACTN2;PRKCG;CAMK2A;MAPT;EPB41L1;KCNQ2;PTPRF;GRIK5;SLC6A1;SHANK3;CASK;DLGAP3;RIMS1;KCNMA1;SHANK1;RASGRF2;KCNQ3;MPP3;KCNQ5;CACNG3;SYN2;KCNG3;LRFN2;ADCY9;CAMK2G;LRFN1;GRIK1;SLC1A1;KCNAB2;STX1A;GABRB1;RPS6KA6;KCNMB4;ADCY6
gsea,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.633786051023257,-1.8023461587921212,0.003968253968253968,0.0086919594414834,0.525,4/15,5.55%,UBB;RPS27A;UBA52;USP14
gsea,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.5474962044010806,-1.8007985994875748,0.0018248175182481751,0.008747433301574837,0.527,6/27,10.27%,UBB;RPS27A;UBA52;RBX1;PCNA;RPA3
gsea,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.3915069817667044,-1.7997629867861829,0.0,0.00877300451524656,0.529,53/147,22.41%,UBB;RPS27A;H2AZ1;PSMC3;PSMB5;PSMA7;PSMC2;TLE4;UBA52;SEM1;CSNK1E;PSMA5;PSMA4;YWHAZ;H2BC4;PPP2CA;PPP2R1A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;FZD2;PSMB3;H2AJ;PSMA1;PSMC6;CSNK2B;PSMD6;SOX9;RUVBL1;FZD4;GSK3B;PSMC1;PSME3;PSMC4;PPP2R5D;PSMB6;TLE1;PSMB7;PSMA2;UBC;SOX4;H2AX;PPP2R5A;CDC73;KREMEN1;CSNK1A1;PSMB10;PSMD5;CSNK1G2
gsea,Signaling By ERBB4 R-HSA-1236394,-0.4625937514387099,-1.7993277894942408,0.0,0.008774887596063643,0.53,14/52,12.71%,UBB;APOE;RPS27A;GABRG2;UBA52;PSENEN;NRG3;NRG4;STMN1;APH1A;HRAS;GFAP;SPARC;PIK3R1
gsea,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.5634713440342798,-1.7991891252507133,0.0,0.008759202898294726,0.531,9/22,11.86%,KCNJ3;GNB2;GNG2;KCNJ2;GNG13;KCNJ4;GNG10;GNG3;KCNJ16
gsea,Neurexins And Neuroligins R-HSA-6794361,0.4590084558891103,1.7981482896738958,0.0020833333333333333,0.055632406986827435,0.562,17/54,14.34%,DLGAP2;DLGAP1;GRIN2A;NLGN1;SHANK2;EPB41L1;SHANK3;CASK;DLGAP3;SHANK1;MPP3;STX1A;BEGAIN;SYT1;EPB41L3;SIPA1L1;DLGAP4
gsea,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.5155828665890951,-1.7977210692980774,0.004048582995951417,0.008848560214510552,0.535,12/32,19.64%,UBB;RPS27A;UBA52;YBX1;WWTR1;MAPK3;SMAD2;SMAD7;COL1A2;UBC;E2F4;MAPK1
gsea,CDC42 GTPase Cycle R-HSA-9013148,0.40601689474341573,1.7935886865891453,0.0,0.05371814459645322,0.579,53/125,23.25%,DOCK9;TRIO;IQGAP2;SHKBP1;DOCK10;DOCK11;FGD4;FMNL2;MYO9B;ABR;DOCK7;SH3PXD2A;ITSN1;SRGAP2;FMNL1;DLC1;FNBP1;RASGRF2;GMIP;PREX2;TIAM1;CDC42BPA;LBR;FGD1;ARHGEF7;ARAP2;WIPF2;ARAP1;FARP1;STEAP3;CPNE8;IQGAP1;ARHGAP31;SCRIB;REPS1;SRGAP1;SPATA13;DNMBP;ARFGAP3;ARHGAP32;VANGL1;STARD13;ARHGEF4;GIT2;ARHGEF11;CDC42EP4;WDR81;FNBP1L;DAAM1;PREX1;ARHGAP24;ARHGDIG;ARHGAP39
gsea,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.49238063197519377,1.7924213951458037,0.002242152466367713,0.05033241111615806,0.584,14/35,13.82%,ATP2B4;RIPOR2;EPB41L1;PLS1;CASK;KCNMA1;PCDH15;SPTAN1;MSN;EPB41L3;MYH9;ESPN;SPTBN1;EPS8
gsea,G-protein Activation R-HSA-202040,-0.591017462283266,-1.791377661121188,0.001941747572815534,0.009355362427753602,0.554,13/18,36.10%,GNB2;GNG2;GNG13;GNG10;GNG3;GNA11;OPRM1;PDYN;GNG7;GNG11;GNB4;GNG5;GNB1
gsea,L1CAM Interactions R-HSA-373760,0.4238031242778912,1.790537720176998,0.0,0.048212412767890324,0.588,30/83,14.11%,ANK3;SPTBN4;SCN1A;NRP1;RPS6KA2;SCN8A;SPTB;SHTN1;LAMB1;DNM1;KCNQ2;DNM3;KCNQ3;NFASC;MPP3;LAMC1;SPTAN1;SCN7A;CSNK2A2;EPHB2;RPS6KA6;MSN;CNTN6;ALCAM;DNM2;L1CAM;DCX;SPTBN1;RPS6KA1;ANK2
gsea,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.5381324456945757,-1.7880844476782423,0.002053388090349076,0.00956331156993796,0.562,10/25,17.72%,UBB;RPS27A;UBA52;PPP1CA;STUB1;BAMBI;SMAD2;SMAD7;PPP1CC;UBC
gsea,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.5822450040496301,1.7852438910734734,0.011928429423459244,0.04733142007680555,0.601,6/17,8.04%,TNRC6C;MOV10;AGO4;CCND2;AGO1;TNRC6B
gsea,Inwardly Rectifying K+ Channels R-HSA-1296065,-0.5466990131285059,-1.7838281332406192,0.0019880715705765406,0.009948387893818902,0.575,9/24,11.86%,KCNJ3;GNB2;GNG2;KCNJ2;GNG13;KCNJ4;GNG10;GNG3;KCNJ16
gsea,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.5779641402771417,-1.7834846638802304,0.002,0.00995160193101101,0.576,7/18,12.71%,UBB;RPS27A;HSP90AA1;UBA52;CDC37;HRAS;PIK3R1
gsea,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.5599385518376805,-1.7828943941959454,0.015779092702169626,0.00998339788511941,0.579,12/24,24.17%,UBB;RPS27A;ELOB;UBA52;RNF7;LYN;HCK;UBC;ELOC;NRAS;JAK1;PTPN11
gsea,HIV Life Cycle R-HSA-162587,-0.3836438925932499,-1.7815634733227494,0.0,0.010094759654315543,0.582,52/136,24.96%,UBB;PPIA;RPS27A;RAN;ELOB;BANF1;PSIP1;UBA52;POLR2F;VPS28;CHMP4B;POLR2I;POLR2G;TAF10;POLR2E;RANBP1;TCEA1;TAF11;NUP50;CHMP2A;TSG101;POLR2C;CHMP6;GTF2H5;NUP37;NUP205;VPS4A;SEH1L;GTF2B;SEC13;UBAP1;NUP107;CHMP4C;NMT1;CHMP7;UBC;POLR2J;TAF5;ELOC;LRIG1;POLR2B;TAF7;NCBP2;NUP35;XRCC6;ERCC3;POLR2L;HMGA1;TAF7L;SSRP1;GTF2H4;NUP62
gsea,Signaling By Insulin Receptor R-HSA-74752,-0.4616507170453412,-1.777631329939346,0.0,0.010426786616406948,0.594,16/55,13.02%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V0E2;FGFR2;ATP6V0B;ATP6V1F;FGF13;IRS2;ATP6V1E1;FGFR1;HRAS;ATP6V1C1;PIK3R1;MAPK3
gsea,Signaling By FGFR2 R-HSA-5654738,-0.43456903239503664,-1.7712978512495228,0.0019342359767891683,0.011118510759050146,0.625,18/58,13.02%,UBB;RPS27A;FGFR2;UBA52;SPRY2;FGF13;POLR2F;PPP2CA;PPP2R1A;HNRNPA1;POLR2I;POLR2G;POLR2E;HRAS;HNRNPF;POLR2C;PIK3R1;MAPK3
gsea,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.5199823792249888,1.7698205204685402,0.006864988558352402,0.05212866994260231,0.65,11/28,16.50%,ADAMTS17;SEMA5B;SPON1;ADAMTS20;ADAMTS3;ADAMTS18;CFP;THSD7B;ADAMTS2;ADAMTS16;THSD1
gsea,Signaling By WNT R-HSA-195721,-0.36641384981932423,-1.7683453596299803,0.0,0.011455653097885331,0.636,78/223,22.41%,CALM1;UBB;RPS27A;PPP3CA;TLE5;H2AZ1;PSMC3;PSMB5;PSMA7;GNB2;CLTA;VPS29;GNG2;PSMC2;TLE4;UBA52;AP2M1;SEM1;CSNK1E;PSMA5;PSMA4;PPP3R1;YWHAZ;H2BC4;PPP2CA;PPP3CB;PPP2R1A;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;GNG13;PSMB1;PFN1;FZD2;PSMB3;GNG10;SNX3;H2AJ;PSMA1;PSMC6;CSNK2B;GNG3;PSMD6;SOX9;RUVBL1;FZD4;GSK3B;PSMC1;AP2B1;PSME3;PSMC4;PPP2R5D;WNT16;PSMB6;TLE1;PSMB7;CLTB;PSMA2;VPS35;AP2S1;UBC;SOX4;H2AX;PPP2R5A;CDC73;KREMEN1;CSNK1A1;PLCB1;AP2A2;RHOA;PSMB10;NRAS;VANGL2;PSMD5;CSNK1G2
gsea,Signaling By FGFR3 R-HSA-5654741,-0.4965188669965913,-1.7659708079385177,0.003976143141153081,0.01177910924423185,0.652,10/33,13.02%,UBB;RPS27A;UBA52;SPRY2;FGF13;PPP2CA;PPP2R1A;HRAS;PIK3R1;MAPK3
gsea,Transcriptional Regulation By TP53 R-HSA-3700989,-0.35747000410630364,-1.765920213147152,0.0,0.011742028084391724,0.652,103/293,25.37%,UBB;RPS27A;YWHAG;COX6C;YWHAH;YWHAB;JUN;COX8A;PRDX5;COX4I1;COX5B;COX7C;ELOB;SESN1;COX6B1;COX6A1;COX7A2L;YWHAE;LAMTOR2;UBA52;BNIP3L;COX5A;USP2;RHEB;PLK2;BAX;RRAGA;COX7B;CYCS;POLR2F;YWHAZ;TRIAP1;PPP2CA;PPP2R1A;BTG2;YWHAQ;LAMTOR3;POLR2I;PIP4K2A;CDK5R1;RRAGD;CHD3;PCNA;POLR2G;TAF10;NPM1;POLR2E;BRD7;PML;RBBP7;TCEA1;COX14;PRDX1;COX20;CSNK2B;TAF11;RPA3;PRELID3A;PHF20;POLR2C;SCO2;GTF2H5;PIP4P1;COX19;DDB2;HIPK1;CDKN1B;KAT6A;PRELID1;CNOT8;UBC;SURF1;MAPKAPK5;RFC3;POLR2J;E2F4;TAF5;ELOC;CNOT6L;SESN3;RAD50;RRM2B;TXNRD1;KMT5A;GNPDA1;POLR2B;TAF7;BBC3;RAD9B;FASN;DDIT4;RBBP8;ERCC3;DAXX;CNOT11;POLR2L;TAF7L;RNF34;AKT1;SSRP1;GTF2H4;PDZD2;LAMTOR1
gsea,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.5700264750948837,-1.7657145811693382,0.011516314779270634,0.011710791225808044,0.652,12/21,20.14%,IDH3B;MDH2;IDH3A;SUCLG1;SDHD;SDHB;LDLR;SDHA;LDHD;FAHD1;IDH3G;IDH2
gsea,Signal Amplification R-HSA-392518,-0.5409854861178739,-1.765691429958293,0.001953125,0.01166866607751377,0.652,9/24,12.97%,GNB2;GNG2;P2RY12;GNG13;GNG10;GNG3;GNAI1;GNAI2;GNA11
gsea,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.542409417857777,-1.7653919165788683,0.006024096385542169,0.011660062452756158,0.653,8/24,8.12%,UBB;RPS27A;UBA52;SPRY2;FGF13;PPP2CA;PPP2R1A;FGFR1
gsea,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.47151962644787476,-1.765370828876378,0.001968503937007874,0.011618419372567742,0.653,11/42,12.91%,UBB;RPS27A;SUMO2;UBA52;CETN2;RBX1;UBE2N;RPA3;PARP1;GTF2H5;DDB2
gsea,Basigin Interactions R-HSA-210991,-0.5835492190530218,-1.7650593659353504,0.014613778705636743,0.011621050168490465,0.655,4/19,5.02%,ATP1B1;PPIA;BSG;ATP1B2
gsea,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.37502957437347295,-1.7630078527342423,0.0,0.011875636135734313,0.662,55/177,19.94%,CALM1;PPIA;TMSB4X;TUBA4A;TTR;RASGRP1;APLP2;GNB2;CDC42;GNG2;FAM3C;P2RY12;MANF;TIMP3;VEGFC;SOD1;YWHAZ;PDGFA;GNG13;PFN1;OLA1;VTI1B;CLU;GNG10;SCCPDH;GNG3;GNAI1;VEGFB;ADRA2C;MAGED2;TAGLN2;SPARC;GNAI2;CD63;LYN;PIK3R1;RAP1A;GNA11;MAPK3;VCL;TTF2;RHOB;CAP1;LAMP2;CHID1;ITGA2B;TLN1;DAGLB;SCG3;PTPN1;PDGFB;AAMP;MAPK1;RASGRP2;SELENOP
gsea,Leishmania Infection R-HSA-9658195,-0.392020982930195,-1.7617324592133088,0.0,0.012030172858296514,0.664,38/145,17.22%,CALM1;HSP90AB1;GNAS;GLP2R;ACTG1;JUN;GNB2;BRK1;CDC42;GNG2;NCK1;ARPC5;WASL;PLK2;NFKB2;ARPC2;RAMP2;IL18;ARPC1A;ACTR2;ARPC3;ABI1;GNG13;GNG10;GNG3;GNAI1;ADRB1;PRKAR1B;GNAI2;LYN;CHGA;MAPK3;RAMP1;ENTPD1;PRKACB;HCK;PTRH2;CD247
gsea,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.5330627860349385,-1.7598137103871412,0.007380073800738007,0.01224345157722068,0.67,12/27,20.86%,H2AZ1;CENPX;H2BC4;HJURP;NPM1;H2AJ;RBBP7;RUVBL1;CENPW;CENPP;H2AX;ITGB3BP
gsea,NGF-stimulated Transcription R-HSA-9031628,-0.5237184921211762,-1.7504219832480283,0.005628517823639775,0.01336037895227713,0.698,12/29,19.46%,CDK5R2;JUND;EGR1;CDK5R1;VGF;EGR4;ID4;ID2;EGR3;ID3;CREB1;ASCL1
gsea,Collagen Chain Trimerization R-HSA-8948216,0.5687896254418493,1.7494431317972334,0.008948545861297539,0.05920083687767545,0.705,14/23,21.05%,COL23A1;COL11A1;COL19A1;COL16A1;COL15A1;COL5A1;COL5A2;COL4A1;COL12A1;COL9A2;COL25A1;COL4A4;COL4A2;COL13A1
gsea,Signaling By FGFR R-HSA-190236,-0.42167727423748014,-1.7485494680620606,0.0,0.013545910817896207,0.704,27/68,21.65%,UBB;RPS27A;FGFR2;UBA52;SPRY2;FLRT2;FGF13;POLR2F;PPP2CA;PPP2R1A;HNRNPA1;POLR2I;FGFR1;POLR2G;POLR2E;HRAS;HNRNPF;POLR2C;PIK3R1;MAPK3;FLRT3;UBC;POLR2J;MAPK1;POLR2B;NRAS;NCBP2
gsea,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.3535445662068523,-1.7482941582380562,0.0,0.013514859307677301,0.704,103/235,30.44%,DDX5;HSPA8;SNRPG;SNW1;HNRNPA2B1;WBP11;SNRPF;SNRPD2;SNRNP27;SF3B2;WBP4;CPSF2;POLR2F;SNU13;SF3B4;TFIP11;ZCRB1;RBM42;RBM8A;HNRNPA1;PCBP1;POLR2I;ZRSR2;MAGOH;RBM22;LSM7;BUD31;POLR2G;POLR2E;LSM4;LSM2;HNRNPF;PUF60;YBX1;CHTOP;U2AF1;NUP50;CTNNBL1;POLR2C;HNRNPK;SNRNP200;MAGOHB;SRSF3;POLDIP3;NUP37;LSM8;TXNL4A;NUP205;SEH1L;SNRPE;SYF2;SEC13;NUP107;PDCD7;U2AF1L4;HNRNPC;PHF5A;SLBP;SF3B6;U2AF2;SNRPN;CDC40;PRPF19;SLU7;PQBP1;POLR2J;LSM5;DDX39B;SNRPC;CWC15;POLR2B;SART1;THOC7;NCBP2;SNRPB;PPIE;NUP35;HNRNPA3;PRPF38A;BCAS2;DNAJC8;POLR2L;GPKOW;HNRNPUL1;NUP62;USP39;SNRPA;NUP85;SNRPB2;CSTF1;RBM17;ELAVL2;PRPF6;DHX16;HNRNPD;XAB2;FYTTD1;LSM3;PPIL4;PPIL6;PPIH;SNRPA1;HNRNPM
gsea,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.4774389153390839,-1.7460061232752575,0.0,0.013687839220715295,0.709,13/44,17.16%,GNAS;GLP2R;GNB2;GNG2;RAMP2;GNG13;FZD2;GNG10;GNG3;FZD4;WNT16;RAMP1;PTRH2
gsea,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.5430482493763956,-1.7457905426183622,0.009041591320072333,0.013656511498100606,0.709,12/23,31.92%,PCNA;RPA3;PARP1;ADPRS;APEX1;RFC3;LRIG1;POLD4;POLD2;POLD3;FEN1;RFC5
gsea,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.5699199817523928,-1.744483383235812,0.005504587155963303,0.01373193149276992,0.71,11/20,23.65%,HSP90AA1;POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;MOV10L1;HENMT1;POLR2J;POLR2B;POLR2L
gsea,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.4898836820129262,-1.7434023898642317,0.0063025210084033615,0.013822757973335214,0.712,13/36,17.72%,UBB;RPS27A;UBA52;CETN2;COPS6;RBX1;PARP1;RUVBL1;GPS1;DDB2;COPS8;YY1;UBC
gsea,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.584106776256122,-1.7427215117926238,0.00398406374501992,0.013860061357172099,0.713,12/17,36.10%,GNB2;GNG2;GNG13;GNG10;GNG3;GNA11;AAMP;GNG7;GNG11;GNB4;GNG5;GNB1
gsea,TNF Signaling R-HSA-75893,-0.48133650415683465,-1.741051344937594,0.00816326530612245,0.014034183275376208,0.717,9/38,10.90%,UBB;RACK1;RPS27A;UBA52;USP2;NSMAF;BAG4;OTULIN;CLIP3
gsea,Deubiquitination R-HSA-5688426,-0.35370178978611055,-1.7406857420982371,0.0,0.014028480859564905,0.719,68/206,21.61%,UBB;RPS27A;PSMC3;PSMB5;PSMA7;VDAC1;PSMC2;UBA52;USP2;SEM1;PSMA5;H2AC25;PSMA4;H2BC4;USP14;NEDD8;MAT2B;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;SENP8;PSMB1;USP22;PSMB3;TAF10;SNX3;ADRM1;PSMA1;TOMM20;PSMC6;OTUB1;PSMD6;RUVBL1;UCHL1;KDM1B;VCPIP1;VDAC2;PSMC1;FOXO4;BABAM2;DDB2;PSME3;STAM2;PSMC4;TADA2B;PSMB6;MUL1;SMAD2;SMAD7;PSMB7;HCFC1;PSMA2;PTRH2;YY1;UBC;FOXK1;VCP;TADA3;UIMC1;JOSD2;NFKBIA;ACTR8;YOD1;USP30;RHOA;PSMB10
gsea,Late Phase Of HIV Life Cycle R-HSA-162599,-0.37669796112884596,-1.7387549095685435,0.0,0.014258450700050784,0.725,47/125,24.96%,UBB;PPIA;RPS27A;RAN;ELOB;UBA52;POLR2F;VPS28;CHMP4B;POLR2I;POLR2G;TAF10;POLR2E;RANBP1;TCEA1;TAF11;NUP50;CHMP2A;TSG101;POLR2C;CHMP6;GTF2H5;NUP37;NUP205;VPS4A;SEH1L;GTF2B;SEC13;UBAP1;NUP107;CHMP4C;NMT1;CHMP7;UBC;POLR2J;TAF5;ELOC;POLR2B;TAF7;NCBP2;NUP35;ERCC3;POLR2L;TAF7L;SSRP1;GTF2H4;NUP62
gsea,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.5737478029535825,-1.7364730311807168,0.018108651911468814,0.014455555018742367,0.73,5/19,9.21%,PRNP;VAMP2;VAPA;SEC61G;EMD
gsea,RAF/MAP Kinase Cascade R-HSA-5673001,-0.3639007106764951,-1.7337470957410166,0.0,0.014744950770676495,0.74,66/210,19.83%,CALM1;UBB;PEBP1;NEFL;RPS27A;YWHAB;RASGRP1;PSMC3;RASAL2;PSMB5;PSMA7;FGFR2;LAMTOR2;PSMC2;UBA52;SEM1;PSMA5;DUSP7;FGF13;PSMA4;NRG3;NRG4;PPP2CA;PPP2R1A;LAMTOR3;PSMD2;PSMD4;PSMA3;PSMC5;PDGFA;PSMD7;ABHD17A;RBX1;IRS2;PSMB1;PSMB3;FGFR1;HRAS;PSMA1;PSMC6;PSMD6;TEK;PSMC1;PIK3R1;RAP1A;MAPK3;PSME3;VCL;PSMC4;PPP2R5D;PSMB6;PSMB7;PPP1CC;CAMK2B;PSMA2;ITGA2B;DUSP8;GPRIN1;LYPLA1;UBC;TLN1;DUSP5;PDGFB;MAPK1;NCAM1;PPP2R5A
gsea,MAP2K And MAPK Activation R-HSA-5674135,-0.4922819035055716,-1.7327942212006548,0.009578544061302681,0.014825060762079977,0.741,13/30,21.64%,PEBP1;YWHAB;LAMTOR2;LAMTOR3;HRAS;RAP1A;MAPK3;VCL;ITGA2B;TLN1;MAPK1;CNKSR2;NRAS
gsea,Signaling By FGFR1 R-HSA-5654736,-0.4621638247588857,-1.7322584192609196,0.001949317738791423,0.014816808629186239,0.742,15/40,19.64%,UBB;RPS27A;UBA52;SPRY2;FLRT2;FGF13;PPP2CA;PPP2R1A;FGFR1;HRAS;PIK3R1;MAPK3;FLRT3;UBC;MAPK1
gsea,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.46243899373864594,1.727861346291481,0.0022727272727272726,0.06712466014522203,0.757,13/42,14.42%,ADAMTS17;SEMA5B;SPON1;ADAMTS20;NOTCH2;ADAMTS3;ADAMTS18;LARGE1;CFP;GALNT3;THSD7B;ADAMTS2;ADAMTS16
gsea,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.3612692390985055,-1.7229899461705094,0.0,0.016126763300042746,0.767,66/213,19.83%,CALM1;UBB;PEBP1;NEFL;RPS27A;YWHAB;RASGRP1;PSMC3;RASAL2;PSMB5;PSMA7;FGFR2;LAMTOR2;PSMC2;UBA52;SEM1;PSMA5;DUSP7;FGF13;PSMA4;NRG3;NRG4;PPP2CA;PPP2R1A;LAMTOR3;PSMD2;PSMD4;PSMA3;PSMC5;PDGFA;PSMD7;ABHD17A;RBX1;IRS2;PSMB1;PSMB3;FGFR1;HRAS;PSMA1;PSMC6;PSMD6;TEK;PSMC1;PIK3R1;RAP1A;MAPK3;PSME3;VCL;PSMC4;PPP2R5D;PSMB6;PSMB7;PPP1CC;CAMK2B;PSMA2;ITGA2B;DUSP8;GPRIN1;LYPLA1;UBC;TLN1;DUSP5;PDGFB;MAPK1;NCAM1;PPP2R5A
gsea,Signaling By Hedgehog R-HSA-5358351,-0.37888818626890525,-1.7228620006087771,0.0,0.01610397755741848,0.768,48/120,25.40%,UBB;GNAS;RPS27A;PSMC3;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;PSMB1;PSMB3;HHIP;PSMA1;PSMC6;PSMD6;P4HB;GSK3B;PRKAR1B;PSMC1;ADCY10;PSME3;PSMC4;PSMB6;GAS8;PSMB7;PRKACB;PSMA2;UBC;VCP;OS9;CDC73;CSNK1A1;PSMB10;PRKAR1A;PSMD5;FUZ;DERL2;PSMD11;SKP1;SMOX
gsea,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.5724280607409552,-1.7227377428306443,0.007259528130671506,0.016065997921086202,0.769,4/21,5.45%,CALM1;PPP3CA;PPP3R1;PPP3CB
gsea,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.5041866770566756,-1.7185244820420735,0.006185567010309278,0.016655329116636843,0.775,8/29,14.29%,UBB;RACK1;RPS27A;UBA52;USP2;OTULIN;CLIP3;SHARPIN
gsea,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.5520274238700573,-1.7179422841814687,0.015384615384615385,0.016702167450355573,0.776,7/20,11.24%,PRDX5;SOD1;CYCS;GSTP1;PRDX1;NCF2;P4HB
gsea,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.5219411431185654,-1.7157835526673495,0.004246284501061571,0.016971541931550545,0.781,9/26,11.52%,UBB;RPS27A;HSP90AA1;UBA52;NRG3;NRG4;CDC37;STUB1;ERBIN
gsea,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.4407249237882116,-1.7132609946459758,0.0019267822736030828,0.017284588416643615,0.788,30/50,32.80%,UBB;RPS27A;UBA52;COPS6;POLR2F;HMGN1;RBX1;POLR2I;POLR2G;POLR2E;TCEA1;POLR2C;GPS1;GTF2H5;COPS8;UBC;PRPF19;POLR2J;POLR2B;PPIE;ERCC3;POLR2L;GTF2H4;COPS7A;XAB2;COPS5;POLR2D;GTF2H3;XPA;POLR2K
gsea,Glycogen Metabolism R-HSA-8982491,-0.5629637029314153,-1.7117850997760593,0.01037344398340249,0.01738426722629316,0.789,4/21,3.17%,CALM1;UBB;RPS27A;UBA52
gsea,RHOBTB GTPase Cycle R-HSA-9706574,-0.4795208290514781,-1.7109215703305363,0.012096774193548387,0.017458222324056076,0.791,13/35,20.78%,HSP90AB1;ACTG1;HSP90AA1;CCT2;CCT6A;CDC37;TWF1;GPS1;CCT7;HNRNPC;TXNL1;DDX39B;VIM
gsea,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.5792434864888677,-1.7091448466569394,0.007782101167315175,0.017671672390746043,0.794,9/20,18.58%,FTH1;APOE;HSP90AA1;CALR;C1D;SPARC;HSPH1;COL1A2;SSC5D
gsea,Stimuli-sensing Channels R-HSA-2672351,0.41973386365641585,1.709048254391856,0.0,0.07579345088161209,0.803,22/62,9.01%,RYR2;UNC80;ASIC2;ANO4;ANO3;ANO6;RYR3;TRPC5;TRPM7;ANO2;TRPM3;CLCN5;TRPC6;TRPC3;WNK2;ASIC4;WNK1;WNK3;TRDN;UNC79;BEST3;ANO10
gsea,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.4582832833180209,-1.7080395078468724,0.0,0.01777910377411708,0.795,14/42,20.09%,UBB;RPS27A;UBA52;RRAGA;H2BC4;UBE2N;PCNA;PEX12;BCL10;RTF1;SKIC8;UBC;VCP;CDC73
gsea,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.41869408146690357,-1.7069231152464057,0.0017667844522968198,0.017870943549282932,0.799,19/74,18.51%,SCG2;SPARCL1;APOE;CST3;PPP3CA;APLP2;CHGB;EVA1A;PDIA6;IGFBP7;TMEM132A;P4HB;VGF;TTF2;GOLM1;IGFBP5;PAPPA2;CXXC1;SCG3
gsea,Calnexin/calreticulin Cycle R-HSA-901042,-0.5214110675727764,-1.706763304479558,0.00796812749003984,0.017823566865652903,0.799,16/26,30.18%,UBB;RPS27A;CALR;UBA52;CANX;PDIA3;RNF5;RNF185;UBC;OS9;RNF139;DERL2;RNF103;UGGT1;EDEM3;EDEM1
gsea,RHO GTPase Effectors R-HSA-195258,-0.35602258630835276,-1.7052656610954524,0.0,0.017964029479929613,0.803,48/196,16.18%,CALM1;DYNLL1;PFN2;YWHAG;DYNLL2;YWHAH;MYL6;ACTG1;YWHAB;RPS27;H2AZ1;BRK1;YWHAE;CDC42;NCK1;ARPC5;WASL;MYL12B;ARPC2;YWHAZ;H2BC4;PPP2CA;PPP2R1A;YWHAQ;PAFAH1B1;ARPC1A;ACTR2;ARPC3;ABI1;PFN1;H2AJ;LIN7B;NCF2;ZWINT;CTNNA1;NUP37;MAPK3;RHOB;PPP2R5D;SEH1L;SEC13;CDKN1B;NUDC;NUP107;PPP1CC;MYH14;CENPP;MYL9
gsea,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.4353272518789241,-1.7029836352434826,0.0019267822736030828,0.01833481185154456,0.81,24/55,29.10%,CALM1;HSP90AA1;GNB2;GNG2;GNG13;GNG10;HRAS;GNG3;GNAI1;GNAI2;PIK3R1;MAPK3;CDKN1B;CREB1;MAPK1;NRAS;AKT1;FOXO3;GNG7;S1PR3;PRMT1;GNG11;AKT3;PIK3R2
gsea,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.5347515512155061,-1.7006388753379116,0.009041591320072333,0.01864439398733884,0.813,8/23,20.53%,UBB;RPS27A;UBA52;PCNA;RPA3;UBC;RFC3;LRIG1
gsea,G-protein Beta:Gamma Signaling R-HSA-397795,-0.5261208736327405,-1.7005471017289955,0.009784735812133072,0.018595169380596358,0.813,16/23,36.10%,GNB2;CDC42;GNG2;GNG13;GNG10;GNG3;PLCB1;RHOA;AKT1;GNG7;GNG11;AKT3;BTK;GNB4;GNG5;GNB1
gsea,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.5393678569911688,-1.6985591358695387,0.007326007326007326,0.018862993804001072,0.819,11/19,23.65%,FGFR2;FGF13;POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;POLR2J;POLR2B;NCBP2;POLR2L
gsea,Cytokine Signaling In Immune System R-HSA-1280215,-0.32901623020459075,-1.698214958368432,0.0,0.018847394396300468,0.819,149/414,26.84%,UBB;HMGB1;PPIA;VAMP2;RPS27A;HSPA8;HSP90AA1;JUN;EIF4A1;PSMC3;PSMB5;PSMA7;CEBPD;ELOB;NDN;CDC42;DUSP3;EIF4A2;AURKAIP1;PSMC2;UBA52;MEF2C;SQSTM1;HNRNPA2B1;SEM1;CANX;PSMA5;DUSP7;NFKB2;SOD1;FGF13;TRIM35;PSMA4;CLSTN1;YWHAZ;IL18;PPP2CA;USP14;EGR1;PPP2R1A;IFNGR2;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;IRS2;UBE2N;PSMB1;SNAP25;PSMB3;PML;HRAS;RNF7;NFKBIB;HNRNPF;PSMA1;PSMC6;RPLP0;NUP50;PSMD6;IRF8;S1PR1;IL1RAPL1;RALA;UBE2V1;P4HB;PSMC1;LYN;PIK3R1;NUP37;MAPK3;PSME3;PSMC4;NUP205;PPP2R5D;SEH1L;PSMB6;SEC13;CDKN1B;MAP3K8;NUP107;SMAD7;PSMB7;EIF4G2;IL17RB;IL27;HSPA9;IRAK4;CAMK2B;HCK;PSMA2;COL1A2;OPRM1;GSTO1;UBA3;CSF1R;UBC;CD27;PTPN1;SAMHD1;NKIRAS1;IL1R2;CREB1;TNFSF12;ELOC;MAPK1;PELI2;NCAM1;TALDO1;CRLF2;NFKBIA;TBK1;IRF3;VIM;PSMB10;NRAS;PSMD5;IL10RA;IL10RB;NUP35;IL13RA1;LONP1;SUMO1;JAK1;TNFRSF9;PTPN11;MTAP;HSP90B1;AKT1;PSMD11;B2M;NUP62;OPRD1;PDZD2;GRB10;SKP1;FOXO3;RELA;KPNA3;INPPL1;PIK3CB;TRIM8;NUP85;FSCN1;PSMD10;RNASEH2A;RAP1B
gsea,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.5905673333040806,-1.6946659048896922,0.006172839506172839,0.01927738884008641,0.825,7/15,17.72%,UBB;RPS27A;UBA52;VPS28;TSG101;UBAP1;UBC
gsea,PIP3 Activates AKT Signaling R-HSA-1257604,-0.34699122868446935,-1.6938013052701109,0.0,0.019323345752535654,0.827,62/221,16.75%,UBB;RPS27A;JUN;PSMC3;PSMB5;PSMA7;FGFR2;LAMTOR2;PSMC2;UBA52;RHEB;SEM1;RRAGA;PSMA5;FGF13;VAPA;PSMA4;NRG3;CLSTN1;NRG4;PPP2CA;EGR1;PPP2R1A;LAMTOR3;PSMD2;PSMD4;PSMA3;PSMC5;PDGFA;PSMD7;IRS2;PIP4K2A;PSMB1;RRAGD;PSMB3;CHD3;FGFR1;BAD;PML;RBBP7;PSMA1;PSMC6;CSNK2B;STUB1;PSMD6;CBX6;GSK3B;PSMC1;FOXO4;PIK3R1;MKRN1;MAPK3;PSME3;PSMC4;PPP2R5D;PSMB6;CDKN1B;PSMB7;AKT1S1;CBX4;IRAK4;PSMA2
gsea,Metabolism Of Cofactors R-HSA-8978934,-0.5799552299197668,-1.6934092945239376,0.011560693641618497,0.019325706727352163,0.828,8/18,26.93%,CALM1;HSP90AA1;DHFR;GCH1;COQ3;COQ7;AKT1;COQ9
gsea,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.5436467503342622,-1.6908147602828008,0.01440329218106996,0.01975020956970205,0.835,8/19,21.11%,UBB;RPS27A;UBA52;STAM2;UBC;SH3GL2;EPS15;CBLL1
gsea,Chromosome Maintenance R-HSA-73886,-0.39762410811879,-1.6902066424986162,0.0017574692442882249,0.01981340532130443,0.835,40/82,31.92%,H2AZ1;POLR2F;CENPX;H2BC4;NOP10;POLR2I;HJURP;PCNA;POLR2G;NPM1;POLR2E;H2AJ;RBBP7;GAR1;RPA3;POLR2C;RUVBL1;TERF1;CENPW;DKC1;NHP2;CENPP;RFC3;POLR2J;H2AX;ANKRD28;LRIG1;POLR2B;ITGB3BP;DAXX;POLR2L;RSF1;POLD4;POLD2;TINF2;POLD3;POLR2D;FEN1;H2AZ2;RFC5
gsea,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.4271345851023223,-1.6885350543797124,0.0018083182640144665,0.02012889487630093,0.837,32/60,32.80%,UBB;RPS27A;UBA52;POLR2F;HMGN1;RBX1;POLR2I;PCNA;POLR2G;POLR2E;TCEA1;RPA3;POLR2C;GTF2H5;UBC;PRPF19;RFC3;POLR2J;LRIG1;POLR2B;PPIE;ERCC3;POLR2L;GTF2H4;POLD4;POLD2;XAB2;POLD3;POLR2D;GTF2H3;RFC5;POLR2K
gsea,Transcriptional Regulation By VENTX R-HSA-8853884,0.4662898140611451,1.685230409701983,0.007751937984496124,0.08776833275326071,0.847,9/33,9.00%,TNRC6C;CDC27;EHMT1;MOV10;AGO4;AGO1;TNRC6B;ANAPC5;EHMT2
gsea,HCMV Infection R-HSA-9609646,-0.3866684852462727,-1.6794545847844067,0.0057361376673040155,0.021711480917947324,0.854,29/89,19.80%,DYNLL1;DYNLL2;CEBPD;H2AC25;H2BC4;TBL1XR1;VPS28;CHMP4B;GPS2;PML;RBBP7;NUP50;CHMP2A;TSG101;HNRNPK;CHMP6;DUT;NUP37;NUP205;TBL1X;VPS4A;SEH1L;SEC13;UBAP1;NUP107;CHMP4C;CHMP7;CREB1;RRM1
gsea,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.5042480816701691,-1.6792103366673803,0.003676470588235294,0.0216827882557047,0.854,16/25,37.27%,GNB2;GNG2;GNG13;GNG10;GNG3;GNA11;MAPK3;TTF2;MAPK1;GNG7;GNG11;F2RL2;GNB4;GNG5;GNB1;ARRB1
gsea,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.4029954084948706,1.6712288438109932,0.006048387096774193,0.09430865620319309,0.873,22/69,10.37%,GRIA3;NBEA;GRIN2A;GRIA1;LRRC7;GRIA4;RPS6KA2;PRKAG2;ADCY8;NRG1;PPM1E;ACTN2;CAMK2A;MAPT;CASK;RASGRF2;MPP3;CAMK2G;RPS6KA6;ARHGEF7;RASGRF1;ERBB4
gsea,Signaling By Nuclear Receptors R-HSA-9006931,-0.355571062112292,-1.6691563827936913,0.0,0.023628853394616626,0.877,54/181,22.07%,CALM1;HSP90AB1;DDX5;APOE;HSP90AA1;JUN;H2AZ1;GNB2;GNG2;JUND;POLR2F;SMC1A;H2BC4;PTGES3;TBL1XR1;GNG13;DLAT;POLR2I;GPS2;POLR2G;GNG10;RAD21;POLR2E;H2AJ;HRAS;GNG3;GNAI1;POLR2C;CXXC5;RDH14;KDM1B;GNAI2;PIK3R1;MAPK3;PLTP;ARL4C;TBL1X;CBFB;ANGPTL3;LDHD;CDKN1B;FKBP4;ALDH1A1;YY1;POLR2J;H2AX;CREB1;DHRS3;MAPK1;POLR2B;GPAM;CXCL12;NRAS;FASN
gsea,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.396899708877349,-1.6687412977595888,0.0018115942028985507,0.023493621561277878,0.878,26/83,19.97%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA
gsea,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.396899708877349,-1.6687412977595888,0.0018115942028985507,0.023493621561277878,0.878,26/83,19.97%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA
gsea,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.396899708877349,-1.6687412977595888,0.0018115942028985507,0.023493621561277878,0.878,26/83,19.97%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA
gsea,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.45488291185463336,1.6681630449836122,0.004464285714285714,0.09216773700113647,0.878,19/41,19.41%,COL23A1;P3H2;COL11A1;ADAMTS3;COL19A1;COLGALT2;COL16A1;P3H1;COL15A1;COL5A1;COL5A2;BMP1;COL4A1;ADAMTS2;COL12A1;COL9A2;COL25A1;COL4A4;COL4A2
gsea,Signaling By NOTCH3 R-HSA-9012852,-0.44483887308863385,-1.66760246980214,0.011650485436893204,0.023669983984968574,0.881,13/44,19.90%,UBB;RPS27A;SNW1;UBA52;PSENEN;APH1A;YBX1;JAG1;FABP7;HEY1;UBC;MAMLD1;PBX1
gsea,RAB Geranylgeranylation R-HSA-8873719,-0.44372098401264687,-1.666385253615296,0.007547169811320755,0.023808062077712782,0.882,12/46,10.57%,RAB3A;RAB2A;RAB40B;RAB6B;RAB14;RAB6A;RAB11A;RAB24;RAB1B;RAB22A;RAB18;RAB31
gsea,Effects Of PIP2 Hydrolysis R-HSA-114508,0.4982129775349753,1.6659443477225664,0.01293103448275862,0.08997708221497296,0.88,12/24,18.12%,DGKG;PRKCE;DGKH;TRPC6;TRPC3;DGKQ;DGKB;DGKI;PRKCD;MGLL;DGKA;DAGLA
gsea,Post-translational Protein Phosphorylation R-HSA-8957275,-0.4128671745349893,-1.6657160728807456,0.005357142857142857,0.023787592823461164,0.882,17/69,18.51%,SCG2;SPARCL1;APOE;CST3;PPP3CA;APLP2;CHGB;EVA1A;PDIA6;IGFBP7;TMEM132A;P4HB;VGF;GOLM1;IGFBP5;CXXC1;SCG3
gsea,EGFR Downregulation R-HSA-182971,-0.4872379882531763,-1.6619178568117194,0.00851063829787234,0.02441010413013789,0.887,10/27,20.08%,UBB;RPS27A;CDC42;UBA52;SPRY2;EPN1;STAM2;UBC;SH3GL2;EPS15
gsea,Protein Ubiquitination R-HSA-8852135,-0.4126603905009027,-1.661383292620937,0.0,0.02445251494828349,0.89,19/61,20.29%,UBB;RPS27A;UBA52;RRAGA;H2BC4;UBE2N;UBA1;UBE2S;PCNA;OTULIN;PEX12;UBE2Z;BCL10;RTF1;SKIC8;UBC;VCP;CDC73;UBE2H
gsea,MAPK Family Signaling Cascades R-HSA-5683057,-0.3393647022289573,-1.6588667785319902,0.0019047619047619048,0.024936018786327726,0.893,73/242,19.83%,CALM1;UBB;PEBP1;NEFL;RPS27A;YWHAB;JUN;RASGRP1;PSMC3;RASAL2;PSMB5;PSMA7;FGFR2;CDC42;LAMTOR2;PSMC2;UBA52;SEM1;PSMA5;DUSP7;FGF13;PSMA4;NRG3;NRG4;PPP2CA;PPP2R1A;LAMTOR3;PSMD2;PSMD4;PSMA3;PSMC5;PDGFA;PSMD7;ABHD17A;RBX1;IRS2;PSMB1;PSMB3;FGFR1;SEPTIN7;HRAS;PSMA1;PSMC6;PSMD6;TEK;PSMC1;MAPK6;PIK3R1;RAP1A;MAPK3;PSME3;VCL;PSMC4;PPP2R5D;PSMB6;PSMB7;PPP1CC;PRKACB;CAMK2B;PSMA2;ITGA2B;DUSP8;GPRIN1;CCND3;LYPLA1;UBC;MAPKAPK5;TLN1;DUSP5;PDGFB;MAPK1;NCAM1;PPP2R5A
gsea,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.40017382128977136,-1.6571045109815814,0.0,0.025159965595101766,0.895,37/73,31.92%,UBB;RPS27A;UBA52;COPS6;POLR2F;HMGN1;RBX1;POLR2I;PCNA;POLR2G;POLR2E;TCEA1;RPA3;POLR2C;GPS1;GTF2H5;COPS8;UBC;PRPF19;RFC3;POLR2J;LRIG1;POLR2B;PPIE;ERCC3;POLR2L;GTF2H4;COPS7A;POLD4;POLD2;XAB2;COPS5;POLD3;POLR2D;GTF2H3;XPA;RFC5
gsea,Apoptotic Factor-Mediated Response R-HSA-111471,-0.5706676619722857,-1.6568877471690893,0.019748653500897665,0.025112948699169923,0.895,9/16,24.14%,BAX;CYCS;GSDME;C1QBP;MAPK3;UACA;MAPK1;DIABLO;SEPTIN4
gsea,Dual Incision In TC-NER R-HSA-6782135,-0.41273596359275505,-1.6514723925130546,0.007017543859649123,0.026200818548821128,0.899,32/61,32.80%,UBB;RPS27A;UBA52;POLR2F;HMGN1;RBX1;POLR2I;PCNA;POLR2G;POLR2E;TCEA1;RPA3;POLR2C;GTF2H5;UBC;PRPF19;RFC3;POLR2J;POLR2B;PPIE;ERCC3;POLR2L;GTF2H4;POLD4;POLD2;XAB2;POLD3;POLR2D;GTF2H3;XPA;RFC5;POLR2K
gsea,Peroxisomal Protein Import R-HSA-9033241,-0.4178428468190526,-1.6502281425057033,0.0,0.026364550211333125,0.9,11/50,18.49%,UBB;RPS27A;UBA52;MPV17;PAOX;PEX12;ACOX1;NUDT19;ZFAND6;UBC;NUDT7
gsea,Regulation Of Complement Cascade R-HSA-977606,-0.5879852774065231,-1.649913189534032,0.019230769230769232,0.0263461240191258,0.9,7/16,15.95%,PSMA7;CD81;VTN;CLU;TTF2;C1QB;HNRNPC
gsea,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.44236429281054107,-1.6494542387000222,0.01195219123505976,0.026382005902721672,0.903,13/40,20.31%,UBB;RPS27A;UBA52;EYA1;H2BC4;UBE2N;UBXN1;RNF168;BABAM2;UBC;H2AX;UIMC1;RAD50
gsea,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.43721742715087286,-1.6467835476572223,0.006,0.026908562804462376,0.906,13/40,17.72%,UBB;RPS27A;FKBP1A;UBA52;PPP1CA;NEDD8;ITGAV;STUB1;BAMBI;SMAD2;SMAD7;PPP1CC;UBC
gsea,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.47896241447964816,-1.6429991968824549,0.011029411764705883,0.02771046520665257,0.911,10/29,18.97%,DDX5;MAP1LC3B;ZCRB1;CHMP4B;CHMP2A;CHMP6;GPC1;CHMP4C;CHMP7;VCP
gsea,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.5502509090756271,-1.6405979397179105,0.009633911368015413,0.028131615807143254,0.913,7/18,20.46%,SET;H2AZ1;H2BC4;H2AJ;NCAPH2;H2AX;KMT5A
gsea,G Alpha (12/13) Signaling Events R-HSA-416482,0.40340041050886877,1.6391015248882925,0.007858546168958742,0.10801040591320148,0.913,18/63,10.47%,KALRN;PLEKHG5;TRIO;FGD4;ROCK1;ABR;ITSN1;ARHGEF33;RASGRF2;SOS1;GNA12;TIAM1;PRPF38B;FGD1;ARHGEF17;ARHGEF7;ARHGEF18;ARHGEF3
gsea,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.3908886898438774,-1.63841808729271,0.003669724770642202,0.028608370215343917,0.918,25/81,19.97%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA
gsea,MyD88-independent TLR4 Cascade R-HSA-166166,-0.3834217290128975,-1.637781413630626,0.0018587360594795538,0.028637215627429137,0.918,26/85,20.33%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;UBC;NKIRAS1;CREB1;MAPK1;NFKBIA;TBK1;IRF3
gsea,O-linked Glycosylation Of Mucins R-HSA-913709,0.4775744124440233,1.6376753045610233,0.00881057268722467,0.10520073311500822,0.914,6/28,4.93%,ST6GALNAC3;GALNT18;GALNT14;GALNTL6;GALNT10;ST3GAL3
gsea,RHO GTPases Activate PAKs R-HSA-5627123,-0.5439103420586084,-1.6361153182970254,0.021526418786692758,0.028905591505339313,0.919,4/19,4.49%,CALM1;MYL6;CDC42;MYL12B
gsea,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.43078890745371834,-1.634394801009181,0.007352941176470588,0.029296360230923312,0.919,20/50,19.64%,CDK5R2;DUSP3;JUND;MEF2C;DUSP7;PPP2CA;EGR1;PPP2R1A;CDK5R1;VGF;EGR4;MAPK3;PPP2R5D;ID4;ID2;EGR3;ID3;CREB1;ASCL1;MAPK1
gsea,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.38633026410155935,-1.6313608939562962,0.0036101083032490976,0.029989424363379983,0.921,26/86,19.97%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA
gsea,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.3827649594900168,-1.6309820716524313,0.0018726591760299626,0.030009605544910403,0.921,25/83,20.33%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;UBC;NKIRAS1;CREB1;MAPK1;NFKBIA;TBK1;IRF3
gsea,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.32026172334525904,-1.6285548059662731,0.0,0.030490451772220317,0.927,116/359,24.75%,CALM1;UBB;PEBP1;RPS27A;FKBP1A;HSP90AA1;YWHAB;RPS6;PSMC3;PSMB5;PSMA7;FGFR2;EEF1G;PSMC2;SNW1;UBA52;SQSTM1;SEM1;PSMA5;DUSP7;PSENEN;FGF13;PSMA4;NRG3;CLSTN1;NRG4;POLR2F;CDC37;PPP2CA;PPP2R1A;PSMD2;PSMD4;TBL1XR1;PSMA3;PSMC5;PDGFA;PSMD7;RBX1;IRS2;POLR2I;PSMB1;APH1A;PSMB3;FGFR1;POLR2G;BAD;NPM1;POLR2E;HRAS;PSMA1;PSMC6;PSMD6;BAG4;POLR2C;CEBPB;FAM131B;FZD4;TRIM24;ERBIN;GSK3B;PSMC1;FOXO4;LYN;PIK3R1;RAP1A;MAPK3;PSME3;VCL;PSMC4;TBL1X;PPP2R5D;JAG1;ATIC;PSMB6;CDKN1B;SMAD2;PSMB7;PPP1CC;AKT1S1;HEY1;CAMK2B;PSMA2;ITGA2B;DUSP8;UBC;TLN1;POLR2J;VCP;PDGFB;FBXW7;CREB1;OS9;MAMLD1;MAPK1;PPP2R5A;POLR2B;KREMEN1;CSNK1A1;CNKSR2;PSMB10;NRAS;NCBP2;PRKAR1A;PSMD5;MIB2;LONP1;DUSP16;DKK2;POLR2L;QKI;PTPN11;DERL2;MRAS;HDAC10;AKT1;PSMD11
gsea,DNA Double Strand Break Response R-HSA-5693606,-0.43258833462676616,-1.6277042961149029,0.011627906976744186,0.030587866309383933,0.928,13/41,20.31%,UBB;RPS27A;UBA52;EYA1;H2BC4;UBE2N;UBXN1;RNF168;BABAM2;UBC;H2AX;UIMC1;RAD50
gsea,Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.5118799176336961,-1.6239677689388545,0.014256619144602852,0.03148326655675921,0.93,6/22,7.56%,RAB3A;VAMP2;PPFIA2;ARL6IP5;SLC38A2;SNAP25
gsea,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.41895275092849865,-1.6238023112976547,0.007722007722007722,0.03145114811200393,0.93,18/52,22.93%,UBB;RPS27A;SUMO2;UBA52;H2BC4;UBE2N;RPA3;PPP4C;RNF168;BABAM2;SIRT6;UBC;RFC3;H2AX;UIMC1;RAD50;RAD9B;RBBP8
gsea,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.3838365154646401,-1.6223506743426819,0.0036101083032490976,0.03167521527248053,0.933,26/87,19.97%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA
gsea,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.4811437441880705,-1.621702747990297,0.011560693641618497,0.03177687349762118,0.934,8/28,11.50%,APOE;PSENEN;NRG3;NRG4;STMN1;APH1A;GFAP;SPARC
gsea,Metalloprotease DUBs R-HSA-5689901,-0.5222948336211584,-1.621638136170951,0.021653543307086614,0.03169242611111485,0.934,4/20,4.57%,UBB;RPS27A;UBA52;H2AC25
gsea,Glucose Metabolism R-HSA-70326,-0.38918915665081566,-1.6184816137130842,0.003838771593090211,0.032469011372085764,0.938,24/72,17.67%,MDH2;PKM;ALDOC;MDH1;TPI1;PPP2CA;PPP2R1A;PGK1;ENO2;GOT2;G6PC3;NUP50;PGAM2;PFKL;NUP37;NUP205;PPP2R5D;SEH1L;SEC13;NUP107;PRKACB;PGP;ENO1;PFKFB3
gsea,Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.5511651168160029,-1.6150181496212794,0.024761904761904763,0.03317262853145766,0.941,5/15,9.69%,GNB2;GNG2;GNG13;GNG10;GNG3
gsea,Nucleotide Excision Repair R-HSA-5696398,-0.36831069074868766,-1.6131310444418434,0.0,0.0335984932849194,0.944,47/103,31.92%,UBB;RPS27A;SUMO2;UBA52;CETN2;COPS6;POLR2F;HMGN1;RBX1;POLR2I;UBE2N;PCNA;POLR2G;POLR2E;TCEA1;RPA3;PARP1;POLR2C;RUVBL1;GPS1;GTF2H5;DDB2;COPS8;YY1;UBC;PRPF19;RFC3;POLR2J;ACTR8;LRIG1;POLR2B;PPIE;ERCC3;SUMO1;POLR2L;GTF2H4;COPS7A;POLD4;POLD2;XAB2;COPS5;POLD3;POLR2D;GTF2H3;ACTL6A;XPA;RFC5
gsea,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.4992534276738796,-1.6114325518413146,0.020366598778004074,0.0339964022807097,0.945,9/23,25.15%,UBB;RPS27A;UBA52;ATG12;UBC;TBK1;IRF3;MAVS;PDZD2
gsea,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.5021482437985757,-1.6101978861634036,0.011516314779270634,0.03425169083785717,0.945,11/25,19.25%,H2AZ1;DEK;H2BC4;CDK4;PML;H2AJ;CEBPB;CEBPA;CBFB;H2AX;CREB1
gsea,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.5554876480867158,-1.609740926239757,0.020964360587002098,0.034335828454761345,0.945,7/15,20.08%,UBB;RPS27A;UBA52;STAM2;UBC;SH3GL2;EPS15
gsea,G2/M DNA Damage Checkpoint R-HSA-69473,-0.41716287633141375,-1.6079227595129513,0.009191176470588236,0.03470728647028042,0.946,17/49,22.93%,YWHAG;YWHAH;YWHAB;YWHAE;YWHAZ;H2BC4;YWHAQ;UBE2N;RPA3;RNF168;BABAM2;RFC3;H2AX;UIMC1;RAD50;RAD9B;RBBP8
gsea,Neurotransmitter Release Cycle R-HSA-112310,-0.42752121475120586,-1.6073005046869615,0.014084507042253521,0.03475595538802316,0.947,9/44,8.98%,RAB3A;VAMP2;HSPA8;LIN7C;PPFIA2;ARL6IP5;SLC38A2;SNAP25;LIN7B
gsea,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.5418899048359813,-1.6054301149839107,0.02240325865580448,0.03509478123225396,0.947,3/17,3.17%,UBB;RPS27A;UBA52
gsea,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.5315496687375396,-1.6052925688905058,0.025179856115107913,0.035053983507896305,0.947,10/19,31.92%,PCNA;RPA3;APEX1;RFC3;LRIG1;POLD4;POLD2;POLD3;FEN1;RFC5
gsea,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.37383298486956845,-1.6021490952981503,0.0018867924528301887,0.03589250966539122,0.95,35/97,21.64%,YWHAB;CDK5R2;CLTA;DUSP3;JUND;AP2M1;MEF2C;DUSP7;PPP2CA;EGR1;PPP2R1A;IRS2;CDK5R1;HRAS;DNAL4;RALA;VGF;EGR4;AP2B1;PIK3R1;RAP1A;MAPK3;PPP2R5D;ID4;ID2;EGR3;ID3;AP2S1;SH3GL2;CREB1;ASCL1;MAPK1;AP2A2;RHOA;NRAS
gsea,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.47667817747924923,-1.6012643756369231,0.018711018711018712,0.03604599625467771,0.95,7/28,13.14%,UBB;RPS27A;UBA52;UBA1;UBE2S;OTULIN;UBE2Z
gsea,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.5043264153130043,1.6010152390254067,0.021912350597609563,0.13479695163636196,0.95,9/21,6.98%,GRIA3;GRIN2A;GRIA1;LRRC7;GRIA4;ACTN2;CAMK2A;MPP3;CAMK2G
gsea,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.47062882993032956,-1.5998940481885606,0.010080645161290322,0.03622176808240454,0.951,6/29,5.59%,UBB;RPS27A;UBA52;USP2;PPP2CA;PPP2R1A
gsea,Regulation Of TP53 Degradation R-HSA-6804757,-0.47062882993032956,-1.5998940481885606,0.010080645161290322,0.03622176808240454,0.951,6/29,5.59%,UBB;RPS27A;UBA52;USP2;PPP2CA;PPP2R1A
gsea,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.49668831583287887,-1.5982350251513457,0.015384615384615385,0.036663029258286454,0.954,2/20,1.14%,CALM1;HSP90AA1
gsea,Adaptive Immune System R-HSA-1280218,-0.304904457659496,-1.5970021895364779,0.0,0.0369738933610913,0.957,112/499,17.72%,CALM1;UBB;HMGB1;PPIA;DYNLL1;RPS27A;DYNLL2;PPP3CA;FKBP1A;YWHAB;ICAM5;UBE3A;CALR;RASGRP1;PSMC3;PSMB5;PSMA7;PIANP;ELOB;CLTA;CAPZA2;PJA1;CDC42;CD81;ORAI2;PSMC2;UBA52;AP2M1;NCK1;RNF220;NDUFA2;SEM1;FBXL16;CANX;PSMA5;KLHL9;PSMA4;PDIA3;CTSB;UBE2J1;PPP3R1;CLSTN1;YWHAZ;PPP2CA;PPP3CB;DCTN6;PPP2R1A;ANAPC13;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;ACTR1B;RNF6;UBE2N;FBXW2;PSMB1;DCTN3;ITGAV;UBA1;UBE2S;PSMB3;FBXO9;SEC61G;ASB13;HRAS;RNF7;ACTR10;NFKBIB;PSMA1;PSMC6;STUB1;PSMD6;NCF2;FBXO6;UBE2V1;FBXO32;CTSO;ANAPC11;PSMC1;NPDC1;AP2B1;LYN;PIK3R1;RAP1A;MKRN1;PSME3;UBE2Z;ASB5;PSMC4;RNF114;BTBD6;PPP2R5D;PSMB6;SEC13;MAP3K8;PJA2;TRIM32;VASP;VAMP3;PSMB7;PRKACB;BCL10;CTSH;PSMA2;CD247;DCTN5;AP2S1;UBA3;UBC
gsea,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.4892764350265955,-1.596913080268433,0.009009009009009009,0.03690825010686667,0.958,13/25,32.18%,UBB;RPS27A;UBA52;PCNA;RPA3;UBC;RFC3;POLD4;POLD2;PCLAF;POLD3;RFC5;POLI
gsea,ESR-mediated Signaling R-HSA-8939211,-0.3528206178550127,-1.5959360771685012,0.002036659877800407,0.037089452156391624,0.958,55/138,29.24%,CALM1;HSP90AB1;DDX5;HSP90AA1;JUN;H2AZ1;GNB2;GNG2;JUND;POLR2F;SMC1A;H2BC4;PTGES3;GNG13;POLR2I;POLR2G;GNG10;RAD21;POLR2E;H2AJ;HRAS;GNG3;GNAI1;POLR2C;CXXC5;GNAI2;PIK3R1;MAPK3;CBFB;CDKN1B;FKBP4;YY1;POLR2J;H2AX;CREB1;MAPK1;POLR2B;GPAM;CXCL12;NRAS;EBAG9;POLR2L;CTSD;NRIP1;AKT1;FOXO3;GNG7;S1PR3;PRMT1;SMC3;GNG11;AKT3;FOSB;PIK3R2;KAT5
gsea,Complement Cascade R-HSA-166658,-0.5311904928668899,-1.5955357380994024,0.03377110694183865,0.037089408567331054,0.958,8/20,15.95%,PSMA7;CD81;VTN;MASP2;CLU;TTF2;C1QB;HNRNPC
gsea,Diseases Of Programmed Cell Death R-HSA-9645723,-0.4295281472287541,-1.595002738572621,0.009900990099009901,0.03717518238269803,0.958,10/44,9.74%,JUN;H2AZ1;YWHAE;H2BC4;CDK5R1;H2AJ;RBBP7;GSDME;PRDX1;C1QBP
gsea,Phase I - Functionalization Of Compounds R-HSA-211945,-0.44040250029625183,-1.5944540792144741,0.012727272727272728,0.037284958063868175,0.959,19/43,26.60%,HSP90AB1;AURKAIP1;PTGES3;FDX2;VDAC2;PAOX;CYB5R3;ADH5;ALDH1A1;ARNT2;MAOB;FDX1;CYB5B;MIA3;TBXAS1;ALDH2;SMOX;BPHL;CYP46A1
gsea,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.4654488411039228,-1.5941988235996412,0.017509727626459144,0.037231555017415686,0.959,11/26,21.64%,PEBP1;YWHAB;HRAS;RAP1A;MAPK3;VCL;ITGA2B;TLN1;MAPK1;CNKSR2;NRAS
gsea,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.5284701768529629,-1.5937452597140946,0.024096385542168676,0.03723519326726214,0.959,13/18,36.10%,GNB2;GNG2;GNG13;GNG10;GNG3;RHOA;AKT1;GNG7;GNG11;AKT3;GNB4;GNG5;GNB1
gsea,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.4196857215462095,-1.5935418774226215,0.011673151750972763,0.03721050628046412,0.959,17/46,19.64%,UBB;RPS27A;JUN;H2AZ1;UBA52;H2BC4;UBE2S;CDK4;H2AJ;IGFBP7;CEBPB;ANAPC11;MAPK3;CDKN1B;UBC;H2AX;MAPK1
gsea,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.45038680909571926,-1.592931267912117,0.015968063872255488,0.03737147463016218,0.962,13/33,21.64%,CALM1;PEBP1;YWHAB;HRAS;RAP1A;MAPK3;VCL;CAMK2B;ITGA2B;TLN1;MAPK1;CNKSR2;NRAS
gsea,Dual Incision In GG-NER R-HSA-5696400,-0.43453184708204795,-1.5868376580311039,0.016697588126159554,0.0390964271315043,0.968,19/39,31.92%,UBB;RPS27A;UBA52;RBX1;PCNA;RPA3;PARP1;GTF2H5;DDB2;UBC;RFC3;ERCC3;GTF2H4;POLD4;POLD2;POLD3;GTF2H3;XPA;RFC5
gsea,Transmission Across Chemical Synapses R-HSA-112315,0.327278107487194,1.5867853418252482,0.002004008016032064,0.14475457028415692,0.959,48/197,10.37%,GRIK4;GRIA3;NBEA;GRIN2A;CACNA1E;GRIA1;CACNA1A;LRRC7;CACNA2D3;GABRA2;CACNB2;GRIA4;GABRG3;RPS6KA2;PRKAG2;GABBR2;ADCY8;CACNA1B;NRG1;CHRNA4;UNC13B;ADCY2;KCNJ6;PPM1E;ACTN2;PRKCG;CAMK2A;MAPT;EPB41L1;GRIK5;SLC6A1;CASK;RIMS1;RASGRF2;MPP3;CACNG3;SYN2;ADCY9;CAMK2G;GRIK1;SLC1A1;STX1A;GABRB1;RPS6KA6;ADCY6;ARHGEF7;RASGRF1;ERBB4
gsea,RAC1 GTPase Cycle R-HSA-9013149,0.3545148238969298,1.5812094563731143,0.004106776180698152,0.14544185973660567,0.964,34/148,12.39%,DOCK9;KALRN;TRIO;CYFIP1;DOCK3;IQGAP2;DOCK10;DOCK11;ARHGAP15;MYO9B;ABR;DOCK7;DOCK4;SRGAP2;FMNL1;DLC1;SH3BP1;RASGRF2;GMIP;ABL2;SOS1;PIK3R3;PREX2;DHDDS;TIAM1;CDC42BPA;LBR;ARHGEF7;ARHGEF18;ARAP2;WIPF2;ARAP1;LEMD3;FARP1
gsea,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.459423595610585,-1.5766903930389629,0.02181818181818182,0.04221268763490813,0.973,12/27,24.72%,ELOB;POLR2F;POLR2I;POLR2G;POLR2E;TCEA1;POLR2C;POLR2J;ELOC;POLR2B;POLR2L;SSRP1
gsea,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.4749156219374996,1.575985659282537,0.026,0.14606929016806375,0.968,8/24,6.98%,NBEA;GRIN2A;LRRC7;ACTN2;CAMK2A;CASK;MPP3;CAMK2G
gsea,COPI-mediated Anterograde Transport R-HSA-6807878,-0.38343905981748533,-1.5758077170387037,0.010183299389002037,0.042387458776043906,0.973,23/70,17.43%,DYNLL1;DYNLL2;TMED9;CAPZA2;ARF4;TMED2;BET1L;DCTN6;ARF3;DCTN3;NAPG;ARF5;RAB1B;ACTR10;TMED7;COPG2;ARFGAP2;COPG1;GOSR1;ANK1;COPB2;NSF;DCTN5
gsea,Telomere Maintenance R-HSA-157579,-0.3853134062289055,-1.574933203468256,0.003590664272890485,0.042593258678793586,0.974,33/64,32.80%,H2AZ1;POLR2F;H2BC4;NOP10;POLR2I;PCNA;POLR2G;POLR2E;H2AJ;GAR1;RPA3;POLR2C;RUVBL1;TERF1;DKC1;NHP2;RFC3;POLR2J;H2AX;ANKRD28;LRIG1;POLR2B;DAXX;POLR2L;POLD4;POLD2;TINF2;POLD3;POLR2D;FEN1;H2AZ2;RFC5;POLR2K
gsea,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.5115552606538549,-1.5716044434324674,0.04038461538461539,0.043590258366949096,0.978,6/22,12.71%,CALM1;ORAI2;NCK1;CLSTN1;LYN;PIK3R1
gsea,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.44933124457731705,-1.5711065137960267,0.029574861367837338,0.043577475513072395,0.978,16/32,32.18%,UBB;RPS27A;UBA52;PCNA;RPA3;UBC;RFC3;VCP;MAD2L2;POLD4;POLD2;RCHY1;PCLAF;POLD3;RFC5;POLI
gsea,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.3387741569928839,1.5693714943984465,0.00625,0.1479605768808102,0.971,37/142,10.37%,GRIK4;GRIA3;NBEA;GRIN2A;GRIA1;LRRC7;GABRA2;GRIA4;GABRG3;RPS6KA2;PRKAG2;GABBR2;ADCY8;NRG1;CHRNA4;ADCY2;KCNJ6;PPM1E;ACTN2;PRKCG;CAMK2A;MAPT;EPB41L1;GRIK5;CASK;RASGRF2;MPP3;CACNG3;ADCY9;CAMK2G;GRIK1;GABRB1;RPS6KA6;ADCY6;ARHGEF7;RASGRF1;ERBB4
gsea,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.4927184970567766,-1.5670835162842214,0.03968253968253968,0.04472130966224153,0.981,5/20,11.42%,UBB;RPS27A;UBA52;UBE2S;ANAPC11
gsea,Inflammasomes R-HSA-622312,-0.5574658631065132,-1.5626680151251007,0.03913894324853229,0.04614769137681143,0.981,2/15,4.39%,HSP90AB1;NFKB2
gsea,Activation Of GABAB Receptors R-HSA-991365,-0.4407076364829415,-1.562636960927968,0.016,0.04603390825883067,0.981,11/32,12.01%,KCNJ3;GNB2;GNG2;KCNJ2;GNG13;KCNJ4;GNG10;GNG3;GNAI1;KCNJ16;GNAI2
gsea,RHOB GTPase Cycle R-HSA-9013026,0.3982353351858426,1.5625087953104047,0.014028056112224449,0.15068133955485816,0.974,28/59,26.19%,ARHGEF28;MYO9A;MYO9B;TJP2;ROCK1;ABR;STK10;DLC1;DHDDS;PRPF38B;ARHGEF17;ARHGEF3;ARHGEF2;ARHGAP32;ARHGEF10L;VANGL1;STARD13;ARHGEF11;AKAP13;DAAM1;PREX1;ARHGDIG;ARHGAP39;FLOT2;MCAM;SNAP23;MCF2;RTKN
gsea,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.5063195691895885,-1.5621198933366882,0.02404809619238477,0.04610937095356513,0.982,6/19,25.28%,ATAD1;PEX12;PEX19;PEX11B;FIS1;SLC25A17
gsea,Fanconi Anemia Pathway R-HSA-6783310,-0.4433769772241589,-1.5612774268661476,0.01107011070110701,0.04625110047518435,0.982,4/33,5.09%,UBB;RPS27A;UBA52;CENPX
gsea,ER To Golgi Anterograde Transport R-HSA-199977,-0.3458512296953203,-1.5599875510000087,0.00392156862745098,0.046591555836051526,0.982,32/116,16.48%,CNIH2;DYNLL1;DYNLL2;TRAPPC6B;TMED9;CAPZA2;CNIH1;ARF4;TMED2;BET1L;DCTN6;ARF3;DCTN3;TRAPPC2L;NAPG;ARF5;TRAPPC2;RAB1B;ACTR10;LMAN2;TMED7;TRAPPC1;MCFD2;LMAN1;COPG2;ARFGAP2;COPG1;GOSR1;ANK1;SEC13;COPB2;NSF
gsea,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.4058427802261273,-1.5560883765015725,0.013592233009708738,0.047858677514663994,0.982,5/49,2.69%,FTH1;VAMP2;HSPA8;CLTA;NECAP1
gsea,RAF Activation R-HSA-5673000,-0.45310333697017374,-1.5560805729971317,0.0297029702970297,0.047738126689690026,0.982,10/30,21.64%,CALM1;YWHAB;PPP2CA;PPP2R1A;HRAS;PPP2R5D;PPP1CC;CAMK2B;PPP2R5A;NRAS
gsea,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.33344558406359653,-1.5557442792118392,0.003968253968253968,0.04775790408147683,0.982,43/150,18.94%,UBB;RPS27A;H2AZ1;PSMC3;LMO1;PSMB5;PSMA7;PSMC2;UBA52;SEM1;PSMA5;PSMA4;H2BC4;SIN3B;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;PSMB1;PSMB3;PML;H2AJ;PSMA1;PSMC6;CSNK2B;PSMD6;CBX6;PSMC1;PSME3;PSMC4;CBFB;PSMB6;SMARCE1;PSMB7;MYL9;CBX4;PSMA2;ITGA2B;CCND3;UBC;ACTL6B;H2AX
gsea,HIV Elongation Arrest And Recovery R-HSA-167287,-0.4469691505725597,-1.554237517982437,0.026119402985074626,0.048211184900813414,0.982,12/29,24.72%,ELOB;POLR2F;POLR2I;POLR2G;POLR2E;TCEA1;POLR2C;POLR2J;ELOC;POLR2B;POLR2L;SSRP1
gsea,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.5170060257682803,-1.5541532959850048,0.044444444444444446,0.0481292746667703,0.982,4/18,7.56%,RAB3A;VAMP2;HSPA8;SNAP25
gsea,Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.3653977245620499,-1.5536209332226885,0.01059322033898305,0.048201858661161966,0.982,22/81,19.64%,UBB;RPS27A;FKBP1A;SNW1;UBA52;PPP1CA;NEDD8;SKIL;ITGAV;YBX1;STUB1;PARP1;WWTR1;BAMBI;MAPK3;SMAD2;SMAD7;PPP1CC;COL1A2;UBC;E2F4;MAPK1
gsea,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.3845158181231188,-1.549351812367853,0.02912621359223301,0.04963050522849167,0.987,13/74,6.68%,HSP90AB1;ACTG1;HSP90AA1;BRK1;CDC42;NCK1;ARPC5;WASL;ARPC2;ARPC1A;ACTR2;ARPC3;ABI1
gsea,Signaling By EGFR R-HSA-177929,-0.4035456341454348,-1.5472626813606078,0.013071895424836602,0.05031612091299476,0.988,15/45,21.64%,UBB;RPS27A;CDC42;UBA52;SPRY2;HRAS;EPN1;PIK3R1;STAM2;UBC;SH3GL2;AAMP;EPS15;LRIG1;NRAS
gsea,Signaling By NOTCH2 R-HSA-1980145,-0.45082889860368464,-1.544898225951303,0.0398406374501992,0.05109010735916012,0.989,9/28,19.61%,UBB;RPS27A;UBA52;PSENEN;APH1A;JAG1;UBC;CREB1;MAMLD1
gsea,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.3945200735788068,-1.5413703629140212,0.025974025974025976,0.05224549540797161,0.989,17/70,15.97%,ATP1B1;PPIA;TSPAN7;BSG;CD47;ATP1B2;SELPLG;ITGAV;HRAS;TEK;ANGPT2;LYN;PIK3R1;TTF2;JAM2;SLC16A1;GPC1
gsea,Intracellular Signaling By Second Messengers R-HSA-9006925,-0.31152932379923354,-1.5404102757337832,0.0038022813688212928,0.052508696257264106,0.989,67/255,16.75%,CALM1;UBB;RPS27A;JUN;PSMC3;PSMB5;PSMA7;FGFR2;LAMTOR2;PSMC2;UBA52;RHEB;SEM1;RRAGA;PSMA5;FGF13;VAPA;PSMA4;NRG3;CLSTN1;NRG4;PPP2CA;EGR1;PPP2R1A;LAMTOR3;PSMD2;PSMD4;PSMA3;PSMC5;PDGFA;PSMD7;IRS2;PIP4K2A;PSMB1;RRAGD;PSMB3;CHD3;FGFR1;BAD;PML;RBBP7;PSMA1;PSMC6;CSNK2B;STUB1;PSMD6;CBX6;GSK3B;PRKAR1B;PSMC1;FOXO4;PIK3R1;MKRN1;MAPK3;PSME3;PSMC4;PPP2R5D;PDE1C;PSMB6;CDKN1B;PSMB7;PRKACB;AKT1S1;CBX4;IRAK4;CAMK2B;PSMA2
gsea,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.4611649119164414,-1.5392632574688514,0.03639846743295019,0.05281994333989826,0.989,8/27,10.93%,TUBB2A;TUBA1A;TUBB2B;TUBB4A;TUBB4B;AGBL2;TPGS1;TUBA1B
gsea,DNA Damage Bypass R-HSA-73893,-0.4195786103378042,-1.5386680028646744,0.020146520146520148,0.05291007369799822,0.989,18/40,32.18%,UBB;RPS27A;UBA52;RBX1;PCNA;RPA3;UBC;RFC3;VCP;MAD2L2;POLD4;POLD2;RCHY1;PCLAF;POLD3;USP1;RFC5;POLI
gsea,Estrogen-dependent Gene Expression R-HSA-9018519,-0.3567756453012033,-1.5348227036007922,0.009861932938856016,0.05427254321389762,0.99,17/85,10.59%,HSP90AB1;DDX5;HSP90AA1;JUN;H2AZ1;JUND;POLR2F;SMC1A;H2BC4;PTGES3;POLR2I;POLR2G;RAD21;POLR2E;H2AJ;POLR2C;CXXC5
gsea,MTOR Signaling R-HSA-165159,-0.4185081992609029,-1.5275452760915458,0.027624309392265192,0.05698469650339841,0.993,8/39,7.76%,FKBP1A;YWHAB;RPS6;LAMTOR2;RHEB;RRAGA;LAMTOR3;RRAGD
gsea,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.3511973049849667,1.5259154894489337,0.008620689655172414,0.18878323641919462,0.987,17/87,9.78%,DOCK9;DOCK3;DOCK10;DOCK11;KIF26B;PHF21A;DOCK7;DOCK4;KIF1B;VPS45;CARMIL1;HDAC1;JAK2;KIF3C;KIFC1;KIF1C;CABLES1
gsea,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.4123039202401202,-1.5255031715598433,0.03515625,0.05764283187738429,0.993,11/50,6.68%,ACTG1;BRK1;CDC42;NCK1;ARPC5;WASL;ARPC2;ARPC1A;ACTR2;ARPC3;ABI1
gsea,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.35943779923446745,-1.5241770556506933,0.01282051282051282,0.05803157254539617,0.993,21/81,17.22%,CALM1;GNAS;GLP2R;GNB2;GNG2;PLK2;RAMP2;GNG13;GNG10;GNG3;GNAI1;ADRB1;PRKAR1B;GNAI2;LYN;CHGA;RAMP1;PRKACB;HCK;PTRH2;CD247
gsea,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.5138604304195317,-1.5229299362584041,0.03815261044176707,0.05849697522396365,0.993,3/16,3.17%,UBB;RPS27A;UBA52
gsea,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.43641522601912064,1.5210400231670982,0.044897959183673466,0.18911508444481148,0.989,8/30,6.98%,GRIA3;GRIA1;GRIA4;PRKCG;CAMK2A;EPB41L1;CACNG3;CAMK2G
gsea,FOXO-mediated Transcription R-HSA-9614085,-0.3850540632219472,-1.519405021262668,0.020257826887661142,0.05980710777397995,0.993,20/51,25.35%,YWHAG;YWHAB;YWHAZ;YWHAQ;AGRP;CITED2;PINK1;NFYB;FBXO32;FOXO4;CDKN1B;SMAD2;BTG1;ABCA6;NPY;BBC3;CCNG2;SIN3A;AKT1;FOXO3
gsea,Signaling By TGFB Family Members R-HSA-9006936,-0.34170937677864094,-1.519156708944449,0.004008016032064128,0.059782104362735206,0.993,34/100,26.76%,UBB;RPS27A;FKBP1A;SNW1;UBA52;DRAP1;PPP1CA;NEDD8;SKIL;ITGAV;INHBA;YBX1;STUB1;PARP1;WWTR1;BAMBI;MAPK3;SMAD2;SMAD7;PPP1CC;BMPR2;COL1A2;UBC;E2F4;BMPR1B;MAPK1;RHOA;SMAD9;TGFB2;FST;SMAD5;LTBP1;BMPR1A;RNASEH2A
gsea,Collagen Formation R-HSA-1474290,0.39612139663309276,1.5162601402965268,0.024943310657596373,0.19000560409157677,0.99,23/52,21.05%,DST;COL23A1;P3H2;COL11A1;ADAMTS3;COL19A1;COLGALT2;LAMB3;COL16A1;P3H1;COL15A1;COL5A1;COL5A2;BMP1;COL4A1;ADAMTS2;COL12A1;COL9A2;COL25A1;COL4A4;COL4A2;PXDN;COL13A1
gsea,Ion Transport By P-type ATPases R-HSA-936837,-0.4115651252257485,-1.5144766712236812,0.042,0.06145788649862942,0.993,12/40,16.44%,CALM1;ATP1B1;ATP1A3;ATP1B2;CUTC;ATP1A2;ATP13A5;ATP2B1;SRI;FXYD1;ATP13A2;CAMK2B
gsea,Transport Of Small Molecules R-HSA-382551,-0.2867109016725963,-1.513689078237434,0.0,0.06162907858145924,0.994,101/471,16.75%,FTH1;CALM1;ATP1B1;UBB;SLC25A4;ATP6V0C;GNAS;APOE;ATP6V1D;RPS27A;ATP6V1A;PSMC3;ATP6V1G2;PSMB5;PSMA7;ATP6V0E2;GNB2;NCEH1;SLC15A2;SLC25A5;CLTA;VDAC1;BSG;ATP1A3;SLC22A17;GNG2;SMDT1;PSMC2;UBA52;ATP6V0B;AP2M1;SEM1;ATP6V1F;PSMA5;PSMA4;ATP1B2;NEDD8;LCAT;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;GNG13;SLC38A2;SLC39A3;EIF2S2;PSMB1;RAB11A;ATP6V1E1;CUTC;PSMB3;SLC3A1;GNG10;CLCN4;AQP4;PSMA1;PSMC6;GNG3;SLC24A5;ATP1A2;PSMD6;HMOX2;ADD2;RNF5;P4HB;ATP13A5;ATP2B1;PRKAR1B;VDAC2;PSMC1;AP2B1;ATP6V1C1;SLC18A2;SRI;SLC8A2;LDLR;AQP11;PSME3;SLC35B3;ALAD;PLTP;PSMC4;SLC35A1;ANGPTL3;PSMB6;SLC41A1;ABCB10;SLC16A1;SLC38A5;FXYD1;ATP13A2;ARL2BP;RNF185;PSMB7;PRKACB;ATP6V1B2;SLC13A4;CAMK2B;ATP6V1G1;PSMA2
gsea,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.5004081949352434,-1.512265380738753,0.04563492063492063,0.06212095800878994,0.994,6/18,12.97%,GNB2;GNG2;GNG13;GNG10;GNG3;GNA11
gsea,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.48962896576419573,-1.5119936308309716,0.04480651731160896,0.062094357634629976,0.994,13/21,30.18%,UBB;RPS27A;UBA52;RNF5;RNF185;UBC;OS9;RNF139;DERL2;RNF103;UGGT1;EDEM3;EDEM1
gsea,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.3445084747973387,-1.509834167692845,0.015444015444015444,0.06285127212972781,0.994,14/93,7.40%,TUBA4A;DYNLL1;YWHAG;TUBA1A;HSP90AA1;YWHAE;CETN2;CSNK1E;PPP2R1A;PAFAH1B1;TUBB4A;TUBB4B;DCTN3;RAB11A
gsea,Signaling By ERBB2 R-HSA-1227986,-0.39531531563221145,-1.5081429454767001,0.03347280334728033,0.06339544969060587,0.996,11/44,12.71%,UBB;RPS27A;HSP90AA1;UBA52;NRG3;NRG4;CDC37;HRAS;STUB1;ERBIN;PIK3R1
gsea,GPER1 Signaling R-HSA-9634597,-0.4196747504249037,-1.507914792687474,0.024291497975708502,0.06336235784799167,0.996,9/33,12.01%,GNAS;GNB2;GNG2;GNG13;GNG10;GNG3;GNAI1;PRKAR1B;GNAI2
gsea,Asparagine N-linked Glycosylation R-HSA-446203,-0.30453091740832844,-1.5068179476308279,0.001890359168241966,0.0636142624491057,0.996,81/246,25.27%,UBB;CNIH2;DYNLL1;RPS27A;DYNLL2;CALR;TRAPPC6B;TMED9;PMM1;CAPZA2;DPM3;UBA52;CNIH1;ARF4;CANX;TMED2;PDIA3;BET1L;DCTN6;ARF3;DAD1;DCTN3;TRAPPC2L;DDOST;NAPG;ARF5;FUCA1;TRAPPC2;RAB1B;ACTR10;UBXN1;LMAN2;CMAS;TMED7;RNF5;TRAPPC1;ALG14;PSMC1;DPM2;MCFD2;CHGA;LMAN1;SLC35A1;COPG2;ARFGAP2;COPG1;GOSR1;GMPPB;ANK1;SEC13;NANP;COPB2;RNF185;NSF;DCTN5;GNE;UBC;EGFL7;VCP;OS9;GNPNAT1;ANKRD28;RNF139;ST6GAL1;COPE;DPM1;STT3A;CHST8;MANEA;MIA3;DERL1;AMDHD2;DERL2;ALG13;ALG5;RNF103;B4GALT6;TUSC3;KDELR1;TMEM115;ALG11
gsea,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.47555399035060303,-1.5047691657941054,0.04181818181818182,0.06439688337931838,0.996,9/23,31.19%,ICAM5;PIANP;CD81;NPDC1;CD247;CD300A;B2M;ICAM4;CD33
gsea,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.5154563144112099,-1.502561197541044,0.057692307692307696,0.06530666733720264,0.997,3/16,3.17%,UBB;RPS27A;UBA52
gsea,EPH-Ephrin Signaling R-HSA-2682334,-0.3599235938738177,-1.4981653508987516,0.017928286852589643,0.06711507337265735,0.997,26/79,17.94%,EPHA5;EPHA7;MYL6;ACTG1;CLTA;CDC42;AP2M1;ARPC5;WASL;PSENEN;MYL12B;ARPC2;ARPC1A;ACTR2;ARPC3;APH1A;HRAS;AP2B1;LYN;MYH14;MYL9;CLTB;EPHA4;GPRIN1;AP2S1;EFNB3
gsea,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.31826478575914136,-1.497182822510255,0.001984126984126984,0.06746435722417318,0.997,35/152,16.48%,DYNLL1;DYNLL2;TMED9;CAPZA2;ARF4;RAB6B;TMED2;BET1L;DCTN6;PAFAH1B1;RAB6A;ARF3;STX16;CYTH2;DCTN3;NAPG;ARF5;RAB1B;ACTR10;RAB18;NAA38;PAFAH1B2;TMED7;SCOC;SURF4;UBE2Z;COPG2;ARFGAP2;COPG1;GOSR1;CYTH4;COPB2;SNAP29;VAMP3;NSF
gsea,GPCR Ligand Binding R-HSA-500792,-0.3295417986667934,-1.4944128003219261,0.004862236628849271,0.06841473419889585,0.997,50/153,25.87%,PLPPR4;GNAS;GLP2R;GNB2;NPY1R;GRM3;GNG2;P2RY14;P2RY12;RAMP2;PROKR2;GNG13;FZD2;GNG10;NPY5R;GNG3;ADRB1;S1PR1;CX3CL1;ADRA2C;FZD4;CHGA;PLPPR5;SSTR2;TTF2;WNT16;RAMP1;HEBP1;GPR37;GRM1;OPRM1;PTRH2;SSTR1;ACKR4;HTR2A;GPR37L1;ADGRE1;NPY;CXCR6;CXCL12;ADORA1;PLPPR3;GRM2;MC4R;PDYN;GPNMB;OPRD1;SMOX;GNG7;S1PR3
gsea,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.3805777234554499,-1.4938285547583958,0.025896414342629483,0.0685217126168434,0.997,23/51,28.99%,UBB;RPS27A;UBA52;NFKB2;POLR2F;POLR2E;NFKBIB;POLR3H;POLR3D;NLRC3;TRIM32;UBC;NKIRAS1;NFKBIA;TBK1;IRF3;XRCC6;POLR2L;POLR3E;RELA;POLR3A;NKIRAS2;POLR1D
gsea,Base Excision Repair R-HSA-73884,-0.40038801321144735,-1.4928380296073205,0.023297491039426525,0.06886528835022264,0.997,21/47,31.92%,H2AZ1;H2BC4;PCNA;MPG;H2AJ;RPA3;PARP1;TERF1;ADPRS;APEX1;TDG;RFC3;H2AX;LRIG1;POLD4;POLD2;TINF2;POLD3;FEN1;H2AZ2;RFC5
gsea,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.45903537823178076,-1.4885857170001033,0.05742574257425743,0.07060503440516178,0.997,5/23,11.42%,UBB;RPS27A;UBA52;UBE2S;ANAPC11
gsea,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.4800334773706824,1.4815368999564578,0.04780876494023904,0.23272012773396097,0.996,5/19,3.81%,PTPRS;IL1RAPL2;NTRK3;PTPRD;PTPRF
gsea,Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.46680694119098043,-1.4810767193336056,0.06666666666666667,0.07411028100536708,0.998,7/23,12.47%,RAB3A;VAMP2;LIN7C;PPFIA2;SNAP25;LIN7B;SLC18A2
gsea,Phase 0 - Rapid Depolarisation R-HSA-5576892,0.442177345953403,1.4807282812385933,0.045081967213114756,0.22755736700486257,0.996,8/27,6.98%,CACNA1C;SCN1A;CACNB2;SCN8A;FGF14;CAMK2A;SCN7A;CAMK2G
gsea,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.5046889591471921,-1.4789516927277848,0.07233273056057866,0.07500579543579029,0.998,10/17,29.48%,DUSP7;MAPK3;DUSP8;DUSP5;MAPK1;DUSP16;JAK1;PTPN11;DUSP6;MAP2K1
gsea,Negative Regulation Of MET Activity R-HSA-6807004,-0.46276715932242535,-1.4779790129342516,0.056451612903225805,0.0752387241113591,0.998,9/21,20.53%,UBB;RPS27A;UBA52;STAM2;UBC;PTPN1;SH3GL2;EPS15;LRIG1
gsea,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.38856912733797827,-1.4765133869690796,0.03171641791044776,0.07566944095666775,0.998,20/50,26.76%,HSPA8;HSP90AA1;CEBPD;NDN;FGF13;IL18;S1PR1;PIK3R1;COL1A2;OPRM1;VIM;IL13RA1;LONP1;JAK1;HSP90B1;AKT1;OPRD1;FOXO3;FSCN1;RNASEH2A
gsea,Interleukin-17 Signaling R-HSA-448424,-0.37291925560152234,-1.4731675622950466,0.03802281368821293,0.07706539669727622,0.998,18/58,19.64%,UBB;RPS27A;JUN;DUSP3;UBA52;MEF2C;DUSP7;PPP2CA;PPP2R1A;UBE2N;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IL17RB;UBC;CREB1;MAPK1
gsea,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.28967235464843116,-1.4719088691508089,0.0038684719535783366,0.07760307598155712,0.998,75/385,13.02%,CALM1;UBB;ATP6V0C;APOE;ATP6V1D;RPS27A;ATP6V1A;HSP90AA1;YWHAB;ATP6V1G2;ATP6V0E2;GABRG2;CDK5R2;FGFR2;CLTA;BRK1;CDC42;DUSP3;JUND;UBA52;ATP6V0B;AP2M1;NCK1;SPRY2;MEF2C;FLRT2;ATP6V1F;BAX;DUSP7;VEGFC;PSENEN;FGF13;NRG3;NRG4;POLR2F;CDC37;PPP2CA;EGR1;PPP2R1A;HNRNPA1;STMN1;PDGFA;ABI1;IRS2;POLR2I;CDK5R1;ATP6V1E1;ITGAV;APH1A;FGFR1;POLR2G;POLR2E;HRAS;EPN1;HNRNPF;AXL;STUB1;GFAP;DNAL4;NCF2;POLR2C;RALA;VEGFB;COL4A5;SPARC;ERBIN;CTNNA1;VGF;EGR4;AP2B1;LYN;ATP6V1C1;PIK3R1;RAP1A;MAPK3
gsea,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.3486126661820052,-1.4700300341850328,0.026871401151631478,0.07838164469800252,0.998,33/79,31.92%,UBB;RPS27A;SUMO2;UBA52;CETN2;COPS6;RBX1;UBE2N;PCNA;RPA3;PARP1;RUVBL1;GPS1;GTF2H5;DDB2;COPS8;YY1;UBC;RFC3;ACTR8;LRIG1;ERCC3;SUMO1;GTF2H4;COPS7A;POLD4;POLD2;COPS5;POLD3;GTF2H3;ACTL6A;XPA;RFC5
gsea,Meiotic Recombination R-HSA-912446,-0.44576335997547833,-1.4687258277720892,0.055449330783938815,0.07886461433680214,0.999,13/27,31.67%,H2AZ1;H2BC4;CDK4;H2AJ;RPA3;H2AX;RAD50;RBBP8;RAD51;PSMC3IP;MLH1;MLH3;H2AZ2
gsea,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.3755666264403004,-1.4684776913722013,0.037037037037037035,0.0788152725718303,0.999,23/51,26.33%,RAN;H2AZ1;POLR2F;H2BC4;POLR2I;POLR2G;POLR2E;H2AJ;NUP50;POLR2C;NUP37;NUP205;SEH1L;SEC13;NUP107;IPO8;POLR2J;H2AX;POLR2B;NUP35;POLR2L;NUP62;NUP85
gsea,Other Semaphorin Interactions R-HSA-416700,0.488396540810208,1.4651187889937722,0.05928853754940711,0.2450670798895078,0.997,4/18,6.20%,PLXNA4;PLXNC1;PLXNA2;SEMA4D
gsea,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.5037192186682464,-1.4647595126544015,0.06191369606003752,0.08042622436848436,0.999,4/17,17.03%,CALM1;RNF7;METAP2;NMT1
gsea,Phototransduction Cascade R-HSA-2514856,-0.5037192186682464,-1.4647595126544015,0.06191369606003752,0.08042622436848436,0.999,4/17,17.03%,CALM1;RNF7;METAP2;NMT1
gsea,Mitotic Prophase R-HSA-68875,-0.3421894964414405,-1.4601001035060956,0.015384615384615385,0.08285289751440364,0.999,24/82,20.46%,SET;RAB2A;H2AZ1;BANF1;H2BC4;PPP2CA;PPP2R1A;ENSA;H2AJ;RAB1B;EMD;NUP50;NCAPH2;NUP37;MAPK3;NUP205;SEH1L;CTDNEP1;SEC13;NUP107;NEK6;H2AX;MAPK1;KMT5A
gsea,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.513005056726774,-1.4597350799547915,0.06336633663366337,0.08287155729156273,0.999,7/15,21.09%,CLTA;AP2M1;FZD4;AP2B1;CLTB;AP2S1;AP2A2
gsea,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.43824308699702336,-1.45859319070575,0.05166051660516605,0.08326850015959048,0.999,14/27,23.65%,H2AZ1;POLR2F;H2BC4;POLR2I;POLR2G;POLR2E;H2AJ;POLR2C;TERF1;POLR2J;H2AX;POLR2B;DAXX;POLR2L
gsea,Membrane Trafficking R-HSA-199991,-0.27880737558182056,-1.4582896529638973,0.0,0.08326536357583107,0.999,108/496,17.72%,FTH1;CALM1;UBB;CNIH2;DYNLL1;RAB3A;VAMP2;RPS27A;YWHAG;DYNLL2;YWHAH;HSPA8;YWHAB;TRAPPC6B;TMED9;CLTA;CAPZA2;YWHAE;NECAP1;UBA52;CNIH1;AP2M1;ARF4;ARPC5;GABARAPL2;WASL;RAB6B;GABARAP;MAP1LC3B;TMED2;COPS6;ARPC2;BET1L;YWHAZ;DCTN6;NEDD8;YWHAQ;RAB14;PAFAH1B1;RAB6A;ARPC1A;ARF3;STX16;ACTR2;VPS28;ARPC3;CHMP4B;CYTH2;SBF1;UBQLN2;DCTN3;TRAPPC2L;RAB11A;NAPG;ARF5;TRAPPC2;RAB1B;EPN1;ACTR10;RAB18;LMAN2;NAA38;PAFAH1B2;CHMP2A;TMED7;TSG101;RAB31;RALA;GPS1;SCOC;CHMP6;FZD4;GJA1;TRAPPC1;AP2B1;HIP1R;MCFD2;LDLR;BLOC1S4;SURF4;UBE2Z;COPS8;LMAN1;STAM2;COPG2;ARFGAP2;VPS4A;PACSIN2;COPG1;GOSR1;SNX5;ANK1;SEC13;UBAP1;CYTH4;COPB2;SNAP29;VAMP3;RAB32;CHMP4C;NSF;CLTB;PUM1;TBC1D7;DCTN5;AP2S1;CHMP7;UBC
gsea,Signaling By RAF1 Mutants R-HSA-9656223,-0.41606378172869946,-1.4577189817531777,0.043824701195219126,0.08337973568006192,0.999,12/31,21.64%,CALM1;YWHAB;HRAS;RAP1A;MAPK3;VCL;CAMK2B;ITGA2B;TLN1;MAPK1;CNKSR2;NRAS
gsea,G Alpha (I) Signaling Events R-HSA-418594,-0.31810525648733706,-1.455269465357619,0.014285714285714285,0.08463488898357306,0.999,44/143,21.73%,CALM1;GNAS;PPP3CA;GNB2;NPY1R;GRM3;GNG2;P2RY14;P2RY12;PPP3R1;PPP1CA;PPP2CA;PPP3CB;PPP2R1A;RGS4;GNG13;GNG10;NPY5R;GNG3;GNAI1;CX3CL1;ADRA2C;PRKAR1B;GNAI2;PPP1R1B;GNA11;SSTR2;PPP2R5D;PDE1C;HEBP1;GPR37;PRKACB;CAMK2B;OPRM1;SSTR1;ACKR4;GPR37L1;CREB1;MAPK1;NPY;CXCR6;PLCB1;CXCL12;PRKAR1A
gsea,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.3657359586133725,-1.4551787194637371,0.025896414342629483,0.08449111688933045,0.999,14/54,19.61%,UBB;RPS27A;SNW1;UBA52;PSENEN;TBL1XR1;RBX1;APH1A;TBL1X;JAG1;HEY1;UBC;FBXW7;MAMLD1
gsea,Translation Of Structural Proteins R-HSA-9683701,-0.44113318708291543,-1.4547125038583426,0.0536779324055666,0.08452648350367233,0.999,9/25,20.74%,UBB;RPS27A;UBA52;CANX;GSK3B;PARP16;UBC;PARP4;ST6GAL1
gsea,Opioid Signaling R-HSA-111885,-0.35425407660561004,-1.454690717857337,0.029469548133595286,0.08434248843853859,0.999,22/74,16.95%,CALM1;PPP3CA;GNB2;GNG2;PPP3R1;PPP1CA;PPP2CA;PPP3CB;PPP2R1A;GNG13;GNG10;GNG3;GNAI1;PRKAR1B;GNAI2;PPP1R1B;GNA11;PPP2R5D;PDE1C;PRKACB;CAMK2B;OPRM1
gsea,Kinesins R-HSA-983189,0.4153718106117889,1.4536023144146304,0.043121149897330596,0.2570889489582969,0.999,9/29,20.97%,KIF26B;KIF1B;KIF3C;KIFC1;KIF1C;CENPE;KIF16B;KIF5A;KIF27
gsea,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.3650514872134452,-1.451501193029578,0.04230769230769231,0.08592957151194242,0.999,20/53,24.87%,ELOB;POLR2F;POLR2I;POLR2G;POLR2E;TCEA1;POLR2C;GTF2H5;RTF1;SKIC8;POLR2J;ELOC;CDC73;DMAP1;POLR2B;NCBP2;ERCC3;POLR2L;SSRP1;GTF2H4
gsea,Ephrin Signaling R-HSA-3928664,0.5076376855427202,1.4491240503738028,0.07128309572301425,0.2575482099351695,0.999,6/16,10.19%,EPHB1;EPHB2;NCK2;EFNB2;ARHGEF7;FYN
gsea,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.3745388821514316,-1.4482123776758635,0.04900181488203267,0.08756079690494567,0.999,20/52,31.92%,UBB;RPS27A;UBA52;SEM1;PCNA;RPA3;UBC;RFC3;XRCC2;RAD50;RAD9B;RBBP8;RAD51;POLD4;POLD2;PALB2;KAT5;POLD3;MUS81;RFC5
gsea,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.3695191815841243,1.4477674432581158,0.042600896860986545,0.253228683337748,0.999,19/50,14.31%,CACNB2;ATP2B4;PCLO;RIPOR2;EPB41L1;PLS1;CASK;KCNMA1;CABP1;PCDH15;SPTAN1;STX1A;MSN;EPB41L3;MYH9;ESPN;SPTBN1;EPS8;OTOF
gsea,Glycolysis R-HSA-70171,-0.36036862047512036,-1.446761000731572,0.036893203883495145,0.0881947253659274,0.999,20/59,17.67%,PKM;ALDOC;TPI1;PPP2CA;PPP2R1A;PGK1;ENO2;NUP50;PGAM2;PFKL;NUP37;NUP205;PPP2R5D;SEH1L;SEC13;NUP107;PRKACB;PGP;ENO1;PFKFB3
gsea,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.36353639819576716,-1.4461517238698918,0.045816733067729085,0.08830643766523764,0.999,15/51,21.64%,CALM1;PEBP1;YWHAB;HRAS;FAM131B;TRIM24;RAP1A;MAPK3;VCL;CAMK2B;ITGA2B;TLN1;MAPK1;CNKSR2;NRAS
gsea,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.45280388249841896,-1.4444851193541908,0.05858585858585859,0.08894950064120002,0.999,8/23,17.66%,APOE;DEK;CITED2;NPM1;KCTD1;CHGA;HSPD1;YY1
gsea,Homology Directed Repair R-HSA-5693538,-0.33627589772253347,-1.4432450835328245,0.03041144901610018,0.08949510632712757,1.0,23/85,23.03%,UBB;RPS27A;SUMO2;UBA52;SEM1;H2BC4;UBE2N;PCNA;RPA3;PARP1;PPP4C;RNF168;BABAM2;SIRT6;UBC;RFC3;H2AX;XRCC2;UIMC1;RAD50;RAD9B;RBBP8;RAD51
gsea,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.3422593252519246,-1.443129417193863,0.03896103896103896,0.08935366580251311,1.0,22/80,23.03%,UBB;RPS27A;SUMO2;UBA52;SEM1;H2BC4;UBE2N;PCNA;RPA3;PPP4C;RNF168;BABAM2;SIRT6;UBC;RFC3;H2AX;XRCC2;UIMC1;RAD50;RAD9B;RBBP8;RAD51
gsea,Cristae Formation R-HSA-8949613,-0.5024329313566814,-1.4430063987505906,0.06431535269709543,0.08920947619711624,1.0,8/15,25.21%,ATP5PB;IMMT;SAMM50;TMEM11;HSPA9;MICOS10;MTX1;MTX2
gsea,HCMV Late Events R-HSA-9610379,-0.35630393033869656,-1.4395776432827334,0.031007751937984496,0.0907348709743368,1.0,19/61,17.53%,CEBPD;H2AC25;H2BC4;VPS28;CHMP4B;NUP50;CHMP2A;TSG101;HNRNPK;CHMP6;NUP37;NUP205;VPS4A;SEH1L;SEC13;UBAP1;NUP107;CHMP4C;CHMP7
gsea,MAP Kinase Activation R-HSA-450294,-0.3656701506202997,-1.4393743209078544,0.0419047619047619,0.09065867717313615,1.0,17/56,19.64%,UBB;RPS27A;JUN;DUSP3;UBA52;MEF2C;DUSP7;PPP2CA;PPP2R1A;UBE2N;UBE2V1;MAPK3;PPP2R5D;MAP3K8;UBC;CREB1;MAPK1
gsea,Aquaporin-mediated Transport R-HSA-445717,-0.4024116835729701,-1.4374256532285128,0.05202312138728324,0.09149893940823876,1.0,12/32,18.06%,GNAS;GNB2;GNG2;GNG13;RAB11A;GNG10;AQP4;GNG3;PRKAR1B;AQP11;PRKACB;RAB11FIP2
gsea,Cardiac Conduction R-HSA-5576891,0.32764266678620824,1.4347808350520654,0.021321961620469083,0.267336404768787,0.999,14/88,3.20%,RYR2;CACNA1C;SCN1A;CACNB2;SLC8A1;ATP2B4;KCND3;SCN8A;KCNK9;ATP2B3;KCNK13;RYR3;FGF14;CAMK2A
gsea,Triglyceride Metabolism R-HSA-8979227,-0.4630253257717549,-1.4346222257375043,0.06378986866791744,0.09291608903829567,1.0,8/19,20.77%,GPD2;PPP1CA;DGAT2;FABP3;FABP7;PPP1CC;PRKACB;GPAM
gsea,DNA Strand Elongation R-HSA-69190,-0.4311827674994357,-1.4322143487661743,0.056466302367941715,0.09420728214274708,1.0,13/29,31.92%,PCNA;RPA3;GINS2;GINS4;CDC45;RFC3;LRIG1;MCM6;POLD4;POLD2;POLD3;FEN1;RFC5
gsea,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.5190518202217891,-1.4303283974487402,0.08519269776876268,0.09513747253119191,1.0,4/15,7.56%,RAB3A;VAMP2;PPFIA2;SNAP25
gsea,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.47165434223729097,-1.428512203672403,0.07677165354330709,0.09605041138038714,1.0,2/16,8.80%,CALM1;HRAS
gsea,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.27870824332605765,-1.4270658273762853,0.0076481835564053535,0.0967146685310882,1.0,64/308,15.76%,UBB;HMGB1;RPS27A;UBE3A;CALR;PSMC3;PSMB5;PSMA7;ELOB;PJA1;PSMC2;UBA52;RNF220;NDUFA2;SEM1;FBXL16;CANX;PSMA5;KLHL9;PSMA4;PDIA3;UBE2J1;ANAPC13;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;RNF6;UBE2N;FBXW2;PSMB1;ITGAV;UBA1;UBE2S;PSMB3;FBXO9;SEC61G;ASB13;RNF7;PSMA1;PSMC6;STUB1;PSMD6;NCF2;FBXO6;UBE2V1;FBXO32;ANAPC11;PSMC1;MKRN1;PSME3;UBE2Z;ASB5;PSMC4;RNF114;BTBD6;PSMB6;SEC13;PJA2;TRIM32;VAMP3;PSMB7
gsea,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.3998369076438665,-1.425952048117746,0.052830188679245285,0.09715164205993103,1.0,9/35,19.44%,PLK2;BAX;BTG2;PCNA;NPM1;CDKN1B;CNOT8;E2F4;CNOT6L
gsea,Sensory Processing Of Sound R-HSA-9659379,0.35439395188732725,1.4237852465314957,0.04856512141280353,0.27981823262728184,0.999,19/54,14.31%,CACNB2;ATP2B4;PCLO;RIPOR2;EPB41L1;PLS1;CASK;KCNMA1;CABP1;PCDH15;SPTAN1;STX1A;MSN;EPB41L3;MYH9;ESPN;SPTBN1;EPS8;OTOF
gsea,Muscle Contraction R-HSA-397014,0.30530922213949685,1.4230808199445686,0.030973451327433628,0.2745212791915521,0.999,18/126,3.20%,RYR2;CACNA1C;SORBS1;SCN1A;GUCY1A2;CACNB2;SLC8A1;ATP2B4;KCND3;SCN8A;KCNK9;ATP2B3;KCNK13;RYR3;DMD;FGF14;ACTN2;CAMK2A
gsea,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.33226657657032166,-1.4222118098143621,0.020522388059701493,0.09919733374806743,1.0,26/74,24.87%,ELOB;POLR2F;POLR2I;POLR2G;TAF10;POLR2E;TCEA1;TAF11;POLR2C;GTF2H5;GTF2B;RTF1;SKIC8;POLR2J;TAF5;ELOC;CDC73;DMAP1;POLR2B;TAF7;NCBP2;ERCC3;POLR2L;TAF7L;SSRP1;GTF2H4
gsea,Apoptotic Execution Phase R-HSA-75153,0.3839998737191137,1.4212766557186958,0.05737704918032787,0.2715376250843072,0.999,7/38,6.77%,TJP2;ROCK1;SATB1;MAPT;TJP1;SPTAN1;PTK2
gsea,TBC/RABGAPs R-HSA-8854214,-0.3841131694018057,-1.4197721351730048,0.05103969754253308,0.10046853903134563,1.0,13/39,23.80%,GABARAPL2;RAB6B;GABARAP;MAP1LC3B;RAB6A;RAB11A;TBC1D7;RAB5A;RAB5B;TBC1D10B;RAB5C;RAB35;ARF6
gsea,Visual Phototransduction R-HSA-2187338,-0.38174268835578407,-1.4170584196051759,0.04642166344294004,0.10186881154115475,1.0,14/50,24.09%,CALM1;TTR;APOE;C1D;RNF7;METAP2;LDLR;RBP1;GPC1;NMT1;DHRS3;STRA6;LRP10;MYO7A
gsea,Circadian Clock R-HSA-400253,-0.34845339550405086,-1.4160135547930344,0.05273833671399594,0.10225843522167341,1.0,17/59,25.29%,UBB;RPS27A;UBA52;MEF2C;CSNK1E;PPP1CA;TBL1XR1;TBL1X;NFIL3;PPP1CC;UBC;CREB1;FBXL3;KLF15;NRIP1;LIN9;SKP1
gsea,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.4977630348921115,-1.4150494448396875,0.07851239669421488,0.10270519530166225,1.0,5/16,12.47%,RAB3A;VAMP2;PPFIA2;SNAP25;SLC18A2
gsea,RHOA GTPase Cycle R-HSA-8980692,0.32331187994662375,1.4144832399020386,0.02636916835699797,0.2766497124729125,0.999,51/123,25.46%,KALRN;PLEKHG5;TRIO;ARHGEF28;MYO9A;MYO9B;TJP2;ROCK1;ABR;STK10;DLC1;RASGRF2;GMIP;PREX2;DHDDS;TIAM1;LBR;PRPF38B;ARHGAP18;ARHGEF17;ARHGEF7;ARHGEF18;ARHGEF3;ARAP2;ARAP1;FARP1;IQGAP1;ARHGAP31;AAAS;ARHGEF2;SRGAP1;ACBD5;ARHGAP32;ARHGEF10L;VANGL1;STARD13;ARHGEF4;SCFD1;ARHGEF11;AKAP13;DAAM1;PREX1;ARHGAP24;ARHGAP39;TMEM87A;OBSCN;FLOT2;MCAM;SNAP23;BCAP31;MCF2
gsea,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.30895297820134593,-1.4120474846281856,0.012589928057553957,0.10429393720421053,1.0,43/134,28.42%,CALM1;TTR;APOE;HSP90AA1;PDXK;C1D;DHFR;GCH1;TCN2;PPCS;SLC25A16;LDLR;RBP1;CYB5R3;ALDH1L1;GPC1;PARP16;MOCS2;MMACHC;GSTO1;NMNAT3;MTHFD2;NAXD;COQ3;VKORC1;CYB5A;PARP4;COQ7;PANK4;PANK3;RFK;FASN;TPK1;NAXE;LRP10;MMADHC;AKT1;CD38;COQ9;MMUT;MTRR;SLC2A1;TTPA
gsea,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.47088121053162,1.4111850089481566,0.09484536082474226,0.2761673485919422,0.999,4/16,3.04%,GRIA3;GRIA1;GRIA4;PRKCG
gsea,Oncogenic MAPK Signaling R-HSA-6802957,-0.345337118252663,-1.4096631460993183,0.0496031746031746,0.1056646084180256,1.0,24/65,27.52%,CALM1;PEBP1;YWHAB;DUSP7;HRAS;FAM131B;TRIM24;RAP1A;MAPK3;VCL;PPP1CC;CAMK2B;ITGA2B;DUSP8;TLN1;MAPK1;CNKSR2;NRAS;DUSP16;QKI;MRAS;RAP1B;FAM114A2;DUSP6
gsea,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.43391562194809236,-1.4084570342351552,0.0690978886756238,0.10616630070207075,1.0,7/23,9.69%,CALM1;GNB2;GNG2;NCALD;GNG13;GNG10;GNG3
gsea,Long-term Potentiation R-HSA-9620244,-0.4319218688756549,-1.407677825631018,0.07597535934291581,0.10647158641951321,1.0,3/23,0.60%,NRGN;CALM1;NEFL
gsea,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.32256610642322736,-1.4021919980400368,0.029197080291970802,0.11004275154560342,1.0,28/104,20.33%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA;TBK1;IRF3
gsea,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.382556183362221,1.4010443745258856,0.06187624750499002,0.2875774249494157,0.999,16/42,19.41%,CACNA1C;SPTBN4;CACNB2;SPTB;SOS1;SPTAN1;PTK2;CACNA1H;FYN;COL4A1;SPTBN1;PTPRA;COL9A2;GFRA2;COL4A4;COL4A2
gsea,Nuclear Receptor Transcription Pathway R-HSA-383280,0.38570470286781167,1.4001097229605022,0.07878787878787878,0.2831353923243328,0.999,12/37,17.09%,NR2F1;RARB;NR3C2;RORA;NR6A1;ESRRG;THRB;PPARD;RARG;PPARG;PPARA;PGR
gsea,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.32411807514027774,-1.3964904368935929,0.036734693877551024,0.11359578089010587,1.0,24/79,21.09%,UBB;VAMP2;RPS27A;CLTA;NECAP1;UBA52;AP2M1;COPS6;NEDD8;UBQLN2;EPN1;GPS1;FZD4;AP2B1;LDLR;COPS8;STAM2;VAMP3;CLTB;AP2S1;UBC;SH3GL2;EPS15;AP2A2
gsea,Ca2+ Pathway R-HSA-4086398,-0.3632399821653875,-1.3931829085252525,0.06944444444444445,0.11579847617844792,1.0,11/45,11.30%,CALM1;PPP3CA;GNB2;GNG2;PPP3R1;PPP3CB;GNG13;FZD2;GNG10;GNG3;FZD4
gsea,Synthesis Of PC R-HSA-1483191,0.42704510995256767,1.389130541233344,0.0918580375782881,0.29526382293430237,0.999,8/22,18.64%,SLC44A5;CHKA;CSNK2A2;LPIN1;SLC44A2;CHKB;LPIN2;STARD10
gsea,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.40260014040194037,-1.3871210776624368,0.06896551724137931,0.11989640456978116,1.0,14/34,31.92%,PCNA;MPG;RPA3;PARP1;ADPRS;APEX1;TDG;RFC3;LRIG1;POLD4;POLD2;POLD3;FEN1;RFC5
gsea,GABA Receptor Activation R-HSA-977443,-0.3631683555737448,-1.3865087325663528,0.04930966469428008,0.12007709879930399,1.0,12/45,12.01%,KCNJ3;GABRG2;GNB2;GNG2;KCNJ2;GNG13;KCNJ4;GNG10;GNG3;GNAI1;KCNJ16;GNAI2
gsea,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.42653686497541254,-1.385274503300821,0.07279693486590039,0.12069839027780024,1.0,11/23,23.65%,FGFR2;FGF13;POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;POLR2J;POLR2B;NCBP2;POLR2L
gsea,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.44019086760218873,-1.3852508081431563,0.08502024291497975,0.12046816272509847,1.0,7/21,12.71%,HSP90AA1;NRG3;NRG4;CDC37;HRAS;ERBIN;PIK3R1
gsea,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.29725624343022217,-1.3850635171715158,0.022494887525562373,0.12036309828809011,1.0,33/139,15.61%,CNIH2;DYNLL1;DYNLL2;TRAPPC6B;TMED9;CAPZA2;CNIH1;ARF4;TMED2;BET1L;DCTN6;ARF3;DCTN3;TRAPPC2L;NAPG;ARF5;FUCA1;TRAPPC2;RAB1B;ACTR10;LMAN2;TMED7;TRAPPC1;MCFD2;CHGA;LMAN1;COPG2;ARFGAP2;COPG1;GOSR1;ANK1;SEC13;COPB2
gsea,HCMV Early Events R-HSA-9609690,-0.33442659674125813,-1.3836661470362073,0.04597701149425287,0.12114206526375079,1.0,16/66,15.27%,DYNLL1;DYNLL2;H2AC25;H2BC4;TBL1XR1;GPS2;PML;RBBP7;NUP50;DUT;NUP37;NUP205;TBL1X;SEH1L;SEC13;NUP107
gsea,Drug ADME R-HSA-9748784,-0.4096657052456761,-1.3816601190523559,0.0707070707070707,0.12229528778832954,1.0,7/27,17.37%,NME2;BSG;GSTM1;GSTP1;SLC16A1;IMPDH2;GMPS
gsea,COPII-mediated Vesicle Transport R-HSA-204005,-0.3371160277729175,-1.3812393044736282,0.06177606177606178,0.12235805605865531,1.0,14/56,16.48%,CNIH2;TRAPPC6B;CNIH1;TMED2;TRAPPC2L;NAPG;TRAPPC2;RAB1B;LMAN2;TRAPPC1;MCFD2;LMAN1;SEC13;NSF
gsea,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.38992724585994687,-1.3809013529971887,0.06809338521400778,0.1223384358343432,1.0,9/31,11.87%,GNAS;GNB2;GNG2;GNG13;RAB11A;GNG10;AQP4;GNG3;PRKAR1B
gsea,Regulation Of Insulin Secretion R-HSA-422356,-0.34243460456372915,-1.3808114491834913,0.05241935483870968,0.12214235750648139,1.0,17/60,12.97%,GNAS;VAMP2;ACSL3;GNB2;GNG2;SYT5;MARCKS;GNG13;SNAP25;GNG10;GNG3;GNAI1;ADRA2C;PRKAR1B;GNAI2;RAP1A;GNA11
gsea,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.43143261504667174,-1.380677144976115,0.08946322067594434,0.12200370671622886,1.0,7/22,12.71%,HSP90AA1;NRG3;NRG4;CDC37;HRAS;ERBIN;PIK3R1
gsea,Transcriptional Regulation By MECP2 R-HSA-8986944,0.352126067055641,1.3803208166028613,0.052941176470588235,0.3049428087706983,0.999,12/56,8.17%,RBFOX1;TNRC6C;GRIN2A;MOV10;CAMK2A;TRPC3;HDAC1;AGO4;CAMK2G;AGO1;TNRC6B;LBR
gsea,Platelet Homeostasis R-HSA-418346,0.33523642430899636,1.380158779804904,0.05639913232104121,0.2994187173028483,0.999,14/64,6.06%,PRKG1;PDE2A;GUCY1A2;PDE1A;SLC8A1;PDE9A;ATP2B4;ATP2B3;MAPK14;PDE10A;LRP8;KCNMA1;TRPC6;TRPC3
gsea,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.3743385846076592,-1.3793134087338401,0.0533596837944664,0.12272902403955062,1.0,12/40,17.94%,EPHA5;EPHA7;CLTA;AP2M1;PSENEN;APH1A;AP2B1;LYN;CLTB;EPHA4;AP2S1;EFNB3
gsea,DAG And IP3 Signaling R-HSA-1489509,0.38915717199245586,1.3763661333758925,0.09619238476953908,0.30039711694809745,0.999,14/35,16.45%,NBEA;PDE1A;ADCY8;PRKCE;ADCY2;PRKCG;CAMK2A;ADCY9;CAMK2G;ADCY6;PLCG1;GRK2;ADCY5;PRKCD
gsea,Retinoid Metabolism And Transport R-HSA-975634,-0.42726193221224673,-1.3762639527829,0.08893280632411067,0.12474231200432527,1.0,6/24,15.97%,TTR;APOE;C1D;LDLR;RBP1;GPC1
gsea,PKMTs Methylate Histone Lysines R-HSA-3214841,0.37150940441319535,1.3737516312216502,0.0860655737704918,0.2990929237037343,0.999,17/44,21.08%,EHMT1;KMT2A;NSD1;SETDB1;KMT2C;NSD3;EHMT2;KMT2B;KMT5B;DPY30;KMT2E;AEBP2;NFKB1;SUZ12;RBBP4;EZH2;SETD2
gsea,Oncogene Induced Senescence R-HSA-2559585,-0.40157836927451424,-1.3734975964658216,0.09108910891089109,0.1266598946421292,1.0,4/26,3.28%,UBB;RPS27A;UBA52;ETS2
gsea,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.37970540956955834,-1.3713799614306053,0.07677165354330709,0.12803922330600137,1.0,9/34,16.04%,GNAS;GNB2;GNG2;GNG13;GNG10;GNG3;PRKAR1B;RAP1A;PRKACB
gsea,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.4559355156644973,-1.367782305674651,0.11287128712871287,0.1305559503424121,1.0,5/19,9.74%,JUN;YWHAE;CDK5R1;PRDX1;C1QBP
gsea,Defective Pyroptosis R-HSA-9710421,-0.43158377646164675,-1.3673757838983684,0.09722222222222222,0.13058231251262287,1.0,5/21,8.97%,H2AZ1;H2BC4;H2AJ;RBBP7;GSDME
gsea,Post NMDA Receptor Activation Events R-HSA-438064,0.34516182629449477,1.3662183723008285,0.047520661157024795,0.3067883943285521,0.999,17/57,10.37%,GRIN2A;GRIA1;LRRC7;RPS6KA2;PRKAG2;ADCY8;NRG1;ACTN2;CAMK2A;MAPT;RASGRF2;MPP3;CAMK2G;RPS6KA6;ARHGEF7;RASGRF1;ERBB4
gsea,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.36538438933816597,-1.3650183432468492,0.075046904315197,0.13223392540355336,1.0,16/39,24.87%,ELOB;POLR2F;POLR2I;POLR2G;POLR2E;TCEA1;POLR2C;GTF2H5;POLR2J;ELOC;POLR2B;NCBP2;ERCC3;POLR2L;SSRP1;GTF2H4
gsea,Toll-like Receptor Cascades R-HSA-168898,-0.30768810511867223,-1.3641661090333317,0.05132743362831858,0.1326035274995645,1.0,30/118,20.33%,UBB;HMGB1;RPS27A;JUN;DUSP3;UBA52;NDUFA2;MEF2C;DUSP7;NFKB2;CTSB;PPP2CA;USP14;PPP2R1A;UBE2N;NFKBIB;GSDME;UBE2V1;MAPK3;PPP2R5D;MAP3K8;IRAK4;UBC;NKIRAS1;CREB1;MAPK1;PELI2;NFKBIA;TBK1;IRF3
gsea,CRMPs In Sema3A Signaling R-HSA-399956,0.48792773736716905,1.3635320604875063,0.12727272727272726,0.3059882668019514,0.999,6/15,13.70%,PLXNA4;NRP1;PLXNA2;PLXNA3;FYN;DPYSL3
gsea,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.3924146014502565,-1.361908965538798,0.09591836734693877,0.13405294757704117,1.0,13/34,26.44%,UBB;RPS27A;TLE4;UBA52;YWHAZ;SOX9;TLE1;UBC;SOX4;CBY1;AKT1;TLE2;TCF7L1
gsea,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.4534187710850536,-1.3618195232612893,0.09695817490494296,0.1338470418584585,1.0,4/17,9.21%,BANF1;PPP2CA;PPP2R1A;EMD
gsea,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.3655369123136938,-1.3610729504416417,0.07862903225806452,0.13411275428345298,1.0,7/42,8.80%,UBB;RPS27A;UBA52;NRG3;NRG4;CDK4;HRAS
gsea,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.4501191280114403,-1.3579159626039226,0.10020449897750511,0.1363428452716646,1.0,6/18,11.52%,HSP90AA1;NRG3;NRG4;CDC37;HRAS;ERBIN
gsea,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.26900936040415613,-1.3543655998406279,0.025096525096525095,0.13887670639701108,1.0,54/263,15.76%,UBB;RPS27A;UBE3A;PSMC3;PSMB5;PSMA7;ELOB;PJA1;PSMC2;UBA52;RNF220;SEM1;FBXL16;PSMA5;KLHL9;PSMA4;UBE2J1;ANAPC13;PSMD2;PSMD4;PSMA3;PSMC5;PSMD7;RBX1;RNF6;UBE2N;FBXW2;PSMB1;UBA1;UBE2S;PSMB3;FBXO9;ASB13;RNF7;PSMA1;PSMC6;STUB1;PSMD6;FBXO6;UBE2V1;FBXO32;ANAPC11;PSMC1;MKRN1;PSME3;UBE2Z;ASB5;PSMC4;RNF114;BTBD6;PSMB6;PJA2;TRIM32;PSMB7
gsea,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.36099935888399104,-1.3512174477390613,0.07331975560081466,0.14106711996346336,1.0,20/43,35.04%,PDIA6;DNAJB9;MYDGF;HDGF;SSR1;SRPRB;TLN1;CXXC1;DNAJB11;EXTL2;TSPYL2;EDEM1;ATP6V0D1;TATDN2;PPP2R5B;LMNA;ACADVL;FKBP14;DCTN1;PREB
gsea,Clathrin-mediated Endocytosis R-HSA-8856828,-0.2987383478234427,-1.3502888976006073,0.055776892430278883,0.1415484746136557,1.0,36/115,21.11%,UBB;VAMP2;RPS27A;HSPA8;CLTA;NECAP1;UBA52;AP2M1;ARPC5;WASL;COPS6;ARPC2;NEDD8;ARPC1A;ACTR2;ARPC3;UBQLN2;EPN1;GPS1;FZD4;AP2B1;HIP1R;LDLR;COPS8;STAM2;PACSIN2;VAMP3;CLTB;AP2S1;UBC;SH3GL2;RAB5A;EPS15;PIK3C2A;AP2A2;RAB5B
gsea,Signaling By FGFR2 In Disease R-HSA-5655253,-0.38061601863073047,-1.3502348657173349,0.08190476190476191,0.14131498775430992,1.0,14/32,23.65%,FGFR2;FGF13;POLR2F;POLR2I;POLR2G;POLR2E;HRAS;POLR2C;PIK3R1;POLR2J;POLR2B;NRAS;NCBP2;POLR2L
gsea,G Alpha (Z) Signaling Events R-HSA-418597,-0.36575226124402593,-1.3497574690575094,0.08045977011494253,0.14138345596863736,1.0,10/35,12.01%,GNAS;GNB2;GNG2;RGS4;GNG13;GNG10;GNG3;GNAI1;ADRA2C;GNAI2
gsea,Mitotic Prometaphase R-HSA-68877,-0.28905120181530486,-1.3497457450304395,0.05009276437847866,0.14112389761657743,1.0,30/153,16.36%,TUBA4A;DYNLL1;YWHAG;DYNLL2;TUBA1A;HSP90AA1;RPS27;NME7;YWHAE;CETN2;CSNK1E;SMC1A;PPP2CA;PPP2R1A;PAFAH1B1;TUBB4A;TUBB4B;DCTN3;RAD21;CSNK2B;ZWINT;NUP37;PPP2R5D;SEH1L;SEC13;NUDC;NUP107;PPP1CC;CENPP;HAUS2
gsea,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.3819030874483623,-1.3471190748212145,0.08282828282828283,0.1428068444958522,1.0,10/33,15.27%,SLC25A4;SLC25A5;BANF1;PSIP1;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107
gsea,Degradation Of Extracellular Matrix R-HSA-1474228,0.328770341146402,1.3463527430280795,0.06578947368421052,0.32992612844826275,0.999,26/62,22.57%,COL23A1;ERC2;LAMB1;COL19A1;LAMC1;ADAMTS18;LAMB3;COL16A1;COL15A1;CAPN15;MMP16;BMP1;ADAMTS16;COL12A1;SPOCK3;COL9A2;CAPN1;COL25A1;MMP24;TIMP2;ADAM17;CD44;CTSK;COL13A1;PSEN1;DCN
gsea,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.3576883153091546,-1.345693344064927,0.07528957528957529,0.14361865105327073,1.0,16/41,24.87%,ELOB;POLR2F;POLR2I;POLR2G;POLR2E;TCEA1;POLR2C;GTF2H5;POLR2J;ELOC;POLR2B;NCBP2;ERCC3;POLR2L;SSRP1;GTF2H4
gsea,ISG15 Antiviral Mechanism R-HSA-1169408,-0.33751282360332324,-1.3456636474788632,0.08216432865731463,0.1433592649455466,1.0,22/60,26.33%,UBB;RPS27A;EIF4A1;EIF4A2;UBA52;UBE2N;NUP50;NUP37;MAPK3;NUP205;SEH1L;SEC13;NUP107;EIF4G2;UBC;IRF3;NUP35;JAK1;NUP62;PDZD2;KPNA3;NUP85
gsea,Potassium Channels R-HSA-1296071,-0.3153665418954466,-1.3410633281022246,0.0549645390070922,0.14689190138132413,1.0,15/76,9.69%,KCNJ3;KCNA1;GNB2;GNG2;KCND2;KCNK2;KCNJ2;KCNK1;KCNA2;GNG13;KCNJ4;KCNN1;GNG10;KCNA4;GNG3
gsea,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.33011858229206065,-1.3392247258991865,0.08029197080291971,0.14809973899885703,1.0,16/63,17.16%,GNAS;GLP2R;GNB2;GNG2;RAMP2;GNG13;GNG10;GNG3;GNAI1;ADRB1;PRKAR1B;GNAI2;CHGA;RAMP1;PRKACB;PTRH2
gsea,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.398328608574815,-1.3372163093841953,0.09441233140655106,0.1495308430601181,1.0,7/25,11.87%,GNAS;GNB2;GNG2;GNG13;GNG10;GNG3;PRKAR1B
gsea,Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.45492788075521956,-1.3369287851663403,0.12526096033402923,0.14950149974830979,1.0,5/18,12.47%,RAB3A;VAMP2;PPFIA2;SNAP25;SLC18A2
gsea,MHC Class II Antigen Presentation R-HSA-2132295,-0.3251987172503667,-1.3363833234025266,0.07739307535641547,0.14968440602013192,1.0,28/75,29.22%,DYNLL1;DYNLL2;CLTA;CAPZA2;AP2M1;CANX;CTSB;DCTN6;ACTR1B;DCTN3;ACTR10;CTSO;AP2B1;SEC13;CTSH;DCTN5;AP2S1;SH3GL2;AP2A2;CTSD;KIF18A;AP1M1;CTSS;KIF15;SAR1B;KIF3B;CTSL;AP1S1
gsea,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.3281343749643981,-1.3295879536266713,0.06976744186046512,0.15505241530675798,1.0,15/62,16.48%,TMED9;ARF4;TMED2;ARF3;NAPG;ARF5;RAB1B;TMED7;SURF4;UBE2Z;COPG2;ARFGAP2;COPG1;COPB2;NSF
gsea,tRNA Processing In Nucleus R-HSA-6784531,-0.3432491871538737,-1.3268432773192038,0.10919540229885058,0.1571168596855795,1.0,19/51,26.33%,RAN;POP5;FAM98B;RPP21;NUP50;NUP37;ZBTB8OS;RTCB;NUP205;SEH1L;SEC13;NUP107;DDX1;RTRAF;RPP38;NUP35;TSEN34;NUP62;NUP85
gsea,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.32899910985819486,-1.3258280992606777,0.0854368932038835,0.15769697843834168,1.0,5/63,2.69%,FTH1;VAMP2;HSPA8;CLTA;NECAP1
gsea,RND1 GTPase Cycle R-HSA-9696273,0.3726733575748203,1.323604724293027,0.09812108559498957,0.36720656478136615,1.0,12/34,19.09%,PLEKHG5;DST;PKP4;DLG5;CCDC88A;ANKRD26;LEMD3;FAM135A;RND1;WDR6;FRS2;VANGL1
gsea,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.42182960815442483,1.3217370469587857,0.1450381679389313,0.3647306171669572,1.0,10/21,19.81%,DOCK3;NTF3;NTRK2;SOS1;TIAM1;FYN;PLCG1;GRIN2B;FRS2;PIK3CA
gsea,Ion Channel Transport R-HSA-983712,-0.29554936654272074,-1.320117851700963,0.060077519379844964,0.16234863290100102,1.0,14/119,5.02%,CALM1;ATP1B1;UBB;ATP6V0C;ATP6V1D;RPS27A;ATP6V1A;ATP6V1G2;ATP6V0E2;ATP1A3;UBA52;ATP6V0B;ATP6V1F;ATP1B2
gsea,Peptide Ligand-Binding Receptors R-HSA-375276,-0.3377717839207953,-1.3184098425065724,0.1011608623548922,0.16362671751599428,1.0,27/54,37.12%,NPY1R;PROKR2;NPY5R;CX3CL1;SSTR2;TTF2;HEBP1;GPR37;OPRM1;SSTR1;ACKR4;GPR37L1;NPY;CXCR6;CXCL12;MC4R;PDYN;GPNMB;OPRD1;TAC1;CCR5;RIPK2;OPRL1;F2RL2;TACR1;PENK;APP
gsea,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.45101867981552063,1.3166669513030034,0.14885496183206107,0.3692868645992485,1.0,4/16,6.07%,PTPRS;NTRK3;NTF3;SOS1
gsea,Regulation Of Beta-Cell Development R-HSA-186712,0.40679781423501027,1.3165041276452827,0.11895161290322581,0.3635091728679961,1.0,6/22,13.11%,MAML2;FGF10;PAX6;AKT2;ONECUT1;MAML3
gsea,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.4492343771249268,-1.3145296026543571,0.14145383104125736,0.16681381808881754,1.0,6/16,20.80%,PPP2CA;PPP2R1A;GSK3B;PPP2R5D;PPP2R5A;CSNK1A1
gsea,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.3080676500273572,-1.3136481492346084,0.062193126022913256,0.1672678256719103,1.0,49/101,37.46%,PLPPR4;NPY1R;P2RY14;P2RY12;PROKR2;NPY5R;ADRB1;S1PR1;CX3CL1;ADRA2C;CHGA;PLPPR5;SSTR2;TTF2;HEBP1;GPR37;OPRM1;SSTR1;ACKR4;HTR2A;GPR37L1;NPY;CXCR6;CXCL12;ADORA1;PLPPR3;MC4R;PDYN;GPNMB;OPRD1;S1PR3;TAC1;LPAR1;CCR5;P2RY13;RIPK2;DRD5;OPRL1;F2RL2;GPR35;PTGER4;TACR1;PENK;S1PR5;HTR1A;ADRA1D;HRH3;APP;GPR39
gsea,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.3828255721141517,-1.3135342448071496,0.11238095238095239,0.16705808550443843,1.0,17/29,38.49%,MCEE;DBI;ACOT11;ACOT13;NDUFAB1;MMUT;ACBD6;ACOT2;ACOT9;MCAT;ACADVL;THEM4;HADH;ECI1;ACAA2;ACOT12;ACOT1
gsea,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.4094414741724144,-1.31021562346802,0.12407407407407407,0.16972418130083738,1.0,9/21,23.65%,POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;POLR2J;POLR2B;NCBP2;POLR2L
gsea,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.3566005916587436,-1.3069502664927317,0.10925925925925926,0.17248274887693216,1.0,8/37,11.74%,H2AZ1;DEK;POLR2F;H2BC4;POLR2E;POLR1G;H2AJ;GSK3B
gsea,Cleavage Of Damaged Purine R-HSA-110331,-0.4513983060625854,-1.306581810820317,0.14738805970149255,0.17248374257674087,1.0,5/16,11.14%,H2AZ1;H2BC4;MPG;H2AJ;TERF1
gsea,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.3802588993100236,-1.3033048076582152,0.11775700934579439,0.17532594609600394,1.0,6/31,13.54%,DOHH;EEF2;ARSA;ARSJ;TTF2;DHPS
gsea,RHO GTPases Activate CIT R-HSA-5625900,-0.4587755013537668,-1.3022077462590946,0.1485148514851485,0.17600066063031905,1.0,8/15,22.71%,MYL6;MYL12B;RHOB;CDKN1B;MYH14;MYL9;RHOA;MYH10
gsea,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.4021647785089428,-1.2983762893151014,0.1434108527131783,0.1794858917334707,1.0,6/23,8.94%,H2AZ1;CBX3;H2BC4;CHD3;H2AJ;RBBP7
gsea,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.4253454485381797,-1.298029708572499,0.12761904761904763,0.17953468951982024,1.0,7/21,18.94%,H2AZ1;H2BC4;MPG;H2AJ;TERF1;TDG;H2AX
gsea,Metabolism Of Carbohydrates R-HSA-71387,-0.26632020672677953,-1.2966368391976855,0.07335907335907337,0.18049332045951175,1.0,52/223,21.77%,CALM1;UBB;NDST4;RPS27A;MDH2;PKM;ALDOC;UBA52;MDH1;B3GALT2;TPI1;PPP2CA;PHGDH;PPP2R1A;PGK1;ENO2;GOT2;PHKG1;G6PC3;NUP50;CHORDC1;PGAM2;PFKL;NUP37;GUSB;SLC35B3;NUP205;HS3ST5;PPP2R5D;SEH1L;OGN;SEC13;NUP107;GPC1;PRKACB;DCXR;AKR1A1;ALDH1A1;PGP;DSEL;ENO1;PFKFB3;UBC;PPP1R3C;B3GALT4;TALDO1;GNPDA1;SHPK;TKFC;CHSY3;HYAL2;B4GALT7
gsea,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.3323730625004882,-1.2949531212572762,0.08979591836734693,0.18176366681701503,1.0,7/45,6.61%,UBB;RPS27A;TLE4;SNW1;UBA52;TBL1XR1;RBX1
gsea,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.38064843923389285,-1.2947242749636632,0.13218390804597702,0.18166356810829834,1.0,7/28,18.62%,TTR;APOE;C1D;LDLR;RBP1;GPC1;VKORC1
gsea,HIV Transcription Initiation R-HSA-167161,-0.3351524903012829,-1.294421335280356,0.11213235294117647,0.18160707170246,1.0,26/45,37.43%,POLR2F;POLR2I;POLR2G;TAF10;POLR2E;TAF11;POLR2C;GTF2H5;GTF2B;POLR2J;TAF5;POLR2B;TAF7;ERCC3;POLR2L;TAF7L;GTF2H4;TAF12;POLR2D;GTF2H3;GTF2E1;POLR2K;CCNH;GTF2F2;TAF13;POLR2A
gsea,Meiosis R-HSA-1500620,-0.32981995205182996,-1.294300529369032,0.10566037735849057,0.18140120493933512,1.0,23/51,32.10%,H2AZ1;HSPA2;SMC1A;H2BC4;CDK4;RAD21;H2AJ;RPA3;TERF1;SYCP3;SUN1;H2AX;RAD50;RBBP8;RAD51;PSMC3IP;SUN2;SMC3;MLH1;MLH3;TINF2;H2AZ2;LMNA
gsea,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.39956416509680004,-1.294212362941018,0.1491395793499044,0.181141550555555,1.0,8/23,22.41%,PPP2CA;PPP2R1A;FZD2;GSK3B;PPP2R5D;PPP2R5A;CSNK1A1;CSNK1G2
gsea,IRE1alpha Activates Chaperones R-HSA-381070,-0.34100272363818956,-1.2909163769017786,0.12778904665314403,0.1839665461363004,1.0,20/45,35.04%,PDIA6;DNAJB9;MYDGF;HDGF;SSR1;SRPRB;TLN1;CXXC1;DNAJB11;EXTL2;TSPYL2;EDEM1;ATP6V0D1;TATDN2;PPP2R5B;LMNA;ACADVL;FKBP14;DCTN1;PREB
gsea,Death Receptor Signaling R-HSA-73887,-0.28412612481145577,-1.2908275142226908,0.09164969450101833,0.1837145450934166,1.0,18/116,10.90%,UBB;RACK1;RPS27A;BEX3;ARHGDIA;MAGED1;YWHAE;UBA52;USP2;SQSTM1;PSENEN;NSMAF;APH1A;BAD;RTN4;BAG4;OTULIN;CLIP3
gsea,Transcription Of HIV Genome R-HSA-167172,-0.3094363253320825,-1.2883115012795707,0.0948905109489051,0.18587048082925808,1.0,22/64,24.87%,ELOB;POLR2F;POLR2I;POLR2G;TAF10;POLR2E;TCEA1;TAF11;POLR2C;GTF2H5;GTF2B;POLR2J;TAF5;ELOC;POLR2B;TAF7;NCBP2;ERCC3;POLR2L;TAF7L;SSRP1;GTF2H4
gsea,Signaling By NOTCH1 R-HSA-1980143,-0.30305084370613133,-1.2870695036969908,0.09919028340080972,0.18671885340273373,1.0,16/69,19.61%,UBB;RPS27A;TLE4;SNW1;UBA52;PSENEN;TBL1XR1;RBX1;APH1A;TBL1X;JAG1;TLE1;HEY1;UBC;FBXW7;MAMLD1
gsea,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.3292688920711729,-1.2860498832924958,0.11873840445269017,0.18738203605104956,1.0,11/51,11.74%,H2AZ1;DEK;CBX3;POLR2F;H2BC4;CHD3;POLR2E;POLR1G;H2AJ;RBBP7;GSK3B
gsea,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.3452178933381439,1.2851636587018636,0.13097713097713098,0.42244850658095423,1.0,12/40,12.97%,TNRC6C;MOV10;KMT2A;HDAC1;AGO4;AGO1;KMT2C;TNRC6B;KMT2B;H2AC4;DPY30;KMT2E
gsea,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.3180890625807966,-1.2832499573700855,0.099609375,0.19005033448696,1.0,22/63,26.33%,UBB;RPS27A;EIF4A1;EIF4A2;UBA52;UBE2N;NUP50;NUP37;MAPK3;NUP205;SEH1L;SEC13;NUP107;EIF4G2;UBC;IRF3;NUP35;JAK1;NUP62;PDZD2;KPNA3;NUP85
gsea,GPCR Downstream Signaling R-HSA-388396,0.2516724649468781,1.2829268378495031,0.06435643564356436,0.4208641312576565,1.0,58/308,10.47%,NBEA;PDE2A;DGKG;KALRN;PDE1A;PLEKHG5;TRIO;RPS6KA2;GABBR2;ADCY8;PRKCE;FGD4;ROCK1;ADCY2;ABR;PDE7B;DGKH;ITSN1;PRKCG;CHRM3;GRM8;CAMK2A;PDE10A;RGS17;TRHR;GPR45;ARHGEF33;RXFP1;RGS8;RASGRF2;TRPC6;TRPC3;SOS1;GRM7;RGS11;RGS7;HTR2C;DGKQ;ADCY9;GNA12;CAMK2G;DGKB;PDE4A;ADCYAP1R1;PIK3R3;DGKI;GRK3;TIAM1;GPR68;AKT2;ADCY6;PRPF38B;FGD1;ARHGEF17;ARHGEF7;GRK5;ARHGEF18;ARHGEF3
gsea,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.4402952036425738,-1.2821714748296422,0.17034068136272545,0.1908070064604868,1.0,8/17,26.76%,RPS6;RBX1;NPM1;CEBPB;MAPK3;MAPK1;SKP1;RNASEH2A
gsea,RHOC GTPase Cycle R-HSA-9013106,0.32092246879924285,1.2816832313963042,0.11591355599214145,0.4171311733493001,1.0,27/63,26.19%,ARHGEF28;FMNL2;MYO9B;TJP2;ROCK1;ABR;STK10;DLC1;DHDDS;LBR;ARHGAP18;ARHGEF17;IQGAP1;ACBD5;ARHGAP32;ARHGEF10L;VANGL1;STARD13;ARHGEF11;AKAP13;DAAM1;PREX1;ARHGAP39;FLOT2;MCAM;MCF2;RTKN
gsea,Telomere Extension By Telomerase R-HSA-171319,-0.423158659635941,-1.2807702314684555,0.15748031496062992,0.19177309206163207,1.0,7/18,19.57%,NOP10;GAR1;RUVBL1;TERF1;DKC1;NHP2;ANKRD28
gsea,Hemostasis R-HSA-109582,-0.2543949562778043,-1.2796629296840003,0.06871609403254973,0.19251820001362607,1.0,67/366,13.99%,CALM1;ATP1B1;PPIA;TMSB4X;TUBA4A;TTR;GNAS;TSPAN7;RASGRP1;APLP2;GNB2;CAPZA2;BSG;CDC42;GNG2;FAM3C;ORAI2;P2RY12;MANF;TIMP3;VEGFC;SOD1;CD47;ATP1B2;YWHAZ;PPP2CA;PPP2R1A;PDGFA;GNG13;PFN1;SELPLG;ITGAV;OLA1;EHD3;VTI1B;CLU;GNG10;HRAS;HMG20B;SCCPDH;GNG3;C1QBP;GNAI1;VEGFB;ADRA2C;MAGED2;TAGLN2;SPARC;ATP2B1;PRKAR1B;TEK;ANGPT2;GNAI2;CD63;LYN;SRI;SLC8A2;PIK3R1;RAP1A;GNA11;MAPK3;VCL;TTF2;CBX5;RHOB;JAM2;PPP2R5D
gsea,Smooth Muscle Contraction R-HSA-445355,-0.382969553160351,-1.2770720917737446,0.14559386973180077,0.1947263709781045,1.0,4/29,5.41%,CALM1;MYL6;MYL12B;TPM1
gsea,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.3768301397302819,-1.2760342256351849,0.1290983606557377,0.19543524835431703,1.0,9/28,21.21%,UBB;RPS27A;UBA52;OTUB1;VCPIP1;UBC;VCP;YOD1;RHOA
gsea,EPHB-mediated Forward Signaling R-HSA-3928662,-0.3647323300886225,-1.2747754750744933,0.14549180327868852,0.19628197609719392,1.0,9/31,8.80%,ACTG1;CDC42;ARPC5;WASL;ARPC2;ARPC1A;ACTR2;ARPC3;HRAS
gsea,CaM Pathway R-HSA-111997,0.3774606573470432,1.273360104935767,0.145610278372591,0.4287213368866753,1.0,9/30,9.46%,NBEA;PDE1A;ADCY8;ADCY2;PRKCG;CAMK2A;ADCY9;CAMK2G;ADCY6
gsea,DNA Repair R-HSA-73894,-0.25441756832666584,-1.272395063133116,0.04736842105263158,0.19834513762473394,1.0,97/254,33.43%,UBB;RPS27A;H2AZ1;SUMO2;UBA52;CETN2;SEM1;COPS6;POLR2F;CENPX;HMGN1;EYA1;H2BC4;RBX1;ALKBH5;POLR2I;UBE2N;PCNA;POLR2G;MPG;POLR2E;H2AJ;UBXN1;TCEA1;RPA3;PARP1;PPP4C;POLR2C;RUVBL1;GPS1;TERF1;GTF2H5;RNF168;BABAM2;DDB2;COPS8;ADPRS;SIRT6;APEX1;YY1;UBC;PRPF19;TDG;RFC3;POLR2J;H2AX;VCP;XRCC2;UIMC1;RAD50;ACTR8;LRIG1;POLR2B;RAD9B;PPIE;MAD2L2;RBBP8;XRCC6;ERCC3;RAD51;SUMO1;POLR2L;ASCC1;GTF2H4;COPS7A;LIG4;POLD4;POLD2;PALB2;FANCE;MLH1;XAB2;COPS5;RCHY1;KAT5;PCLAF;POLL;TINF2;POLD3;POLR2D;MUS81;GTF2H3;USP1;FEN1;ACTL6A;H2AZ2;XPA;KPNA2;RFC5;POLI;CNKSR3;MSH6;DCLRE1B;POLR2K;FAAP20;RAD23B;XRCC3
gsea,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.31397485378410195,-1.2701264910055936,0.125,0.20028049332695794,1.0,10/63,8.39%,UBB;RPS27A;BEX3;MAGED1;YWHAE;UBA52;SQSTM1;PSENEN;APH1A;BAD
gsea,RHO GTPase Cycle R-HSA-9012999,0.2513082031934324,1.26763773617003,0.07112970711297072,0.4349378911133051,1.0,69/373,11.55%,DOCK9;KALRN;PLEKHG5;TRIO;DST;CYFIP1;DOCK3;IQGAP2;SHKBP1;DOCK10;DOCK11;WDR11;FGD4;ARHGEF28;ARHGAP15;MYO9A;FMNL2;MYO9B;TJP2;ROCK1;ABR;DOCK7;SH3PXD2A;DOCK4;ITSN1;PKP4;SRGAP2;STK10;FMNL1;DLG5;CCDC88A;OCRL;DLC1;RALGAPA1;SH3BP1;FNBP1;RASGRF2;GMIP;LCK;ABL2;SOS1;SPTAN1;ITSN2;PIK3R3;HGS;PREX2;DHDDS;TIAM1;SENP1;CDC42BPA;LBR;MTMR1;CPSF7;FAM169A;NCK2;PRPF38B;SLC4A7;FGD1;COPS4;ARHGAP18;ARHGEF17;ARHGEF7;ARHGEF18;ARHGEF3;ARAP2;ANKRD26;WIPF2;RNF20;ARAP1
gsea,Metabolism Of Porphyrins R-HSA-189445,-0.4164713317258999,-1.2619793006319464,0.1791907514450867,0.20833740620135177,1.0,6/19,27.59%,HMOX2;GUSB;ALAD;COX15;SLCO2B1;FECH
gsea,Lagging Strand Synthesis R-HSA-69186,-0.40833457557577424,-1.260719431975718,0.16549295774647887,0.20934712286306997,1.0,9/20,31.92%,PCNA;RPA3;RFC3;LRIG1;POLD4;POLD2;POLD3;FEN1;RFC5
gsea,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.426876324958003,-1.259717205746103,0.20281124497991967,0.21003312604175312,1.0,5/16,18.94%,H2AZ1;H2BC4;H2AJ;TAF1C;H2AX
gsea,RND3 GTPase Cycle R-HSA-9696264,0.346856186783595,1.2593162461094352,0.15352697095435686,0.4473307575349499,1.0,6/35,3.71%,PLEKHG5;DST;ROCK1;PKP4;DLG5;CCDC88A
gsea,G Alpha (Q) Signaling Events R-HSA-416476,0.28337511312139446,1.2587888089026493,0.09318181818181819,0.44199735722839334,1.0,18/101,8.21%,DGKG;KALRN;TRIO;RPS6KA2;PRKCE;DGKH;CHRM3;RGS17;TRHR;TRPC6;TRPC3;SOS1;HTR2C;DGKQ;DGKB;PIK3R3;DGKI;GPR68
gsea,RMTs Methylate Histone Arginines R-HSA-3214858,-0.34824932571597056,-1.2582452424287751,0.13725490196078433,0.2111889647338594,1.0,11/37,19.88%,RPS2;H2AZ1;H2AC25;CDK4;H2AJ;RBBP7;SMARCE1;PRMT7;ACTL6B;H2AX;SMARCB1
gsea,SUMOylation Of Intracellular Receptors R-HSA-4090294,0.3920671528408697,1.2564041998231477,0.16396761133603238,0.44083513019061343,1.0,9/21,17.09%,NR3C2;RORA;PIAS2;THRB;PIAS1;PPARG;HDAC4;PPARA;PGR
gsea,Cargo Concentration In ER R-HSA-5694530,-0.38335397916701625,-1.2560103202822153,0.15445544554455445,0.2131920458407255,1.0,6/23,13.37%,CNIH2;CNIH1;TMED2;LMAN2;MCFD2;LMAN1
gsea,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.41152597576910954,-1.253640342743704,0.20384615384615384,0.2154343257830935,1.0,8/19,28.47%,HMGB1;NFKB2;NFKBIB;NKIRAS1;NFKBIA;MAVS;RELA;NKIRAS2
gsea,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.4219986026176256,-1.2504235641126933,0.201980198019802,0.21859430339650743,1.0,4/18,9.34%,JUN;YWHAE;CDK5R1;PRDX1
gsea,Voltage Gated Potassium Channels R-HSA-1296072,0.3443024485754139,1.249754058178892,0.1258426966292135,0.44961013219757073,1.0,12/37,14.28%,KCNAB1;KCND3;KCNH1;KCNQ2;KCNQ3;KCNQ5;KCNG3;KCNAB2;KCNH8;KCNB2;KCNA6;KCNG1
gsea,RNA Polymerase III Chain Elongation R-HSA-73780,-0.41356701550051655,-1.2482716818822628,0.18181818181818182,0.22056239625605809,1.0,9/17,32.80%,POLR2F;POLR2E;POLR3H;POLR3D;POLR2L;POLR3E;POLR3A;POLR1D;POLR2K
gsea,Ca-dependent Events R-HSA-111996,0.35981422309580263,1.2479777813090414,0.16701461377870563,0.4472225598709323,1.0,9/32,9.46%,NBEA;PDE1A;ADCY8;ADCY2;PRKCG;CAMK2A;ADCY9;CAMK2G;ADCY6
gsea,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.3881353851663073,1.2474813019534747,0.16260162601626016,0.4421226135910035,1.0,7/21,6.98%,GRIN2A;LRRC7;PPM1E;ACTN2;CAMK2A;MPP3;CAMK2G
gsea,Integration Of Energy Metabolism R-HSA-163685,-0.2924339670099403,-1.2470939668470344,0.12757201646090535,0.22140280141336235,1.0,23/81,16.04%,GNAS;VAMP2;ACSL3;GNB2;GNG2;SYT5;MARCKS;PPP2CA;PPP2R1A;GNG13;SNAP25;GNG10;GNG3;GNAI1;ADRA2C;PRKAR1B;GNAI2;ACLY;RAP1A;GNA11;PPP2R5D;ADIPOR2;PRKACB
gsea,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.3691912671843977,-1.2454597375726602,0.18401486988847585,0.222993330219875,1.0,18/26,38.26%,POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;GTF2H5;POLR2J;POLR2B;ERCC3;POLR2L;GTF2H4;POLR2D;GTF2H3;POLR2K;CCNH;GTF2F2;POLR2A;RNMT
gsea,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.4078608410812732,-1.2452184240876025,0.18043478260869567,0.22282497769311427,1.0,5/20,20.47%,TECR;ACSL3;HACD4;ACSBG1;HSD17B12
gsea,Diseases Of Glycosylation R-HSA-3781865,0.28336856343873124,1.2446447209584788,0.13304721030042918,0.4421589950679954,1.0,24/105,16.50%,ADAMTS17;SEMA5B;SPON1;ADAMTS20;NOTCH2;ADAMTS3;ST3GAL3;ADAMTS18;HEXA;HEXB;DHDDS;LARGE1;GPC3;ALG8;CFP;GALE;GALNT3;THSD7B;ADAMTS2;ADAMTS16;ALG12;EXT1;VCAN;THSD1
gsea,Ion Homeostasis R-HSA-5578775,-0.3431482610113962,-1.2442407871660364,0.13157894736842105,0.22352543633433686,1.0,9/39,12.64%,CALM1;ATP1B1;ATP1A3;ORAI2;ATP1B2;ATP1A2;ATP2B1;SRI;SLC8A2
gsea,RNA Polymerase I Promoter Escape R-HSA-73772,-0.3445887688498467,-1.244151982672491,0.15953307392996108,0.2232255060390415,1.0,19/38,32.80%,H2AZ1;CBX3;POLR2F;H2BC4;POLR2E;POLR1G;H2AJ;GTF2H5;TAF1C;H2AX;RRN3;ERCC3;POLR2L;GTF2H4;POLR1D;POLR1F;GTF2H3;H2AZ2;POLR2K
gsea,RHO GTPases Activate Formins R-HSA-5663220,-0.28518800950475026,-1.2441010197251026,0.11317254174397032,0.2228911563831843,1.0,20/91,16.13%,DYNLL1;PFN2;DYNLL2;ACTG1;RPS27;CDC42;PPP2CA;PPP2R1A;PAFAH1B1;PFN1;ZWINT;NUP37;RHOB;PPP2R5D;SEH1L;SEC13;NUDC;NUP107;PPP1CC;CENPP
gsea,P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.28859680875462435,-1.2422373952634833,0.13070539419087138,0.22453314326589888,1.0,12/84,8.47%,UBB;RPS27A;BEX3;ARHGDIA;MAGED1;YWHAE;UBA52;SQSTM1;PSENEN;APH1A;BAD;RTN4
gsea,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.3281473551372158,-1.2385371017950293,0.14901960784313725,0.22842114279740544,1.0,19/42,35.63%,RAB6B;RAB6A;STX16;NAPG;NAA38;SCOC;VAMP3;NSF;SYS1;TMF1;VPS52;ARFRP1;M6PR;VPS53;STX6;RABEPK;VAMP4;ARFIP2;COG8
gsea,RNA Polymerase II Transcription Termination R-HSA-73856,-0.30508801403934616,-1.2381181323441426,0.1348314606741573,0.2285463667483787,1.0,20/65,21.67%,SNRPG;SNRPF;CPSF2;RBM8A;MAGOH;CHTOP;U2AF1;MAGOHB;SRSF3;POLDIP3;SNRPE;U2AF1L4;SLBP;U2AF2;CDC40;SLU7;DDX39B;THOC7;NCBP2;SNRPB
gsea,Unfolded Protein Response (UPR) R-HSA-381119,-0.29519599099939803,-1.2380544098201662,0.13894324853228962,0.22819960853051685,1.0,37/76,40.62%,CALR;PDIA6;DNAJB9;EIF2S2;NFYB;CEBPB;EXOSC4;EXOSC3;MYDGF;HDGF;SSR1;CREB3L2;SRPRB;TLN1;CXXC1;EXOSC9;HSP90B1;DNAJB11;EXTL2;TSPYL2;EDEM1;ATP6V0D1;HERPUD1;TATDN2;PPP2R5B;LMNA;ACADVL;FKBP14;DCTN1;PREB;DCP2;DDIT3;CEBPG;HSPA5;EXOSC7;GOSR2;SERP1
gsea,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.4052950047441578,-1.2365754117554304,0.1803921568627451,0.22941230035533294,1.0,6/19,23.21%,PLK2;BTG2;NPM1;CNOT8;CNOT6L;CNOT11
gsea,FGFR2 Alternative Splicing R-HSA-6803529,-0.37044967401636725,-1.2355817688296193,0.16917293233082706,0.23005903958863194,1.0,11/24,23.65%,POLR2F;HNRNPA1;POLR2I;POLR2G;POLR2E;HNRNPF;POLR2C;POLR2J;POLR2B;NCBP2;POLR2L
gsea,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.4255748697212248,-1.2353392097302789,0.188715953307393,0.2299082523449121,1.0,5/16,23.08%,H2AZ1;H2BC4;H2AJ;H2AX;ORC4
gsea,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.3733639846406325,-1.2334046803742078,0.1871345029239766,0.2317521184785436,1.0,5/27,7.62%,TTR;FGF13;PDGFA;VTN;ITGAV
gsea,Metabolism Of Non-Coding RNA R-HSA-194441,-0.31988784003805376,-1.232186851723237,0.1579961464354528,0.23279438176998238,1.0,20/47,26.33%,SNRPG;SNRPF;SNRPD2;NUP50;DDX20;GEMIN7;NUP37;NUP205;SEH1L;SNRPE;SEC13;NUP107;GEMIN6;CLNS1A;NCBP2;SNRPB;NUP35;NUP62;LIN9;NUP85
gsea,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.3735394901514121,-1.2314478817739363,0.17159763313609466,0.2332966687554243,1.0,8/23,12.01%,GNB2;GNG2;GNG13;GNG10;GNG3;GNAI1;ADRA2C;GNAI2
gsea,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.3160162924060173,-1.2312102111548957,0.13984674329501914,0.23315737852137208,1.0,16/53,20.93%,JUN;H2AZ1;POLR2F;H2BC4;POLR2I;POLR2G;POLR2E;H2AJ;RBBP7;POLR2C;YY1;POLR2J;H2AX;PBX1;POLR2B;CTCF
gsea,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.324708666302966,1.2290571815763136,0.18067226890756302,0.471097252432678,1.0,11/46,6.79%,CNTN5;CNTN4;NTNG2;GPLD1;NEGR1;NTM;PIGT;MDGA2;RTN4RL1;MDGA1;PIGO
gsea,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.3681510358552671,1.2284119080533513,0.17802197802197803,0.4660739150183755,1.0,12/27,20.76%,DST;COL11A1;LAMB3;COL15A1;COL5A1;COL5A2;BMP1;COL4A1;COL9A2;COL4A4;COL4A2;PXDN
gsea,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.4229274784489859,-1.2274922144694387,0.20454545454545456,0.23700862342417886,1.0,7/16,30.84%,GOT2;ADO;ETHE1;MTAP;MTRR;TXN2;APIP
gsea,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.4221082684121473,1.227414838017648,0.19839679358717435,0.4620916581001167,1.0,3/16,7.03%,LRRFIP1;ZMYM2;GAB2
gsea,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.4094874878208076,-1.2267665411540936,0.19305019305019305,0.2374983615119716,1.0,6/19,18.94%,H2AZ1;H2BC4;H2AJ;TERF1;TDG;H2AX
gsea,Glycerophospholipid Biosynthesis R-HSA-1483206,0.26941115142420546,1.2264086433861672,0.11991434689507495,0.458212836426488,1.0,28/97,20.35%,SLC44A5;MIGA2;PITPNM2;PLA2G4E;PCYT2;OSBPL10;CHKA;CSNK2A2;MBOAT2;TAFAZZIN;ETNK1;LPIN1;CHEK2;CPNE1;PNPLA2;ETNK2;ABHD4;SLC44A2;DGAT1;CHKB;PGS1;LPIN2;MGLL;ACP6;PLA2G3;STARD10;MBOAT1;PLA2G4A
gsea,Cilium Assembly R-HSA-5617833,-0.2548447911243936,-1.2261241536648755,0.09980430528375733,0.23787721589211225,1.0,19/174,7.40%,TUBA4A;DYNLL1;YWHAG;DYNLL2;TUBA1A;HSP90AA1;YWHAE;ARF4;CCT2;CETN2;CSNK1E;PPP2R1A;PAFAH1B1;BBIP1;TUBB4A;TUBB4B;DYNLRB1;DCTN3;RAB11A
gsea,Signaling By GPCR R-HSA-372790,0.2373936111116357,1.225543736445936,0.09828009828009827,0.45440647224930997,1.0,61/339,10.47%,NBEA;PDE2A;DGKG;KALRN;PDE1A;PLEKHG5;TRIO;RPS6KA2;GABBR2;ADCY8;PRKCE;FGD4;ROCK1;ADCY2;ABR;PDE7B;DGKH;ITSN1;PRKCG;CHRM3;GRM8;CAMK2A;PDE10A;RGS17;TRHR;PLPPR1;GPR45;ARHGEF33;ECE1;RXFP1;RGS8;RASGRF2;TRPC6;TRPC3;SOS1;GRM7;RGS11;RGS7;HTR2C;DGKQ;ADCY9;GNA12;CAMK2G;DGKB;PDE4A;ADCYAP1R1;PIK3R3;DGKI;GRK3;TIAM1;GPR68;AKT2;WNT7A;ADCY6;PRPF38B;FGD1;ARHGEF17;ARHGEF7;GRK5;ARHGEF18;ARHGEF3
gsea,RHOG GTPase Cycle R-HSA-9013408,0.2945191159526015,1.2242893718585555,0.13806706114398423,0.4512509519675215,1.0,7/65,3.02%,KALRN;TRIO;CYFIP1;DOCK3;IQGAP2;DOCK4;ITSN1
gsea,Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.36315628621140505,1.2238984959184904,0.18446601941747573,0.4464842878969319,1.0,9/29,8.17%,TNRC6C;MOV10;CAMK2A;HDAC1;AGO4;CAMK2G;AGO1;TNRC6B;LBR
gsea,Extracellular Matrix Organization R-HSA-1474244,0.2618744843011941,1.223847324582455,0.10321100917431193,0.4411229332317824,1.0,54/172,21.24%,PTPRS;DST;COL23A1;P3H2;COL11A1;ERC2;DMD;SH3PXD2A;LAMB1;TNR;FBN2;ADAMTS3;COL19A1;LTBP4;CASK;LAMC1;ADAMTS18;COLGALT2;LAMB3;COL16A1;ITGA8;ITGA3;P3H1;COL15A1;ADAM12;CAPN15;MMP16;COL5A1;COL5A2;BMP1;COL4A1;ADAMTS2;ADAMTS16;MATN4;COL12A1;SPOCK3;VCAN;COL9A2;DMTF1;ITGB8;ITGA4;CAPN1;COL25A1;MMP24;COL4A4;ITGA1;TIMP2;COL4A2;ADAM17;CD44;CTSK;PXDN;COL13A1;FBN1
gsea,Signaling By NTRKs R-HSA-166520,-0.27801112976790443,-1.2234855405985365,0.13127413127413126,0.24048542182118732,1.0,36/113,21.64%,YWHAB;CDK5R2;CLTA;DUSP3;JUND;AP2M1;MEF2C;BAX;DUSP7;PPP2CA;EGR1;PPP2R1A;IRS2;CDK5R1;HRAS;DNAL4;RALA;VGF;EGR4;AP2B1;PIK3R1;RAP1A;MAPK3;PPP2R5D;ID4;ID2;EGR3;ID3;AP2S1;SH3GL2;CREB1;ASCL1;MAPK1;AP2A2;RHOA;NRAS
gsea,Signaling By VEGF R-HSA-194138,-0.28860830030094337,-1.2186252082165363,0.146,0.24586354879069397,1.0,14/80,12.71%,CALM1;HSP90AA1;BRK1;CDC42;NCK1;VEGFC;ABI1;ITGAV;HRAS;AXL;NCF2;VEGFB;CTNNA1;PIK3R1
gsea,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.4229462781193629,-1.2147951336253415,0.2302025782688766,0.2501395449069642,1.0,5/15,24.02%,VPS29;SNX3;WNT16;VPS35;TMED5
gsea,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.3079488153028272,-1.2139928742205024,0.18329938900203666,0.2507269229213169,1.0,15/51,24.84%,UBB;RPS27A;UBA52;CANX;DAD1;DDOST;GSK3B;PARP16;UBC;PARP4;ST6GAL1;CSNK1A1;STT3A;SUMO1;TUSC3
gsea,Processing Of Intronless Pre-mRNAs R-HSA-77595,0.3839984865515282,1.213697389895486,0.21748400852878466,0.45731661995151557,1.0,9/20,20.16%,PABPN1;NCBP1;CPSF7;PAPOLA;SYMPK;CSTF2;NUDT21;CSTF3;FIP1L1
gsea,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.4133902201910503,-1.2135519013535376,0.22021660649819494,0.25080003029134496,1.0,5/16,23.17%,PRNP;GCLM;FDX2;FDX1;TBXAS1
gsea,Rab Regulation Of Trafficking R-HSA-9007101,-0.2739575086798648,-1.211222951921983,0.13686131386861314,0.2531372313926329,1.0,17/104,11.68%,RAB3A;TRAPPC6B;YWHAE;GABARAPL2;RAB6B;GABARAP;MAP1LC3B;RAB14;RAB6A;SBF1;TRAPPC2L;RAB11A;TRAPPC2;RAB1B;RAB18;RAB31;TRAPPC1
gsea,Collagen Degradation R-HSA-1442490,0.3764287390996526,1.210337208652766,0.20162932790224034,0.4589721150779772,1.0,10/21,21.05%,COL23A1;COL19A1;COL16A1;COL15A1;COL12A1;COL9A2;COL25A1;ADAM17;CTSK;COL13A1
gsea,HDACs Deacetylate Histones R-HSA-3214815,-0.35221635358183717,-1.2101267341184285,0.1653061224489796,0.2539743907937832,1.0,8/35,8.94%,H2AC25;SAP18;H2BC4;TBL1XR1;GPS2;CHD3;HMG20B;RBBP7
gsea,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.40456369321319346,-1.2097245888345265,0.19488188976377951,0.2540704998822286,1.0,6/17,19.64%,WWTR1;MAF;MAPK3;CBFB;HEY1;MAPK1
gsea,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.40634173424398773,-1.2096968610523504,0.2037037037037037,0.25366536676066886,1.0,3/18,4.39%,HMGB1;NDUFA2;NFKB2
gsea,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.35874722580349794,-1.2041356445624771,0.21584158415841584,0.26013425351737895,1.0,10/26,26.33%,RAN;NUP37;NUP205;SEH1L;SEC13;NUP107;NUP35;SUMO1;NUP62;NUP85
gsea,NCAM1 Interactions R-HSA-419037,0.3744490897879503,1.2021097132905973,0.2315369261477046,0.47172470342557477,1.0,12/24,25.39%,CACNA1C;CACNB2;CACNA1H;COL4A1;COL9A2;GFRA2;COL4A4;COL4A2;GFRA1;CACNB1;CACNB4;NCAN
gsea,Reproduction R-HSA-1474165,-0.29488425325817685,-1.2019995770257625,0.16390423572744015,0.2624515697219455,1.0,25/61,32.10%,H2AZ1;HSPA2;SMC1A;H2BC4;CDK4;RAD21;H2AJ;RPA3;TERF1;SYCP3;SUN1;ADAM21;H2AX;RAD50;RBBP8;RAD51;PSMC3IP;SUN2;SMC3;MLH1;MLH3;OVGP1;TINF2;H2AZ2;LMNA
gsea,RHOU GTPase Cycle R-HSA-9013420,0.33681129089021633,1.2011771002805653,0.20449897750511248,0.4682512284758641,1.0,15/36,20.25%,DST;SRGAP2;DLG5;SPTAN1;ITSN2;HGS;NCK2;ARHGEF7;SPTBN1;IQGAP1;ARHGAP31;WDR6;VANGL1;GIT2;USP9X
gsea,Extension Of Telomeres R-HSA-180786,-0.3185933473566141,-1.1932952498174543,0.17422867513611615,0.2730299477429865,1.0,17/42,31.92%,NOP10;PCNA;GAR1;RPA3;RUVBL1;TERF1;DKC1;NHP2;RFC3;ANKRD28;LRIG1;POLD4;POLD2;TINF2;POLD3;FEN1;RFC5
gsea,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.23781503274955335,-1.1928889871051938,0.1,0.2731373957062896,1.0,24/243,7.40%,CALM1;TUBA4A;DYNLL1;YWHAG;DYNLL2;TUBA1A;HSP90AA1;ATP5PB;YWHAE;ARF4;MEF2C;CCT2;CETN2;CSNK1E;CYCS;PPP2R1A;PAFAH1B1;BBIP1;TUBB4A;TBL1XR1;TUBB4B;DYNLRB1;DCTN3;RAB11A
gsea,Cell-Cell Communication R-HSA-1500931,0.27431884640937154,1.1926510943523536,0.1693227091633466,0.48129480443778205,1.0,22/88,15.47%,DST;SDK2;CDH12;ACTN2;NECTIN1;CASK;FLNA;SPTAN1;PTK2;LAMB3;ACTN4;PATJ;PARVB;NCK2;CADM1;FYN;RSU1;CDH11;CDH13;SPTBN1;IQGAP1;SKAP2
gsea,Peptide Hormone Metabolism R-HSA-2980736,-0.3105272626650011,-1.1912316718762144,0.18613861386138614,0.2747059743669156,1.0,9/46,12.83%,VAMP2;SPCS2;CPE;GNG13;ATP6AP2;PLA2G7;INHBA;CHGA;SPCS1
gsea,Gene Silencing By RNA R-HSA-211000,-0.28114095007321005,-1.191033985469764,0.19274809160305342,0.2744883217344763,1.0,19/73,15.72%,HSP90AA1;RAN;H2AZ1;POLR2F;H2BC4;POLR2I;POLR2G;POLR2E;H2AJ;NUP50;POLR2C;NUP37;NUP205;SEH1L;MOV10L1;SEC13;HENMT1;NUP107;IPO8
gsea,Signaling By FGFR In Disease R-HSA-1226099,-0.30633610345247864,-1.189245090235807,0.1977401129943503,0.276158225395172,1.0,12/49,12.71%,FGFR2;FGF13;POLR2F;POLR2I;FGFR1;POLR2G;POLR2E;HRAS;BAG4;POLR2C;TRIM24;PIK3R1
gsea,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.35959425543165374,-1.1888988413479502,0.22007722007722008,0.2761148161043823,1.0,7/24,22.07%,BNIP3L;BAX;TRIAP1;PRELID3A;PRELID1;BBC3;FASN
gsea,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.4024518013623152,1.1879306879691287,0.24904942965779467,0.4861423935593833,1.0,7/17,17.79%,GRIN2A;TRPC3;HDAC1;MECP2;GRIN2B;FKBP5;PTPN4
gsea,mRNA Capping R-HSA-72086,-0.34398831508208855,-1.1871564318153325,0.24060150375939848,0.2778564918073652,1.0,19/28,38.26%,POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;GTF2H5;POLR2J;POLR2B;NCBP2;ERCC3;POLR2L;GTF2H4;POLR2D;GTF2H3;POLR2K;CCNH;GTF2F2;POLR2A;RNMT
gsea,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.3014452165365579,-1.1866396587894676,0.17333333333333334,0.27813274394097287,1.0,17/53,24.87%,JUN;ELOB;POLR2F;POLR2I;POLR2G;POLR2E;TCEA1;POLR2C;GTF2H5;DDB2;POLR2J;ELOC;POLR2B;ERCC3;POLR2L;SSRP1;GTF2H4
gsea,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.28552385591694646,-1.1861834694348823,0.1807465618860511,0.27825102980608557,1.0,12/75,12.71%,CALM1;HSP90AA1;BRK1;CDC42;NCK1;ABI1;ITGAV;HRAS;AXL;NCF2;CTNNA1;PIK3R1
gsea,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.4039804489361513,-1.1851677566844359,0.22857142857142856,0.2790603143131245,1.0,7/16,27.89%,YWHAB;EXOSC4;EXOSC3;ZFP36L1;EXOSC9;AKT1;XRN1
gsea,Interferon Signaling R-HSA-913531,-0.2683148840781704,-1.1839431456274405,0.15594541910331383,0.28018508945621357,1.0,36/109,26.33%,UBB;RPS27A;EIF4A1;EIF4A2;UBA52;TRIM35;EGR1;IFNGR2;UBE2N;PML;NUP50;IRF8;NUP37;MAPK3;NUP205;SEH1L;SEC13;NUP107;SMAD7;EIF4G2;CAMK2B;UBC;PTPN1;SAMHD1;NCAM1;IRF3;NUP35;SUMO1;JAK1;PTPN11;B2M;NUP62;PDZD2;KPNA3;TRIM8;NUP85
gsea,Signaling To RAS R-HSA-167044,0.40639964100876735,1.1807880453586967,0.25793650793650796,0.49633137127562527,1.0,6/15,16.76%,MAPK14;SOS1;MAPKAPK2;MAPK12;MAPK11;SHC3
gsea,Meiotic Synapsis R-HSA-1221632,-0.3293514389607921,-1.17787863562677,0.2172211350293542,0.2877641965434167,1.0,10/32,18.94%,H2AZ1;HSPA2;SMC1A;H2BC4;RAD21;H2AJ;TERF1;SYCP3;SUN1;H2AX
gsea,PLC Beta Mediated Events R-HSA-112043,0.32204535872323325,1.1750879083048134,0.22626262626262628,0.5037358379038218,1.0,8/39,6.98%,NBEA;PDE1A;ADCY8;ADCY2;PRKCG;CAMK2A;ADCY9;CAMK2G
gsea,Sensory Perception R-HSA-9709957,-0.2634403201713801,-1.175031656439676,0.18330308529945555,0.2909295965471192,1.0,23/124,15.99%,CALM1;TTR;RAB3A;APOE;VAMP2;CAPZA2;KCNJ2;SYP;GNG13;C1D;SNAP25;RNF7;SCN1B;TWF1;ATP2B1;METAP2;EZR;LDLR;RBP1;OR4A47;SCN2B;GPC1;GRM1
gsea,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.27248697712068864,-1.1748204327063934,0.170018281535649,0.290765322721283,1.0,17/79,16.13%,DYNLL1;DYNLL2;RPS27;SMC1A;PPP2CA;PPP2R1A;PAFAH1B1;RAD21;ZWINT;NUP37;PPP2R5D;SEH1L;SEC13;NUDC;NUP107;PPP1CC;CENPP
gsea,Arachidonic Acid Metabolism R-HSA-2142753,-0.370102575406134,-1.173957108201567,0.23719165085388993,0.2913510043927876,1.0,9/25,23.17%,GPX4;PTGDS;PTGES3;HPGDS;PRXL2B;CBR1;PON2;PTGR1;TBXAS1
gsea,HDMs Demethylate Histones R-HSA-3214842,0.37908198386040376,1.172027515400816,0.24329501915708812,0.5052615930957591,1.0,7/19,18.86%,KDM2B;KDM5B;KDM2A;KDM3A;KDM4B;KDM4A;KDM7A
gsea,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.3486958653585824,-1.168778651087444,0.22476190476190477,0.2977547724122469,1.0,6/27,5.59%,JUN;DUSP3;MEF2C;DUSP7;PPP2CA;PPP2R1A
gsea,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.30631823466957797,-1.1676496659251634,0.21442885771543085,0.29873353409609205,1.0,11/46,21.97%,CALM1;MEF2C;CYCS;TBL1XR1;TBL1X;TFAM;HCFC1;TFB2M;CREB1;IDH2;ESRRA
gsea,FLT3 Signaling R-HSA-9607240,-0.33388324663963564,-1.1656695273874045,0.24643584521384929,0.3009037579738424,1.0,13/33,25.35%,UBB;RPS27A;UBA52;HRAS;PIK3R1;CDKN1B;HCK;UBC;NRAS;PTPN11;AKT1;GRB10;FOXO3
gsea,DNA Double-Strand Break Repair R-HSA-5693532,-0.258424357819932,-1.1628083467077839,0.17518248175182483,0.30457105853108174,1.0,39/114,32.41%,UBB;RPS27A;SUMO2;UBA52;SEM1;EYA1;H2BC4;UBE2N;PCNA;UBXN1;RPA3;PARP1;PPP4C;RNF168;BABAM2;SIRT6;UBC;RFC3;H2AX;XRCC2;UIMC1;RAD50;RAD9B;RBBP8;XRCC6;RAD51;SUMO1;LIG4;POLD4;POLD2;PALB2;KAT5;POLL;POLD3;MUS81;FEN1;KPNA2;RFC5;CNKSR3
gsea,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.29515107878488855,1.161624909472401,0.21649484536082475,0.5234950291480828,1.0,17/50,17.18%,PHC2;RANBP2;SATB1;PIAS2;NUP188;HDAC1;NUP210;SCMH1;NDC1;PHC3;PIAS1;NUP98;HDAC4;POM121;NUP160;AAAS;NUP133
gsea,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.349760330022612,-1.1582902022403097,0.22879684418145957,0.31032473220685064,1.0,13/26,34.39%,POLR2F;POLR2E;POLR3H;SNAPC5;POLR3D;SNAPC1;SNAPC2;POLR2L;POLR3E;POLR3A;POLR1D;POLR2K;BRF2
gsea,Viral Messenger RNA Synthesis R-HSA-168325,-0.302506823209856,-1.1566120289214208,0.2378167641325536,0.31222054651728953,1.0,17/43,26.33%,POLR2F;POLR2I;POLR2G;POLR2E;NUP50;POLR2C;NUP37;NUP205;SEH1L;SEC13;NUP107;POLR2J;POLR2B;NUP35;POLR2L;NUP62;NUP85
gsea,RHOV GTPase Cycle R-HSA-9013424,0.32964486845793395,1.1560926402902585,0.24329896907216494,0.5309121691373828,1.0,14/32,20.83%,DST;MYO9A;DLG5;SPTAN1;NCK2;ARHGEF7;SH3RF1;SPTBN1;IQGAP1;WDR6;VANGL1;GIT2;USP9X;PARD6B
gsea,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.3361085232158201,-1.1536862042132652,0.2768595041322314,0.31579851986097157,1.0,8/29,22.07%,TECR;ACSL3;HSD17B8;HACD4;ACLY;ACSBG1;HSD17B12;FASN
gsea,RET Signaling R-HSA-8853659,0.3406195273062218,1.1522947821617018,0.26294820717131473,0.5342884963508706,1.0,14/30,21.88%,DOK5;SHANK3;SOS1;DOK6;GAB2;PIK3R3;PLCG1;SHC3;RAP1GAP;GFRA2;MAPK7;FRS2;PIK3CA;GFRA1
gsea,Processive Synthesis On Lagging Strand R-HSA-69183,-0.4130976955744205,-1.1520060701544816,0.2718631178707224,0.3177044020460173,1.0,7/15,31.63%,PCNA;RPA3;LRIG1;POLD4;POLD2;POLD3;FEN1
gsea,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.37722576538064534,1.1513239456102904,0.294478527607362,0.5309838613458632,1.0,6/18,10.86%,LCK;PIK3R3;AKT2;RICTOR;FYN;MTOR
gsea,Mitochondrial Biogenesis R-HSA-1592230,-0.2799780698808348,-1.1494484397493103,0.238,0.3207494315451451,1.0,18/69,21.97%,CALM1;ATP5PB;MEF2C;CYCS;TBL1XR1;IMMT;SAMM50;TBL1X;TMEM11;TFAM;HSPA9;HCFC1;TFB2M;MICOS10;CREB1;IDH2;MTX1;ESRRA
gsea,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.2788035781021865,-1.1492680837920035,0.2045028142589118,0.32044689950394684,1.0,20/69,25.15%,UBB;RPS27A;UBA52;CDK5R1;TAF10;CSNK2B;TAF11;RPA3;HIPK1;UBC;MAPKAPK5;RFC3;TAF5;RAD50;TAF7;RAD9B;RBBP8;TAF7L;SSRP1;PDZD2
gsea,Nephrin Family Interactions R-HSA-373753,0.3701526231518278,1.1487668034302883,0.2584745762711864,0.5311671009708273,1.0,8/20,14.88%,ACTN2;CASK;SPTAN1;ACTN4;NCK2;FYN;SPTBN1;IQGAP1
gsea,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.28855407419964607,-1.1459812246573249,0.24531835205992508,0.32445150646575627,1.0,15/54,23.21%,EIF4A1;EIF4A2;LSM7;LSM4;LSM2;PABPC1;EXOSC4;EXOSC3;LSM1;CNOT8;SKIC8;LSM5;CNOT6L;EXOSC9;CNOT11
gsea,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.318620730116953,-1.1452936702123675,0.26499032882011603,0.3249363138790092,1.0,9/33,15.27%,RAN;NPM1;RANBP1;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107
gsea,PRC2 Methylates Histones And DNA R-HSA-212300,-0.3624782233429044,-1.145125744295445,0.2785571142284569,0.3246534390350214,1.0,4/20,8.94%,H2AZ1;H2BC4;H2AJ;RBBP7
gsea,ERK/MAPK Targets R-HSA-198753,-0.36730814420128827,-1.1446406651273868,0.272552783109405,0.32483987236170947,1.0,7/21,13.99%,DUSP3;MEF2C;DUSP7;PPP2CA;PPP2R1A;MAPK3;PPP2R5D
gsea,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.27153329271788484,-1.1442967378201438,0.21923076923076923,0.32487894545453866,1.0,23/76,24.96%,HSP90AB1;HSP90AA1;CNBP;UBE2N;MASP2;G3BP2;NUP50;UBE2V1;NUP37;NUP205;SEH1L;SEC13;G3BP1;NUP107;TBK1;IRF3;TKFC;NUP35;JAK1;MAVS;PTPN11;B2M;NUP62
gsea,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.27142513203690466,-1.1359282771071473,0.24593128390596744,0.33628715077153293,1.0,15/69,16.13%,DYNLL1;DYNLL2;RPS27;PPP2CA;PPP2R1A;PAFAH1B1;ZWINT;NUP37;PPP2R5D;SEH1L;SEC13;NUDC;NUP107;PPP1CC;CENPP
gsea,Formation Of Early Elongation Complex R-HSA-113418,-0.3170330571663974,-1.1348233521947932,0.2833333333333333,0.33732430623680304,1.0,12/31,24.87%,POLR2F;POLR2I;POLR2G;POLR2E;POLR2C;GTF2H5;POLR2J;POLR2B;NCBP2;ERCC3;POLR2L;GTF2H4
gsea,NOD1/2 Signaling Pathway R-HSA-168638,0.3434954632711855,1.1334928881889383,0.25203252032520324,0.5611195131519181,1.0,6/25,15.79%,CHUK;MAPK14;MAP3K7;IKBKB;MAPK12;MAPK11
gsea,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.2982045925363735,-1.1332576551084974,0.27091633466135456,0.33901166827091217,1.0,3/40,2.12%,DDX5;PARK7;SUMO2
gsea,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.37382503415184687,1.133094203436292,0.27044025157232704,0.5562987404690153,1.0,7/17,19.46%,HLCS;ACACA;MCCC1;PCCB;ABCD4;AMN;MMAB
gsea,ECM Proteoglycans R-HSA-3000178,0.33272581977214827,1.1319133488289845,0.29012345679012347,0.553390054043668,1.0,9/34,17.14%,PTPRS;LAMB1;TNR;LAMC1;ITGA8;MATN4;VCAN;COL9A2;DMTF1
gsea,Deadenylation Of mRNA R-HSA-429947,-0.34869767740081425,-1.1286301042835545,0.282,0.3453870749621109,1.0,6/24,23.21%,EIF4A1;EIF4A2;PABPC1;CNOT8;CNOT6L;CNOT11
gsea,Pre-NOTCH Transcription And Translation R-HSA-1912408,0.30848657572521737,1.1272636473209454,0.2702169625246548,0.5590277803846785,1.0,7/37,8.04%,TNRC6C;MAML2;MOV10;NOTCH2;AGO4;AGO1;TNRC6B
gsea,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.28370896018887815,-1.1269311217538502,0.27091633466135456,0.3472708462635899,1.0,11/54,13.02%,JUN;LAMTOR2;RHEB;RRAGA;EGR1;LAMTOR3;RRAGD;CHD3;RBBP7;CBX6;MAPK3
gsea,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.3701981650494356,1.1252942195939797,0.2884990253411306,0.5580748234711154,1.0,7/18,16.63%,PRKCE;NRG1;SOS1;ERBB4;NRG2;PRKCD;EGF
gsea,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.3563632453660145,-1.1236621441442407,0.31954887218045114,0.35175761505203323,1.0,10/25,26.84%,RASGRP1;ADRA2C;RAP1A;TTF2;ITGA2B;TLN1;PTPN1;RASGRP2;AKT1;RAP1B
gsea,Lysosome Vesicle Biogenesis R-HSA-432720,-0.32502002169119,-1.1229600164640343,0.2691552062868369,0.352260093918909,1.0,3/30,2.30%,VAMP2;HSPA8;CLTA
gsea,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.3814744193463536,-1.121823327704886,0.300187617260788,0.3533847526917766,1.0,7/15,29.12%,CITED2;PINK1;NFYB;FOXO4;BBC3;FOXO3;STK11
gsea,Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.40427308265275086,1.120397688758459,0.32504780114722753,0.5644427836267544,1.0,4/15,7.03%,ZMYM2;TRIP11;SOS1;GAB2
gsea,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.33278134394052167,-1.118831030309079,0.287593984962406,0.35725689451935905,1.0,6/24,10.53%,RAN;POLR2F;POLR2I;POLR2G;POLR2E;POLR2C
gsea,Signaling By Erythropoietin R-HSA-9006335,-0.36564087022448477,-1.1141801021887612,0.30991735537190085,0.3637141268406517,1.0,6/19,14.68%,CLSTN1;IRS2;HRAS;LYN;PIK3R1;EPOR
gsea,Oxidative Stress Induced Senescence R-HSA-2559580,-0.2708554835335702,-1.1134376401659667,0.2600806451612903,0.3641896186101971,1.0,16/62,19.64%,UBB;RPS27A;JUN;H2AZ1;UBA52;H2BC4;CDK4;H2AJ;RBBP7;CBX6;MAPK3;CBX4;UBC;MAPKAPK5;H2AX;MAPK1
gsea,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.2693756609134529,-1.1120596125876294,0.26119402985074625,0.36583739174972735,1.0,13/75,11.68%,RAB3A;TRAPPC6B;YWHAE;RAB6B;RAB14;RAB6A;SBF1;TRAPPC2L;TRAPPC2;RAB1B;RAB18;RAB31;TRAPPC1
gsea,FLT3 Signaling In Disease R-HSA-9682385,-0.3508569028229372,-1.1113302645127998,0.3032258064516129,0.36646640377935946,1.0,3/23,3.17%,UBB;RPS27A;UBA52
gsea,Semaphorin Interactions R-HSA-373755,-0.2816233415352882,-1.1093471852874568,0.2732793522267207,0.3688424832723446,1.0,12/57,16.18%,HSP90AB1;MYL6;HSP90AA1;SEMA5A;MYL12B;DPYSL2;CDK5R1;GSK3B;RHOB;SEMA7A;MYH14;MYL9
gsea,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.37324104668800434,-1.1079964154112123,0.3225152129817444,0.3703342983717406,1.0,2/19,0.60%,CALM1;NEFL
gsea,RORA Activates Gene Expression R-HSA-1368082,0.37240832317995093,1.1066074701043773,0.3012295081967213,0.5930503365404468,1.0,6/17,15.97%,RORA;NCOA6;NCOA2;NCOA1;CHD9;PPARA
gsea,Fatty Acid Metabolism R-HSA-8978868,-0.24908488167058707,-1.105980635018079,0.24470134874759153,0.3727283702746005,1.0,51/119,38.49%,TECR;ACSL3;HSD17B8;GPX4;PTGDS;PTGES3;MCEE;HPGDS;DBI;ACOT11;ACOT13;HACD4;PRXL2B;ACLY;CBR1;PON2;ACOX1;ACSBG1;NUDT19;THRSP;NDUFAB1;MID1IP1;NUDT7;HSD17B12;PTGR1;FASN;TBXAS1;SLC25A17;MMUT;ACOT6;ACBD6;EHHADH;CROT;ALOX5AP;ACOT2;PTGIS;ACOT9;MCAT;ACADVL;THEM4;ELOVL4;CRAT;HADH;ACOX3;ECI1;SYCP2;ACSL6;ACAA2;ACOT12;PPT1;ACOT1
gsea,G-protein Mediated Events R-HSA-112040,0.2946021630088669,1.1055188112024323,0.29740518962075846,0.590011910913901,1.0,8/43,6.98%,NBEA;PDE1A;ADCY8;ADCY2;PRKCG;CAMK2A;ADCY9;CAMK2G
gsea,RHOF GTPase Cycle R-HSA-9035034,0.30774601639873705,1.1041436039303711,0.29961089494163423,0.5877730519882728,1.0,10/34,19.09%,MYO9B;SRGAP2;SENP1;MTMR1;FAM169A;SLC4A7;FARP1;STEAP3;ARHGAP32;VANGL1
gsea,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.32568347969646877,-1.1021886865064174,0.3314285714285714,0.37809782384255386,1.0,12/27,31.67%,H2AZ1;H2BC4;H2AJ;TERF1;ASF1A;CDKN1B;H2AX;RAD50;HMGA1;KAT5;TINF2;H2AZ2
gsea,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.2591299852144757,-1.1019141156024888,0.26422018348623855,0.37795092033046473,1.0,23/77,22.69%,CPSF2;RBM8A;MAGOH;CHTOP;U2AF1;NUP50;MAGOHB;SRSF3;POLDIP3;NUP37;NUP205;SEH1L;SEC13;NUP107;U2AF1L4;SLBP;U2AF2;CDC40;SLU7;DDX39B;THOC7;NCBP2;NUP35
gsea,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.3316617054631629,-1.1005824033264375,0.3125,0.37953503283721285,1.0,12/25,29.86%,NME2;DTYMK;NME4;DUT;RRM1;RRM2B;TXNRD1;AK1;CMPK1;GSR;DCTPP1;TXN2
gsea,Regulation Of TP53 Activity R-HSA-5633007,-0.24357621483563,-1.100558235565503,0.25806451612903225,0.3789742624562947,1.0,35/124,25.15%,UBB;RPS27A;UBA52;USP2;PPP2CA;PPP2R1A;PIP4K2A;CDK5R1;CHD3;TAF10;BRD7;PML;RBBP7;CSNK2B;TAF11;RPA3;PHF20;PIP4P1;HIPK1;KAT6A;UBC;MAPKAPK5;RFC3;TAF5;RAD50;KMT5A;TAF7;RAD9B;RBBP8;DAXX;TAF7L;RNF34;AKT1;SSRP1;PDZD2
gsea,Metabolism Of Nucleotides R-HSA-15869,-0.2577608970187738,-1.0967338916675209,0.27915869980879543,0.3843727153504119,1.0,26/74,27.22%,NME2;DTYMK;PAICS;APRT;ITPA;UCKL1;SCO2;NME4;TK2;DUT;ATIC;ENTPD1;IMPDH2;NUDT18;GMPS;NT5C1A;SAMHD1;RRM1;RRM2B;TXNRD1;ADK;AK1;CMPK1;GSR;DCTPP1;NUDT5
gsea,Signaling By WNT In Cancer R-HSA-4791275,-0.32758686183183944,-1.095566473794865,0.33648393194706994,0.385555074213183,1.0,9/29,23.54%,PPP2CA;PPP2R1A;FZD4;GSK3B;PPP2R5D;PPP2R5A;KREMEN1;CSNK1A1;DKK2
gsea,Cell Junction Organization R-HSA-446728,0.27013871988906074,1.090770682544484,0.30724070450097846,0.6152167013727076,1.0,12/60,13.62%,DST;SDK2;CDH12;NECTIN1;FLNA;LAMB3;PATJ;PARVB;CADM1;RSU1;CDH11;CDH13
gsea,Signaling By SCF-KIT R-HSA-1433557,0.32649270637353905,1.089499918143311,0.3333333333333333,0.6126193902458977,1.0,8/30,12.42%,CBL;LCK;SOS1;JAK2;GAB2;PIK3R3;FYN;CHEK1
gsea,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.3740505652738739,-1.0889283193620223,0.3384321223709369,0.3954863133424877,1.0,3/15,14.04%,PPP2CA;PPP2R1A;LCMT1
gsea,tRNA Processing R-HSA-72306,-0.24713144508885668,-1.085875290607663,0.28909090909090907,0.39986172853787416,1.0,30/96,29.33%,RAN;POP5;TRMT112;FAM98B;RPP21;NUP50;WDR4;NUP37;ZBTB8OS;RTCB;NUP205;TRMT12;SEH1L;SEC13;NUP107;LAGE3;TRDMT1;DDX1;RTRAF;LCMT2;RPP38;HSD17B10;NUP35;TSEN34;NUP62;NUP85;TRMT10C;URM1;TSEN2;QTRT2
gsea,Acyl Chain Remodelling Of PC R-HSA-1482788,0.37364791147776844,1.0858436090545829,0.3368869936034115,0.6158059199164563,1.0,9/16,33.55%,PLA2G4E;MBOAT2;PLA2G3;PLA2G4A;PLA2G12A;PLA2G2F;PLB1;LPCAT2;PLA2G4B
gsea,Platelet Calcium Homeostasis R-HSA-418360,-0.3515390756908766,-1.0825886062817232,0.38095238095238093,0.4043718513734577,1.0,5/19,12.64%,CALM1;ORAI2;ATP2B1;SRI;SLC8A2
gsea,Peroxisomal Lipid Metabolism R-HSA-390918,-0.3252483419899631,-1.0779032975373974,0.3401869158878505,0.41139161455371176,1.0,14/25,46.71%,ACOX1;NUDT19;NUDT7;SLC25A17;ACOT6;EHHADH;CROT;CRAT;ACOX3;SYCP2;ACOT8;ACOT4;ABCD1;PHYH
gsea,Recycling Pathway Of L1 R-HSA-437239,0.32386742969046595,1.0741882220064511,0.34274193548387094,0.6394236372061867,1.0,9/25,13.75%,RPS6KA2;SHTN1;DNM1;DNM3;RPS6KA6;MSN;DNM2;L1CAM;RPS6KA1
gsea,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.2921240956978904,-1.0728651821742785,0.3229571984435798,0.41931701403731475,1.0,11/35,20.40%,CCT2;CCT6A;FBXW2;FBXO6;CCT7;FKBP9;CCT5;CCT8;FBXW7;FBXL3;AP3M1
gsea,Phospholipid Metabolism R-HSA-1483257,0.22167597534287825,1.0705250887619264,0.28817204301075267,0.6430786167727348,1.0,53/170,23.18%,SLC44A5;MTMR12;MIGA2;PITPNM2;PLEKHA5;PLA2G4E;OCRL;PIP5K1B;SYNJ1;PCYT2;PLEKHA6;PIKFYVE;OSBPL10;CHKA;CSNK2A2;MTMR7;PIK3R3;MBOAT2;MTMR1;TAFAZZIN;ETNK1;SBF2;LPIN1;CHEK2;CPNE1;GDPD1;PNPLA2;ETNK2;ABHD4;SLC44A2;PNPLA6;DGAT1;CHKB;INPP5K;PGS1;LPIN2;MGLL;ACP6;PLA2G3;STARD10;TNFAIP8L1;PI4KA;PIK3CA;MBOAT1;PLA2G4A;VAC14;TNFAIP8L3;PLEKHA1;ENPP6;PNPLA3;MTM1;INPP5J;CPNE7
gsea,Signal Transduction By L1 R-HSA-445144,-0.36128890678842085,-1.068254166569607,0.3791748526522593,0.42645158588101334,1.0,7/17,19.72%,ITGAV;FGFR1;CSNK2B;MAPK3;ITGA2B;MAPK1;NCAM1
gsea,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.33449521360667495,-1.068022841878139,0.3801980198019802,0.4262208956473131,1.0,2/21,3.55%,RACK1;USP2
gsea,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.2467164168988341,-1.067996612553999,0.3142857142857143,0.42560177082592754,1.0,14/88,11.74%,H2AZ1;DEK;CBX3;POLR2F;SAP18;H2BC4;SIN3B;CHD3;POLR2E;POLR1G;H2AJ;RBBP7;GTF2H5;GSK3B
gsea,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.25481997534234935,-1.0675866145380213,0.35514018691588783,0.425735577052597,1.0,21/68,22.69%,RBM8A;MAGOH;CHTOP;U2AF1;NUP50;MAGOHB;SRSF3;POLDIP3;NUP37;NUP205;SEH1L;SEC13;NUP107;U2AF1L4;U2AF2;CDC40;SLU7;DDX39B;THOC7;NCBP2;NUP35
gsea,Nuclear Import Of Rev Protein R-HSA-180746,-0.3063235132161236,-1.0646979805518806,0.3643410852713178,0.4299779470518576,1.0,8/30,15.27%,RAN;NPM1;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107
gsea,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.31281002668119795,-1.0624167861091307,0.36654135338345867,0.4330854216750205,1.0,5/28,7.76%,LAMTOR2;RHEB;RRAGA;LAMTOR3;RRAGD
gsea,Signaling By NODAL R-HSA-1181150,-0.36080470255232955,-1.0578338580580986,0.38293650793650796,0.4401430515306481,1.0,7/15,34.12%,DRAP1;MAPK3;SMAD2;MAPK1;FOXO3;SMAD4;ACVR1C
gsea,RNA Polymerase I Transcription R-HSA-73864,-0.2715294501669485,-1.057217848793576,0.3781190019193858,0.4397977332022364,1.0,11/55,13.02%,H2AZ1;CBX3;POLR2F;H2BC4;CHD3;POLR2E;POLR1G;H2AJ;RBBP7;GTF2H5;MAPK3
gsea,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.2715294501669485,-1.057217848793576,0.3781190019193858,0.4397977332022364,1.0,11/55,13.02%,H2AZ1;CBX3;POLR2F;H2BC4;CHD3;POLR2E;POLR1G;H2AJ;RBBP7;GTF2H5;MAPK3
gsea,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.36182538977861756,-1.0560907228372955,0.3593155893536122,0.44101915131032887,1.0,3/15,12.56%,YWHAB;EXOSC4;EXOSC3
gsea,Pre-NOTCH Expression And Processing R-HSA-1912422,0.26787080130960544,1.0532184159637636,0.34824902723735407,0.6813120760397468,1.0,8/50,8.04%,TNRC6C;MAML2;MOV10;NOTCH2;ST3GAL3;AGO4;AGO1;TNRC6B
gsea,Mitotic Spindle Checkpoint R-HSA-69618,-0.24373696811276457,-1.0510945612778466,0.36585365853658536,0.44868526133935116,1.0,17/85,16.13%,DYNLL1;DYNLL2;RPS27;PPP2CA;PPP2R1A;PAFAH1B1;UBE2S;ZWINT;ANAPC11;NUP37;PPP2R5D;SEH1L;SEC13;NUDC;NUP107;PPP1CC;CENPP
gsea,Interferon Alpha/Beta Signaling R-HSA-909733,-0.3316018890442788,-1.0507089687008357,0.3889980353634578,0.4486584258627938,1.0,8/21,29.00%,EGR1;IRF8;PTPN1;SAMHD1;IRF3;JAK1;PTPN11;IFI27
gsea,Cholesterol Biosynthesis R-HSA-191273,-0.3287858378637631,-1.049567639589376,0.3784313725490196,0.4498468739228454,1.0,4/23,7.16%,MSMO1;HMGCS1;FDPS;SQLE
gsea,RHOQ GTPase Cycle R-HSA-9013406,0.2732713803890452,1.0472128582566844,0.37575757575757573,0.6910428122304078,1.0,17/50,23.58%,ITSN1;SRGAP2;DLC1;FNBP1;CDC42BPA;SLC4A7;ARHGEF7;STEAP3;CPNE8;IQGAP1;SCRIB;ARHGAP32;VANGL1;GIT2;CDC42EP4;PREX1;OBSCN
gsea,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.2569632668836021,-1.0450549759524117,0.38223938223938225,0.45727123635314687,1.0,18/75,19.83%,FGFR2;FGF13;NRG3;CLSTN1;NRG4;PPP2CA;PPP2R1A;PDGFA;IRS2;PIP4K2A;FGFR1;PIK3R1;MAPK3;PPP2R5D;IRAK4;PDGFB;MAPK1;PPP2R5A
gsea,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.22439299670512583,-1.043191419488355,0.3575525812619503,0.45985967452395315,1.0,25/135,16.26%,DDX5;PARK7;SUMO2;CETN2;NFKB2;SMC1A;NSMCE3;CHD3;PCNA;RAD21;NPM1;PML;NUP50;PARP1;HNRNPK;RNF168;NUP37;NUP205;CBX5;SEH1L;NR4A2;SEC13;NUP107;HNRNPC;CBX4
gsea,Growth Hormone Receptor Signaling R-HSA-982772,-0.3612061082129988,-1.0400864692469352,0.41025641025641024,0.46467595696585745,1.0,5/15,19.64%,IRS2;LYN;MAPK3;PTPN1;MAPK1
gsea,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.36014322087304224,-1.0400620382736498,0.4148296593186373,0.46401668493309983,1.0,7/15,29.14%,LSM7;LSM4;LSM2;LSM1;LSM5;XRN1;LSM3
gsea,Synthesis Of PA R-HSA-1483166,-0.31557350988077415,-1.0396530531449288,0.4015594541910331,0.46407608206660006,1.0,7/24,22.78%,GPD2;GPD1;AGPAT5;GPD1L;GPAM;AGPAT1;GNPAT
gsea,HATs Acetylate Histones R-HSA-3214847,-0.24441603771345924,-1.036919686832965,0.3742802303262956,0.4680237068346486,1.0,17/78,20.28%,MORF4L1;MORF4L2;H2AC25;H2BC4;USP22;TAF10;RBBP7;PHF20;RUVBL1;MRGBP;ENY2;TADA2B;KAT6A;HCFC1;TADA3;MBIP;DMAP1
gsea,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.3096397680295061,-1.0346211977642954,0.4178217821782178,0.4713790902243234,1.0,8/27,21.73%,CALM1;PRKAR1B;LYN;PRKACB;HCK;CD247;CREB1;PRKAR1A
gsea,Intraflagellar Transport R-HSA-5620924,0.28147460791603823,1.0340597967764826,0.4090909090909091,0.7204183601838141,1.0,7/37,9.04%,DYNC2H1;TRIP11;IFT140;IFT88;TTC21B;KIF3C;DYNLT2B
gsea,Sialic Acid Metabolism R-HSA-4085001,0.30058464016279296,1.0315014870280896,0.4099009900990099,0.7213038745180468,1.0,3/27,4.93%,ST6GALNAC3;ST6GALNAC5;ST3GAL3
gsea,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.32793982342803535,-1.0309448370633374,0.3818525519848771,0.47728972185738366,1.0,11/21,30.29%,AP2M1;AP2B1;HCK;CD247;AP2S1;DOCK2;AP2A2;B2M;AP1M1;AP1S1;AP1S2
gsea,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.2909170576003376,-1.026306133637062,0.41682974559686886,0.4846651694699471,1.0,8/31,15.27%,RAN;RANBP1;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107
gsea,Adherens Junctions Interactions R-HSA-418990,-0.30379409755031594,-1.0226441129359167,0.40524193548387094,0.4903519132015042,1.0,4/26,11.59%,CADM2;CDH18;CTNNA1;CDH9
gsea,Metabolism Of Steroid Hormones R-HSA-196071,-0.3511603129915385,-1.0224157227875335,0.4229390681003584,0.49002219218235615,1.0,7/17,35.02%,FDX2;CHGA;HSD17B12;FDX1;HSD3B2;STARD4;SRD5A3
gsea,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.342761071995345,-1.0216871788518365,0.4418604651162791,0.49063450709881656,1.0,2/17,5.59%,PPP2CA;PPP2R1A
gsea,Intra-Golgi Traffic R-HSA-6811438,0.2851441492823426,1.020202358194411,0.41699604743083,0.7456423608469909,1.0,11/34,17.68%,MAN2A1;MAN1C1;TRIP11;MAN2A2;VPS45;COG4;COG3;VTI1A;MAN1A2;COG7;RIC1
gsea,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.24236492886692598,-1.0195216452763773,0.4076086956521739,0.4937087473611976,1.0,16/73,17.49%,DYNLL1;DYNLL2;RPS27;PPP2CA;PPP2R1A;PAFAH1B1;ZWINT;NUP37;PPP2R5D;SEH1L;SEC13;NUDC;NUP107;PPP1CC;CENPP;NEK6
gsea,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.2751738897666486,1.0188643600640428,0.40987124463519314,0.7428064008215572,1.0,9/38,11.58%,NFIA;GTF3C2;NFIB;POLR3G;GTF3C1;BDP1;SNAPC4;POLR2H;BRF1
gsea,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.3409666833851629,1.0149567939889494,0.43121149897330596,0.7470452503442295,1.0,3/16,7.64%,MAPK14;MAP3K7;MAPKAPK2
gsea,SUMOylation R-HSA-2990846,-0.2177609439131369,-1.013776315404205,0.4108527131782946,0.5034470221980423,1.0,39/141,26.33%,DDX5;PARK7;SUMO2;CETN2;NFKB2;SMC1A;NSMCE3;CHD3;PCNA;RAD21;NPM1;PML;NUP50;PARP1;HNRNPK;RNF168;NUP37;NUP205;CBX5;SEH1L;NR4A2;SEC13;NUP107;HNRNPC;CBX4;UBA2;THRA;TDG;NFKBIA;RING1;NUP35;DAXX;SUMO1;SIN3A;NRIP1;NUP62;RELA;CASP8AP2;NUP85
gsea,RHO GTPases Activate ROCKs R-HSA-5627117,-0.33711518019608067,-1.0134865942186153,0.4107142857142857,0.5031912836348326,1.0,7/17,22.71%,MYL6;MYL12B;RHOB;MYH14;MYL9;RHOA;MYH10
gsea,Integrin Signaling R-HSA-354192,-0.32242793634880684,-1.0125390919939765,0.42463235294117646,0.5042003609272152,1.0,10/22,33.50%,RASGRP1;RAP1A;ITGA2B;TLN1;PTPN1;RASGRP2;AKT1;RAP1B;FN1;BCAR1
gsea,Notch-HLH Transcription Pathway R-HSA-350054,0.3008146132620169,1.0095240445803495,0.46548323471400394,0.75515716338279,1.0,7/27,14.25%,MAML2;NOTCH2;HDAC1;HDAC8;HDAC7;MAML3;HDAC4
gsea,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.25953636032169375,-1.0088438332987208,0.44696969696969696,0.5103987803271788,1.0,9/54,11.57%,H2AZ1;POLR2F;SAP18;H2BC4;SIN3B;POLR2E;POLR1G;H2AJ;GTF2H5
gsea,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.34384541458166384,-1.008064863967892,0.4435946462715105,0.5110803237300322,1.0,7/17,29.24%,SEM1;XRCC2;RAD50;RBBP8;RAD51;PALB2;KAT5
gsea,Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.3192172382109069,1.0075846338938406,0.43917525773195876,0.7540866725503794,1.0,6/20,19.81%,PRKCE;PLPP4;PLCG2;PLCG1;PRKCD;PIK3CA
gsea,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.26330710341825114,-1.0064089757083376,0.4540229885057471,0.5134340546928754,1.0,9/51,11.57%,H2AZ1;POLR2F;SAP18;H2BC4;SIN3B;POLR2E;POLR1G;H2AJ;GTF2H5
gsea,Signaling By KIT In Disease R-HSA-9669938,0.3364217385800527,1.005747313181267,0.42658730158730157,0.7527439402072924,1.0,5/18,10.19%,LCK;SOS1;JAK2;PIK3R3;FYN
gsea,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.34171061519916573,-1.0054290271486497,0.43902439024390244,0.5144448471263094,1.0,9/18,31.63%,PCNA;RPA3;TERF1;LRIG1;POLD4;POLD2;TINF2;POLD3;FEN1
gsea,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.2795103055782613,-1.004841532721927,0.42828282828282827,0.5147754495095301,1.0,8/34,20.09%,H2AZ1;TLE4;H2BC4;H2AJ;RUVBL1;TLE1;H2AX;CDC73
gsea,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.26794923016576466,-1.0046581452072836,0.43155893536121676,0.5143406450257655,1.0,8/49,8.12%,FGFR2;FGF13;NRG3;CLSTN1;NRG4;PDGFA;IRS2;FGFR1
gsea,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.3239714028221564,0.9994892027300795,0.4867075664621677,0.7635468885493661,1.0,2/17,2.56%,MAML2;NOTCH2
gsea,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.24304513318009988,-0.9992704025372228,0.4632768361581921,0.5235502522189747,1.0,17/66,20.91%,CEBPD;NR2F2;TBL1XR1;MED10;MED4;CDK4;MED19;CEBPB;CEBPA;TBL1X;MED31;CCND3;MED9;MED21;MED22;MED25;MED7
gsea,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.28842534391099617,0.9958778626876281,0.46975806451612906,0.7668091228858083,1.0,6/30,9.02%,TNRC6C;MOV10;AGO4;AGO1;TNRC6B;NCOA1
gsea,RUNX2 Regulates Bone Development R-HSA-8941326,-0.3201734279858418,-0.9912054559049314,0.4589178356713427,0.5378699735435852,1.0,6/21,19.64%,WWTR1;MAF;MAPK3;CBFB;HEY1;MAPK1
gsea,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.30382266646714207,-0.9906941360079603,0.46942800788954636,0.5380721785358252,1.0,1/24,0.03%,CALM1
gsea,G Alpha (S) Signaling Events R-HSA-418555,0.2277297427608704,0.9857614247083434,0.4684095860566449,0.7880945982262834,1.0,14/83,10.17%,PDE2A;PDE1A;ADCY8;ADCY2;PDE7B;PDE10A;GPR45;RXFP1;ADCY9;PDE4A;ADCYAP1R1;GRK3;ADCY6;GRK5
gsea,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.2969824906419428,0.9838095299992968,0.4787018255578093,0.7869813283754509,1.0,9/26,10.15%,LRRC7;RPS6KA2;ACTN2;CAMK2A;RASGRF2;MPP3;CAMK2G;RPS6KA6;RASGRF1
gsea,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.311310086492422,-0.9825475949404053,0.45315487571701724,0.5527540376425221,1.0,3/21,4.70%,CALR;CANX;PDIA3
gsea,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.3069041325839587,-0.9809490373452303,0.47265625,0.5549165474112961,1.0,6/22,15.55%,FLRT2;FGF13;FGFR1;HRAS;PIK3R1;FLRT3
gsea,CTLA4 Inhibitory Signaling R-HSA-389513,-0.3165370366530036,-0.9801271414481001,0.46601941747572817,0.5557679603263095,1.0,9/19,31.94%,PPP2CA;PPP2R1A;LYN;PPP2R5D;PPP2R5A;PTPN11;AKT1;AKT3;PPP2R5B
gsea,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.29183519796437274,-0.9783814081512917,0.474,0.5582959370390582,1.0,5/28,15.48%,SLC25A4;SLC25A5;SLC35B3;SLC35A1;ARL2BP
gsea,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.32296218721489306,-0.9752944868557533,0.48367346938775513,0.5633583252214394,1.0,8/17,28.47%,NFKB2;NFKBIB;NKIRAS1;NFKBIA;TBK1;IRF3;RELA;NKIRAS2
gsea,Signaling By MET R-HSA-6806834,-0.24460854008652072,-0.9748408731211147,0.5077821011673151,0.5633880097955685,1.0,16/54,25.25%,UBB;RPS27A;UBA52;HRAS;PIK3R1;RAP1A;STAM2;UBC;PTPN1;SH3GL2;EPS15;LRIG1;NRAS;ARF6;PTPN11;STAM
gsea,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.27992559553693125,0.9738711235343477,0.501002004008016,0.8070373118323972,1.0,10/30,17.18%,RANBP2;NEK7;NUP188;NUP210;NDC1;NUP98;POM121;NUP160;AAAS;NUP133
gsea,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.2515314497105913,-0.9737012607524527,0.5099206349206349,0.5647215839381541,1.0,10/52,14.65%,RPS6;EEF1G;SQSTM1;RBX1;NPM1;CEBPB;PIK3R1;MAPK3;VCL;ATIC
gsea,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.27047567588715316,0.9719689061955776,0.486328125,0.8057802039889334,1.0,14/41,25.39%,CHST11;XYLT1;HEXA;HEXB;GPC3;CHST9;VCAN;XYLT2;UST;GPC5;DCN;CSPG4;CHPF;NCAN
gsea,RAC3 GTPase Cycle R-HSA-9013423,0.23130276626700233,0.9711366924947663,0.51440329218107,0.8018086468183507,1.0,10/78,8.17%,TRIO;CYFIP1;DOCK10;ARHGAP15;ABR;SRGAP2;OCRL;ABL2;TIAM1;LBR
gsea,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.2296439814786469,-0.968014584888133,0.5098425196850394,0.5746718602505378,1.0,15/67,16.26%,SUMO2;CETN2;SMC1A;NSMCE3;RAD21;PML;NUP50;PARP1;RNF168;NUP37;NUP205;SEH1L;SEC13;NUP107;CBX4
gsea,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.3336128561045552,-0.9629166949247339,0.521978021978022,0.5839200539463505,1.0,8/16,31.63%,PCNA;RPA3;TERF1;POLD4;POLD2;TINF2;POLD3;FEN1
gsea,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.2683507395838669,-0.9624524826108842,0.5209580838323353,0.5840531897858244,1.0,8/35,14.46%,APOE;TBL1XR1;GPS2;KDM1B;PLTP;ARL4C;TBL1X;ANGPTL3
gsea,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.2655551344610927,-0.9624161941536562,0.5193050193050193,0.5832706424951833,1.0,4/40,10.68%,HSP90AB1;NFKB2;UBE2N;UBE2V1
gsea,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.23274565609400621,-0.961360040298772,0.5105162523900574,0.5844820827548317,1.0,11/81,8.12%,FGFR2;FGF13;NRG3;CLSTN1;NRG4;PPP2CA;PPP2R1A;PDGFA;IRS2;PIP4K2A;FGFR1
gsea,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.2666662212912092,0.9593686406837612,0.5195071868583162,0.8271077875599201,1.0,11/35,17.18%,RANBP2;PIAS2;NUP188;NUP210;NDC1;PIAS1;NUP98;POM121;NUP160;AAAS;NUP133
gsea,PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.330244183675314,0.9570503701836975,0.5050301810865191,0.8270231139282322,1.0,5/16,9.46%,NBEA;ADCY8;ADCY2;ADCY9;ADCY6
gsea,Insulin Receptor Signaling Cascade R-HSA-74751,-0.26677160475775746,-0.9559528829015477,0.5274509803921569,0.5941693828785503,1.0,14/36,29.66%,FGFR2;FGF13;IRS2;FGFR1;HRAS;PIK3R1;MAPK3;MAPK1;NRAS;PTPN11;GRB10;PIK3CB;PIK3R2;FGF5
gsea,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.30092454390503653,-0.9549717579839455,0.536779324055666,0.5951367060639201,1.0,7/21,21.36%,ACAD8;ALDH6A1;LDHD;DBT;PPM1K;IVD;HSD17B10
gsea,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.31415147974935664,-0.9545283205727673,0.5122873345935728,0.5952000054548983,1.0,8/19,33.43%,SEM1;XRCC2;RAD50;RBBP8;RAD51;PALB2;KAT5;XRCC3
gsea,NS1 Mediated Effects On Host Pathways R-HSA-168276,0.2655891859642442,0.9511590163429721,0.5324165029469549,0.836222296272751,1.0,10/35,17.18%,RANBP2;PABPN1;NUP188;NUP210;NDC1;NUP98;POM121;NUP160;AAAS;NUP133
gsea,Costimulation By CD28 Family R-HSA-388841,-0.2563178537479498,-0.9509007069039465,0.5374280230326296,0.6013913508910206,1.0,17/39,34.17%,CDC42;PPP2CA;PPP2R1A;LYN;PIK3R1;PPP2R5D;MAP3K8;CD247;PPP2R5A;PTPN11;AKT1;AKT3;PIK3R2;MLST8;PPP2R5B;THEM4;PKN2
gsea,Cellular Senescence R-HSA-2559583,-0.20874161081423298,-0.9506798323012072,0.564299424184261,0.6009423890672011,1.0,25/112,20.31%,UBB;RPS27A;JUN;H2AZ1;UBA52;ETS2;H2BC4;UBE2S;CDK4;H2AJ;IGFBP7;RBBP7;CEBPB;TERF1;ANAPC11;CBX6;MAPK3;ASF1A;CDKN1B;CBX4;UBC;MAPKAPK5;H2AX;MAPK1;RAD50
gsea,CD28 Co-Stimulation R-HSA-389356,0.2815878314082026,0.9492567605883747,0.5251509054325956,0.834886236940992,1.0,7/26,10.86%,LCK;PIK3R3;AKT2;RICTOR;ARHGEF7;FYN;MTOR
gsea,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.3256710436826521,-0.947389054096203,0.5282258064516129,0.6066647624601237,1.0,8/15,30.29%,AP2M1;AP2B1;AP2S1;AP2A2;B2M;AP1M1;AP1S1;AP1S2
gsea,PERK Regulates Gene Expression R-HSA-381042,-0.28348392114819615,-0.9472260067635294,0.5334608030592735,0.6061394798135683,1.0,5/26,12.56%,EIF2S2;NFYB;CEBPB;EXOSC4;EXOSC3
gsea,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.2439976323102647,-0.9460984691776493,0.5419103313840156,0.607462334659401,1.0,13/50,22.07%,RAN;TBL1XR1;HMGCS1;FDPS;SQLE;NFYB;TBL1X;HMGCR;INSIG2;INSIG1;GPAM;FDFT1;FASN
gsea,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.263203585636398,-0.9456252548183027,0.5512572533849129,0.6075994280510152,1.0,10/37,22.07%,TBL1XR1;HMGCS1;FDPS;SQLE;NFYB;TBL1X;HMGCR;GPAM;FDFT1;FASN
gsea,Other Interleukin Signaling R-HSA-449836,-0.32694721260361537,-0.9436841458580061,0.5375494071146245,0.6105724644935903,1.0,5/16,23.91%,VAMP2;SNAP25;CSF1R;IL10RB;JAK1
gsea,Activation Of SMO R-HSA-5635838,0.32679526044532803,0.9436477344144727,0.5029940119760479,0.8441743182743053,1.0,5/15,16.36%,CDON;EVC2;GRK2;EVC;IQCE
gsea,Metal Ion SLC Transporters R-HSA-425410,-0.30066553377916183,-0.9436062377394475,0.5364372469635628,0.6098877662917614,1.0,6/20,26.79%,SLC39A3;SLC41A1;SLC30A6;SLC30A1;SLC31A1;SLC39A7
gsea,Interleukin-2 Family Signaling R-HSA-451927,0.29509470279197275,0.9426779605043467,0.5469728601252609,0.8404689418027156,1.0,5/24,7.52%,LCK;SOS1;JAK2;GAB2;PIK3R3
gsea,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.29100848531732654,-0.9375211711022601,0.5501930501930502,0.6210600954657335,1.0,5/23,12.71%,FGF13;FGFR1;BAG4;TRIM24;PIK3R1
gsea,Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.2673722251155242,0.936866725958434,0.5688622754491018,0.8498508939069397,1.0,10/31,17.18%,RANBP2;NUP188;NUP210;NCBP1;NDC1;NUP98;POM121;NUP160;AAAS;NUP133
gsea,Insulin Processing R-HSA-264876,0.28539537987817654,0.9364384055450605,0.5409181636726547,0.8446842880201955,1.0,11/24,22.21%,RAB27A;MYRIP;STX1A;MYO5A;ERO1B;EXOC1;EXOC6;KIF5A;ERO1A;EXOC2;EXOC5
gsea,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.3189289749717188,-0.9303168028115681,0.5555555555555556,0.6341128738304309,1.0,5/16,24.17%,FGF13;HRAS;PIK3R1;NRAS;PTPN11
gsea,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.27190132333711386,0.9266667286211758,0.5562248995983936,0.864325978536657,1.0,10/28,18.77%,RANBP2;NUP188;NUP210;NDC1;NUP98;POM121;NUP160;AAAS;NUP133;MAP4K5
gsea,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.3099326138585585,-0.9251899703266202,0.5533596837944664,0.6434320989487115,1.0,7/17,22.71%,MYL6;MYL12B;RHOB;MYH14;MYL9;RHOA;MYH10
gsea,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.2833252577938803,-0.9229771651554045,0.5465116279069767,0.6469319823286159,1.0,5/22,15.05%,CCT2;BBIP1;CCT5;CCT8;BBS2
gsea,Endogenous Sterols R-HSA-211976,-0.32983848342113964,-0.9219938046317312,0.5676691729323309,0.64802927738538,1.0,9/15,36.61%,FDX2;ARNT2;FDX1;MIA3;CYP46A1;PTGIS;CYP27A1;AHR;CYP7B1
gsea,Integrin Cell Surface Interactions R-HSA-216083,-0.2563513996283004,-0.9214814570025264,0.5918003565062389,0.6481750732848545,1.0,5/41,7.62%,ICAM5;BSG;CD47;VTN;ITGAV
gsea,Resolution Of D-Loop Structures R-HSA-5693537,-0.28717673448491937,-0.9206331850546058,0.5512104283054003,0.648816667379473,1.0,9/23,33.43%,SEM1;XRCC2;RAD50;RBBP8;RAD51;PALB2;KAT5;MUS81;XRCC3
gsea,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.2762277479308966,-0.9206310323752652,0.5831702544031311,0.6479203803071353,1.0,7/27,15.75%,PIP4K2A;CHD3;BRD7;PML;RBBP7;PIP4P1;KAT6A
gsea,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.2916873318365838,-0.9203967550233277,0.5539033457249071,0.6474826878160739,1.0,9/22,33.43%,SEM1;XRCC2;RAD50;RBBP8;RAD51;PALB2;KAT5;MUS81;XRCC3
gsea,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.302119963180328,-0.9201415566138799,0.5968379446640316,0.6470075413899244,1.0,4/19,12.71%,FGFR2;FGF13;HRAS;PIK3R1
gsea,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.3050611562890452,-0.9162269813124916,0.5763358778625954,0.6538024294356144,1.0,2/18,3.57%,MAGED1;NDUFA2
gsea,mRNA 3-End Processing R-HSA-72187,-0.230793552837518,-0.9136421208702485,0.599624060150376,0.6581125047450633,1.0,15/57,21.65%,CPSF2;RBM8A;MAGOH;CHTOP;U2AF1;MAGOHB;SRSF3;POLDIP3;U2AF1L4;U2AF2;CDC40;SLU7;DDX39B;THOC7;NCBP2
gsea,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.25027462718485366,-0.9119986305418706,0.6208251473477406,0.6603866867220411,1.0,12/37,26.33%,SUMO2;PCNA;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107;NUP35;SUMO1;NUP62;NUP85
gsea,RND2 GTPase Cycle R-HSA-9696270,0.2543427748276691,0.9095845435642306,0.5897959183673469,0.9039610604121072,1.0,10/35,19.09%,DST;PKP4;DLG5;FNBP1;ANKRD26;LEMD3;SCRIB;WDR6;FRS2;VANGL1
gsea,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.2761172743149265,-0.9081534176191691,0.592156862745098,0.6671946979297294,1.0,11/24,31.32%,BAD;GSK3B;FOXO4;CDKN1B;AKT1S1;CREB1;AKT1;FOXO3;AKT3;NR4A1;MLST8
gsea,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.30122874114060433,-0.9052354592692894,0.6025408348457351,0.6720551496423214,1.0,11/19,36.61%,FDX2;VDAC2;ARNT2;FDX1;MIA3;TBXAS1;CYP46A1;PTGIS;CYP27A1;AHR;CYP7B1
gsea,PI3K/AKT Signaling In Cancer R-HSA-2219528,0.21484007749966083,0.9046173857746101,0.6242171189979123,0.9107025920441363,1.0,15/74,11.29%,FGF10;CHUK;NRG1;FLT3;LCK;SOS1;GAB2;PIK3R3;AKT2;RICTOR;FYN;ERBB4;MTOR;NRG2;KL
gsea,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.25738097657571934,0.9041210630193551,0.6189516129032258,0.905360768845457,1.0,9/31,17.18%,RANBP2;NUP188;NUP210;NDC1;NUP98;POM121;NUP160;AAAS;NUP133
gsea,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.2542027030916625,-0.9025388459165841,0.6,0.6765314630214524,1.0,11/31,26.33%,SUMO2;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107;NUP35;SUMO1;NUP62;NUP85
gsea,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.25464039036443337,-0.9012468689039655,0.6257425742574257,0.6781719890175428,1.0,7/31,15.27%,RAN;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107
gsea,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.2505716196469778,0.9011463582409839,0.5954356846473029,0.906789421664964,1.0,7/34,11.45%,PHC2;SMARCA4;CSNK2A2;ARID2;SMARCA2;SCMH1;PHC3
gsea,Sema4D In Semaphorin Signaling R-HSA-400685,-0.2944141088500505,-0.8997095284394953,0.6081871345029239,0.6803816902717682,1.0,7/19,22.71%,MYL6;MYL12B;RHOB;MYH14;MYL9;RHOA;MYH10
gsea,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.260850683159083,-0.899379904762785,0.6203703703703703,0.6800772904377712,1.0,11/31,31.92%,SEM1;RPA3;RFC3;XRCC2;RAD50;RAD9B;RBBP8;RAD51;PALB2;KAT5;RFC5
gsea,Chromatin Modifying Enzymes R-HSA-3247509,0.18324680373986646,0.8988387306281738,0.7333333333333333,0.9064948471852712,1.0,43/199,16.52%,YEATS2;KAT6B;PHF21A;EHMT1;BRWD1;MTA2;KMT2A;KDM2B;ATXN7;SMARCA4;NSD1;HDAC1;SETDB1;ARID2;JAK2;KMT2C;HDAC8;NCOA2;NSD3;SMARCA2;EHMT2;NCOA1;KDM5B;MTA3;KMT2B;KANSL1;KDM2A;BRD1;KMT5B;WDR77;H2AC4;DPY30;CHD4;KDM3A;KMT2E;BRPF3;TRRAP;KDM4B;SMARCC2;ARID4B;ZZZ3;AEBP2;H2AC6
gsea,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.2823596033939938,-0.8985061790133163,0.6122047244094488,0.6807886992075475,1.0,6/20,24.94%,VDAC1;SMDT1;VDAC2;PHB2;PMPCA;PARL
gsea,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.26629527858273694,-0.898499195786476,0.6320582877959927,0.6798645761079665,1.0,11/29,31.92%,PCNA;RPA3;TERF1;RFC3;LRIG1;POLD4;POLD2;TINF2;POLD3;FEN1;RFC5
gsea,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.2568123570301502,-0.8970165321028027,0.632,0.6818548954503478,1.0,8/31,15.27%,BANF1;PSIP1;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107
gsea,IRS-mediated Signaling R-HSA-112399,-0.2591407890174958,-0.8965793959413293,0.6276391554702495,0.6817548414901323,1.0,6/31,12.71%,FGFR2;FGF13;IRS2;FGFR1;HRAS;PIK3R1
gsea,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.24711001090871637,0.8917665377373795,0.6296296296296297,0.9183532932290399,1.0,6/32,10.36%,HERC2;PRKDC;BRCC3;TDP1;PAXIP1;DCLRE1C
gsea,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.2819163322456393,-0.8911625590892631,0.6227544910179641,0.6913005362180592,1.0,5/23,17.79%,DLAT;GOT2;LDHD;DBT;NDUFAB1
gsea,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.24179814619615736,0.8897457784470177,0.6326530612244898,0.9171004887150046,1.0,14/38,21.89%,RANBP2;NUP188;NUP210;NCBP1;NDC1;SYMPK;NUP98;POM121;NUP160;AAAS;NUP133;NXF1;FIP1L1;NUP155
gsea,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.30590017746435316,0.8889024006438091,0.620889748549323,0.9127961026049147,1.0,7/15,27.38%,PHC2;SCMH1;PHC3;DNMT3B;DNMT3A;RNF2;DNMT1
gsea,SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.2328982576860413,-0.8832878465675584,0.6516393442622951,0.7055785142562837,1.0,15/42,26.33%,SUMO2;NUP50;HNRNPK;NUP37;NUP205;SEH1L;SEC13;NUP107;HNRNPC;CBX4;RING1;NUP35;SUMO1;NUP62;NUP85
gsea,RNA Polymerase I Transcription Initiation R-HSA-73762,0.22918098377716667,0.8829458337625342,0.6428571428571429,0.9216961913807105,1.0,10/45,13.56%,MTA2;TAF1B;GTF2H2;ERCC2;HDAC1;EHMT2;MTA3;POLR2H;CHD4;UBTF
gsea,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.29873323020805354,0.8822968149089518,0.6322314049586777,0.9170476709863262,1.0,2/16,5.71%,MAPK10;MAP3K7
gsea,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.24658496160204096,-0.8768784916914067,0.666,0.716829101360359,1.0,7/32,15.27%,RAN;NUP50;NUP37;NUP205;SEH1L;SEC13;NUP107
gsea,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.24873041972370594,0.8745025487370175,0.6829268292682927,0.930481757126348,1.0,10/32,17.18%,RANBP2;NUP188;NUP210;NCBP1;NDC1;NUP98;POM121;NUP160;AAAS;NUP133
gsea,RHOH GTPase Cycle R-HSA-9013407,-0.25727232728338867,-0.8736907999462609,0.6421663442940039,0.7218555881764069,1.0,8/29,19.36%,ARHGDIA;TMEM59;TUBA1B;NIPSNAP2;DBT;VAMP3;VCP;UACA
gsea,Heme Signaling R-HSA-9707616,0.2520209775061792,0.8731598698375993,0.6593186372745491,0.9276017100485153,1.0,8/33,15.97%,RORA;CRTC3;NCOA6;NCOA2;NCOA1;MEF2D;CHD9;PPARA
gsea,Signaling By FGFR1 In Disease R-HSA-5655302,-0.2556700994939059,-0.8658898414796984,0.6706114398422091,0.7359124235884201,1.0,6/29,12.71%,FGF13;FGFR1;HRAS;BAG4;TRIM24;PIK3R1
gsea,Signaling To ERKs R-HSA-187687,-0.2531684250889565,-0.8655025773324667,0.6773547094188377,0.7356289999965246,1.0,5/29,13.02%,YWHAB;HRAS;RALA;RAP1A;MAPK3
gsea,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.20046647636390427,-0.8640502944657223,0.7486818980667839,0.737327918895652,1.0,28/90,29.11%,PDXK;DHFR;TCN2;PPCS;SLC25A16;CYB5R3;ALDH1L1;PARP16;MOCS2;MMACHC;GSTO1;NMNAT3;MTHFD2;NAXD;CYB5A;PARP4;PANK4;PANK3;RFK;FASN;TPK1;NAXE;MMADHC;CD38;MMUT;MTRR;SLC2A1;GSTO2
gsea,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.2769847873130323,-0.8622606302529319,0.6549165120593692,0.7396484795524939,1.0,11/21,41.48%,PCNA;TERF1;RFC3;POLD4;POLD2;TINF2;POLD3;RFC5;CTC1;PRIM1;TERF2IP
gsea,FCERI Mediated MAPK Activation R-HSA-2871796,-0.26744640180862267,-0.8617635467637708,0.6780952380952381,0.7396071475826735,1.0,6/23,21.64%,JUN;HRAS;LYN;MAPK3;MAPK1;NRAS
gsea,RHOJ GTPase Cycle R-HSA-9013409,0.23298728329591134,0.8597485574129549,0.6666666666666666,0.9543549929745577,1.0,15/46,22.45%,TRIO;OCRL;FNBP1;CDC42BPA;SLC4A7;ARHGEF7;WIPF2;STEAP3;CPNE8;SCRIB;ARHGAP32;VANGL1;GIT2;FNBP1L;PREX1
gsea,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.29059863801271424,0.8591519004752184,0.6274900398406374,0.9494057228088428,1.0,2/16,5.61%,MTMR12;PIKFYVE
gsea,Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.29381845141535223,0.8562119435909781,0.6358267716535433,0.9501776438039393,1.0,7/17,25.39%,CHST11;CHST9;VCAN;DCN;CSPG4;CHPF;NCAN
gsea,PI3K Cascade R-HSA-109704,-0.25652118412465497,-0.8544888650727213,0.6912621359223301,0.7522067273262236,1.0,5/28,12.71%,FGFR2;FGF13;IRS2;FGFR1;PIK3R1
gsea,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.2434723752472167,-0.8526042470689434,0.7011494252873564,0.7536478044383828,1.0,6/33,12.71%,FGFR2;FGF13;IRS2;FGFR1;HRAS;PIK3R1
gsea,IGF1R Signaling Cascade R-HSA-2428924,-0.2434723752472167,-0.8526042470689434,0.7011494252873564,0.7536478044383828,1.0,6/33,12.71%,FGFR2;FGF13;IRS2;FGFR1;HRAS;PIK3R1
gsea,Metabolism Of Steroids R-HSA-8957322,-0.19436689595267492,-0.8513808170905158,0.7623400365630713,0.7548630659141097,1.0,21/100,22.07%,RAN;SUMO2;TBL1XR1;MSMO1;HMGCS1;FDPS;SQLE;NFYB;FDX2;CHGA;TBL1X;HMGCR;INSIG2;INSIG1;OSBPL9;HSD17B12;GPAM;FDX1;HSD3B7;FDFT1;FASN
gsea,DAP12 Interactions R-HSA-2172127,0.2754692638126268,0.8489364720946893,0.6783369803063457,0.9547280292443542,1.0,5/21,11.53%,LCK;SOS1;PLCG2;FYN;PLCG1
gsea,DAP12 Signaling R-HSA-2424491,0.2754692638126268,0.8489364720946893,0.6783369803063457,0.9547280292443542,1.0,5/21,11.53%,LCK;SOS1;PLCG2;FYN;PLCG1
gsea,Interferon Gamma Signaling R-HSA-877300,0.23125894391576185,0.8487902261889213,0.7006369426751592,0.9487632654746666,1.0,15/40,19.72%,CAMK2A;TRIM46;JAK2;CAMK2G;PTPN2;TRIM14;TRIM2;PIAS1;IRF2;PRKCD;IRF9;TRIM17;CAMK2D;MID1;CD44
gsea,Inositol Phosphate Metabolism R-HSA-1483249,-0.22712509429152525,-0.8481020182482525,0.7210216110019646,0.7598747224670256,1.0,12/44,22.55%,CALM1;NUDT3;ITPKA;INPP4B;IMPA1;NUDT10;NUDT11;MINPP1;INPP1;PLCB1;PLCH2;MTMR9
gsea,RNA Polymerase III Transcription Termination R-HSA-73980,-0.26295219625111044,-0.8478156885266289,0.6673189823874756,0.7593868654581798,1.0,9/21,28.99%,POLR2F;POLR2E;POLR3H;POLR3D;POLR2L;POLR3E;POLR3A;SSB;POLR1D
gsea,SLC Transporter Disorders R-HSA-5619102,0.20550777010224536,0.8477223375039095,0.7415506958250497,0.9452417508576405,1.0,18/60,18.77%,RANBP2;SLC9A7;NUP188;NUP210;SLC24A4;SLC1A1;SLC26A4;NDC1;NUP98;SLC17A5;SLC35A3;POM121;NUP160;AAAS;NUP133;SLC9A9;SLCO2A1;MAP4K5
gsea,Signaling By Hippo R-HSA-2028269,-0.27335242595911335,-0.8476621918680566,0.6626506024096386,0.7586318473896166,1.0,2/20,2.64%,YWHAB;YWHAE
gsea,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.2441705038756914,-0.8472549043120999,0.7131782945736435,0.7583799993535337,1.0,6/32,12.71%,FGFR2;FGF13;IRS2;FGFR1;HRAS;PIK3R1
gsea,PI Metabolism R-HSA-1483255,-0.20634755822626363,-0.847013711197255,0.7595190380761523,0.75779722535266,1.0,18/74,22.55%,GDE1;CLSTN1;RAB14;ARF3;SBF1;PIP4K2A;PLEKHA2;INPP5F;INPP4B;PLEKHA3;PIP4P1;PIK3R1;RUFY1;PI4K2B;RAB5A;PIK3C2A;PITPNB;MTMR9
gsea,VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.2692779061492109,0.8467275689434651,0.7056451612903226,0.9415156774699726,1.0,7/18,22.21%,PKD1;RAB3IP;RAB11FIP3;EXOC1;EXOC6;EXOC2;EXOC5
gsea,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.2034184074268297,0.8454466352698489,0.7647058823529411,0.9384070630612317,1.0,21/73,17.70%,SLC8A1;SLC9A7;SLC24A3;SLC24A4;SLC9A5;SLC1A1;SLC25A22;SLC26A4;AHCYL2;SLC4A7;SLC7A8;SLC15A4;SLC9A1;SLC25A10;SLC17A5;SLC20A1;SLC1A4;SLC26A11;SLC7A6;SLC9A9;SLC8A3
gsea,RAC2 GTPase Cycle R-HSA-9013404,0.20380674268478893,0.841877756478405,0.7591093117408907,0.9406391625191441,1.0,9/74,8.17%,TRIO;CYFIP1;DOCK3;DOCK10;ABR;DOCK4;PIK3R3;TIAM1;LBR
gsea,Diseases Of Metabolism R-HSA-5668914,0.1758330733706475,0.840189898115405,0.8251121076233184,0.9385404541113759,1.0,35/169,16.50%,ADAMTS17;HLCS;SEMA5B;SPON1;ADAMTS20;NOTCH2;ADAMTS3;ST3GAL3;ABCA3;ADAMTS18;HEXA;ACACA;HEXB;DHDDS;LARGE1;GPC3;ALG8;CFP;GALE;MCCC1;GALNS;NAGLU;GALNT3;THSD7B;ADAMTS2;ADAMTS16;CSF2RA;ALG12;CYP2U1;PCCB;CYP2R1;EXT1;ABCD4;VCAN;THSD1
gsea,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.2535923077630031,-0.8388684405858029,0.6854990583804144,0.7713940060385553,1.0,7/26,23.03%,SEM1;RPA3;RFC3;RAD50;RAD9B;RBBP8;RAD51
gsea,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.20048901214018178,0.8387169860745042,0.770042194092827,0.9360178137765378,1.0,14/70,13.27%,POU2F2;INTS11;INTS2;ELL2;NABP1;NCBP1;ICE2;INTS1;SNAPC4;INTS6;RPRD2;POLR2H;TAF6;RPRD1A
gsea,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.22551432656634973,0.835539050927663,0.7464212678936605,0.9371173658999876,1.0,13/39,20.16%,RANBP2;NUP188;NUP210;NCBP1;NDC1;SYMPK;NUP98;POM121;NUP160;AAAS;NUP133;NXF1;FIP1L1
gsea,Interleukin Receptor SHC Signaling R-HSA-912526,0.29110550356312026,0.8345383908042667,0.691358024691358,0.9334419612319973,1.0,4/16,7.52%,SOS1;JAK2;GAB2;PIK3R3
gsea,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.27204160271838584,0.8322835595787269,0.7113821138211383,0.9324950792143261,1.0,3/21,5.70%,LAMB1;SMARCA4;LAMC1
gsea,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.2195991081628961,-0.8311636849088966,0.7445109780439122,0.7840836720545107,1.0,16/46,29.10%,CLSTN1;RAB14;PIP4K2A;PLEKHA2;INPP4B;PLEKHA3;PIK3R1;RUFY1;PI4K2B;RAB5A;PIK3C2A;MTMR9;INPPL1;PIK3CB;PTEN;PIK3R2
gsea,Downstream Signal Transduction R-HSA-186763,-0.2504064180348417,-0.830348725655294,0.7042801556420234,0.7844947881113791,1.0,9/25,29.10%,NCK1;PDGFA;HRAS;PIK3R1;PDGFB;NRAS;PTPN11;PIK3CB;PIK3R2
gsea,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.2604617458064011,-0.8280544337784461,0.7126654064272212,0.7874431354386986,1.0,4/22,12.56%,NFYB;CEBPB;EXOSC4;EXOSC3
gsea,tRNA Aminoacylation R-HSA-379724,-0.24667684582935023,-0.8265966438180287,0.7265469061876247,0.7890210549857001,1.0,11/26,31.46%,WARS2;AIMP1;FARS2;WARS1;AIMP2;PPA1;DTD1;MARS1;PPA2;YARS2;EEF1E1
gsea,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.24081588174433252,-0.8250815448032034,0.7439252336448599,0.7907153528388907,1.0,8/31,23.03%,SEM1;RPA3;RFC3;XRCC2;RAD50;RAD9B;RBBP8;RAD51
gsea,GPVI-mediated Activation Cascade R-HSA-114604,-0.2612682815209837,-0.8244854019902335,0.7042513863216266,0.7907421123363125,1.0,8/22,29.10%,CDC42;LYN;PIK3R1;RHOB;RHOA;PTPN11;PIK3CB;PIK3R2
gsea,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.27351258028055037,0.8244584883727046,0.71875,0.9431257918244826,1.0,4/15,14.87%,SKIC2;SKIC3;EXOSC8;HBS1L
gsea,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.2742065170561426,-0.8208225670269795,0.7292490118577075,0.7959857608173729,1.0,8/19,35.66%,ALG14;EGFL7;ALG13;ALG11;MOGS;ALG3;ALG6;ALG1
gsea,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.2372650581266031,0.8181828962583979,0.7714285714285715,0.9502727372527059,1.0,7/26,15.31%,GTF3C2;POLR3G;GTF3C1;BDP1;POLR2H;BRF1;GTF3C4
gsea,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.2852870895883928,-0.8160601966390089,0.688659793814433,0.8031836206688663,1.0,5/15,25.39%,HRAS;LYN;PRKACB;NRAS;RELA
gsea,Nucleotide Salvage R-HSA-8956321,0.26179513586041725,0.8155115784789356,0.7067209775967414,0.9498230769519534,1.0,7/17,19.71%,UPP2;UPP1;AMPD3;DGUOK;UCK2;ADAL;DCK
gsea,Signaling By FGFR3 In Disease R-HSA-5655332,-0.2841162444186366,-0.8145642293611307,0.7038539553752535,0.804667440129099,1.0,3/15,12.71%,FGF13;HRAS;PIK3R1
gsea,Glycosaminoglycan Metabolism R-HSA-1630316,0.18584007747796516,0.8142415809849582,0.826171875,0.9466157150383755,1.0,31/94,25.39%,CHST11;ABCC5;ST3GAL3;HS3ST4;XYLT1;HEXA;HEXB;GPC3;HS6ST3;SLC9A1;NAGLU;HS3ST2;CHST9;EXT1;VCAN;PAPSS1;XYLT2;UST;ST3GAL2;CD44;HS2ST1;GPC5;GLB1L;ST3GAL4;DCN;CSPG4;GLCE;HS6ST2;B3GNT2;CHPF;NCAN
gsea,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.20690418233884178,-0.812655573814015,0.8074766355140187,0.8067035364122611,1.0,8/46,16.21%,ARF4;CCT2;BBIP1;RAB11A;CCT5;CCT8;BBS2;NUDT19
gsea,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.256143923896581,-0.8111504655159321,0.7413441955193483,0.8080977549278768,1.0,8/22,25.35%,AGRP;FBXO32;FOXO4;SMAD2;ABCA6;NPY;SIN3A;FOXO3
gsea,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.19895329206441253,-0.8107191317139194,0.8330134357005758,0.8077593783810447,1.0,29/68,37.80%,PMM1;DPM3;CMAS;ALG14;DPM2;SLC35A1;GMPPB;NANP;GNE;EGFL7;GNPNAT1;ST6GAL1;DPM1;AMDHD2;ALG13;ALG5;ALG11;UAP1;FUOM;ST6GALNAC6;PGM3;GFPT2;ALG3;ALG6;SRD5A3;ALG1;ST8SIA5;ST3GAL1;GFUS
gsea,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.25676491466407614,0.8102141625295479,0.75,0.9487457096378329,1.0,7/21,20.41%,NCOA2;NCOA1;OSBPL7;OSBPL2;OSBPL1A;SLC27A2;OSBP
gsea,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.24569623897788911,-0.8098977190972181,0.7619893428063943,0.8079677926951417,1.0,6/26,23.08%,RPA3;CDC45;RFC3;RAD9B;MCM6;ORC4
gsea,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.23210318378474507,0.8094626500554114,0.7793814432989691,0.9445976557200079,1.0,7/27,15.31%,GTF3C2;POLR3G;GTF3C1;BDP1;POLR2H;BRF1;GTF3C4
gsea,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.2322630902293057,-0.8082380986755459,0.7810760667903525,0.8096153714273958,1.0,12/33,33.43%,SEM1;RPA3;RFC3;XRCC2;RAD50;RAD9B;RBBP8;RAD51;PALB2;KAT5;RFC5;XRCC3
gsea,Cell-cell Junction Organization R-HSA-421270,0.21650473808217113,0.808165909160935,0.781563126252505,0.9415255017930824,1.0,7/40,13.62%,SDK2;CDH12;NECTIN1;PATJ;CADM1;CDH11;CDH13
gsea,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.2689386134782901,-0.8075709582103451,0.732,0.8096574746957077,1.0,5/18,24.17%,FGF13;HRAS;PIK3R1;NRAS;PTPN11
gsea,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.2377690835444277,-0.807212277414882,0.7773654916512059,0.8091738240017802,1.0,7/28,21.67%,SNRPG;SNRPF;CPSF2;SNRPE;SLBP;NCBP2;SNRPB
gsea,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,0.264518414379896,0.8053694572893333,0.7313131313131314,0.9412767890324978,1.0,3/16,9.15%,MAPK14;KHSRP;EXOSC8
gsea,Nuclear Envelope Breakdown R-HSA-2980766,0.21174860268649875,0.8050428640249349,0.8070539419087137,0.9363510771395185,1.0,13/45,17.18%,RANBP2;NEK7;NUP188;NUP210;NDC1;LPIN1;NUP98;LEMD3;POM121;LPIN2;NUP160;AAAS;NUP133
gsea,RNA Polymerase I Transcription Termination R-HSA-73863,-0.23171731172853563,-0.8003680307129369,0.7825278810408922,0.8188668019299149,1.0,12/29,32.80%,POLR2F;POLR2E;POLR1G;GTF2H5;TAF1C;ERCC3;POLR2L;GTF2H4;POLR1D;POLR1F;GTF2H3;POLR2K
gsea,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.2005112739532879,-0.7906122553557925,0.817658349328215,0.8327870402857148,1.0,18/54,30.65%,PMM1;DPM3;CMAS;DPM2;SLC35A1;GMPPB;NANP;GNE;EGFL7;GNPNAT1;ST6GAL1;DPM1;AMDHD2;ALG5;UAP1;FUOM;ST6GALNAC6;PGM3
gsea,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.21481572736823895,0.7877305191485956,0.744721689059501,0.9616345811274225,1.0,17/43,25.39%,HS3ST4;XYLT1;GPC3;HS6ST3;NAGLU;HS3ST2;EXT1;VCAN;XYLT2;HS2ST1;GPC5;GLB1L;DCN;CSPG4;GLCE;HS6ST2;NCAN
gsea,Signaling By ALK R-HSA-201556,0.26084906615891734,0.7865497672728566,0.7643564356435644,0.9581357003070264,1.0,8/20,25.70%,PTPRZ1;HDAC1;PLCG1;ALK;FRS2;PIK3CA;EP300;HDAC3
gsea,RHOBTB1 GTPase Cycle R-HSA-9013422,0.24159000064268588,0.7810190299860416,0.7751937984496124,0.961817930692745,1.0,8/23,19.25%,ROCK1;CPSF7;COPS4;RNF20;TRA2B;PDE5A;SRRM1;COPS2
gsea,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.2593393169231255,0.7791758482314838,0.7476979742173112,0.9593183065025159,1.0,8/22,25.39%,XYLT1;GPC3;VCAN;XYLT2;GPC5;DCN;CSPG4;NCAN
gsea,Activation Of Pre-Replicative Complex R-HSA-68962,-0.24488354332418066,-0.7762758726465102,0.7779850746268657,0.852984368447004,1.0,4/22,23.08%,RPA3;CDC45;MCM6;ORC4
gsea,SLC-mediated Transmembrane Transport R-HSA-425407,-0.16654685187331422,-0.7718365335662379,0.9191729323308271,0.8582992950202022,1.0,19/151,16.32%,CALM1;SLC25A4;SLC15A2;SLC25A5;BSG;SLC38A2;SLC39A3;SLC3A1;SLC24A5;SLC18A2;SRI;SLC8A2;SLC35B3;SLC35A1;SLC41A1;SLC16A1;SLC38A5;ARL2BP;SLC13A4
gsea,Amine Ligand-Binding Receptors R-HSA-375280,0.24230683587898103,0.7701340397918197,0.796875,0.9685255849572239,1.0,6/20,19.53%,CHRM3;HTR2C;CHRM2;HRH2;ADRA1A;HTR4
gsea,Elastic Fibre Formation R-HSA-1566948,0.23835826037361751,0.7678000025678272,0.8076109936575053,0.9665374442802822,1.0,3/22,7.51%,FBN2;LTBP4;ITGA8
gsea,Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.21734153194187913,0.7673872409986526,0.8428571428571429,0.9617108512777495,1.0,4/32,8.57%,CDC27;ATRX;CCND2;ANAPC5
gsea,Bile Acid And Bile Salt Metabolism R-HSA-194068,0.23565559524836246,0.7667694658017705,0.8318777292576419,0.95725349222567,1.0,7/23,20.41%,NCOA2;NCOA1;OSBPL7;OSBPL2;OSBPL1A;SLC27A2;OSBP
gsea,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.24608332435542782,0.7628390984758053,0.806,0.9577244635311283,1.0,5/21,15.97%,NCOA6;NCOA2;NCOA1;CHD9;PPARA
gsea,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.2583255037295543,0.7612995160556185,0.8054968287526427,0.9546135916119378,1.0,2/15,5.61%,OCRL;PIKFYVE
gsea,Transcriptional Regulation By E2F6 R-HSA-8953750,0.216343473374873,0.7609083544090823,0.8303030303030303,0.9498937945235999,1.0,10/30,20.61%,EHMT1;EHMT2;MGA;PHC3;CHEK1;PCGF6;SUZ12;RBBP4;APAF1;EZH2
gsea,RNA Polymerase III Transcription Initiation R-HSA-76046,-0.20646322321908456,-0.7543492112111786,0.8536121673003803,0.8808503712597421,1.0,11/34,28.99%,POLR2F;POLR2E;POLR3H;SNAPC5;POLR3D;SNAPC1;SNAPC2;POLR2L;POLR3E;POLR3A;POLR1D
gsea,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.23927309929478832,0.754174416221234,0.823170731707317,0.9544572739513023,1.0,4/20,13.16%,MAN2A1;MAN2A2;MGAT4C;CHST10
gsea,Regulation Of Signaling By CBL R-HSA-912631,-0.25663648305983894,-0.7535214025421952,0.7945736434108527,0.880692029488414,1.0,4/17,16.45%,CLSTN1;LYN;PIK3R1;HCK
gsea,Signaling By Retinoic Acid R-HSA-5362517,-0.2411901657372065,-0.7514589498622238,0.8130841121495327,0.8821326911994581,1.0,5/23,19.63%,DLAT;RDH14;LDHD;ALDH1A1;DHRS3
gsea,PPARA Activates Gene Expression R-HSA-1989781,0.17116558583665845,0.7512184412662359,0.9206680584551148,0.9533674691332534,1.0,19/92,15.97%,MED13;PPARGC1B;CDK8;RORA;NCOA6;MED13L;NCOA2;TNFRSF21;NCOA1;MED14;GRHL1;PPARG;ACADM;NRF1;MED27;CHD9;MED24;MED23;PPARA
gsea,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.17342729010181857,-0.749233084662133,0.9224806201550387,0.8836633142080647,1.0,24/94,25.16%,SIN3B;TBL1XR1;HMGCS1;GPS2;MED10;NFYB;MED4;MED19;TBL1X;MED31;HMGCR;ACOX1;MED9;MED21;ARNT2;MED22;MED25;TXNRD1;MED7;FDFT1;ESRRA;MIA3;SIN3A;LIN9
gsea,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.224047565992642,0.7472645709415168,0.8145315487571702,0.9535689581475599,1.0,10/31,25.39%,ST3GAL3;HEXA;HEXB;GPC3;EXT1;VCAN;GPC5;DCN;CSPG4;NCAN
gsea,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.2525752520494777,-0.7471273821332259,0.8252427184466019,0.8852278137984,1.0,7/17,34.72%,PIGF;DPM2;PIGH;PIGM;PIGP;PIGB;PIGN
gsea,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.2600204679758862,-0.7439238874079511,0.8080614203454894,0.8880447293088648,1.0,6/16,29.24%,XRCC2;RAD50;RBBP8;RAD51;PALB2;KAT5
gsea,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.2226213074539956,0.7417841642655802,0.8362068965517241,0.9557044038645207,1.0,6/31,10.19%,CBL;SOS1;JAK2;GAB2;PIK3R3;FYN
gsea,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.2358596243075648,-0.7318310066032863,0.8385214007782101,0.9011491551014736,1.0,8/19,32.70%,MAPK3;CDKN1B;CREB1;MAPK1;AKT1;FOXO3;AKT3;XPO1
gsea,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.21485270944330734,0.7263156987407987,0.8704761904761905,0.9691238686572544,1.0,3/25,6.99%,ST3GAL3;HEXA;HEXB
gsea,Nucleotide Catabolism R-HSA-8956319,-0.2146825771315911,-0.7223637468886347,0.8681732580037664,0.9105396027248718,1.0,10/25,32.03%,ITPA;SCO2;ENTPD1;NUDT18;NT5C1A;SAMHD1;NUDT5;NT5C;ENTPD6;NUDT1
gsea,G1/S-Specific Transcription R-HSA-69205,-0.22651676133941434,-0.7210440442580766,0.8563106796116505,0.910792188420137,1.0,5/22,25.16%,PCNA;DHFR;CDC45;E2F4;LIN9
gsea,Sphingolipid Metabolism R-HSA-428157,0.16959979860717858,0.7142016923156407,0.9513274336283186,0.9773574743959537,1.0,8/69,8.60%,CERS4;SPNS2;SGMS1;HEXA;HEXB;CERS6;ESYT3;ESYT2
gsea,HS-GAG Biosynthesis R-HSA-2022928,-0.22026664877377133,-0.7123505822613798,0.8414634146341463,0.918607466222246,1.0,1/23,0.76%,NDST4
gsea,Diseases Of DNA Repair R-HSA-9675135,-0.1978511806839435,-0.7096304540096353,0.8907103825136612,0.9202041662744992,1.0,13/39,32.49%,SEM1;RPA3;RFC3;XRCC2;RAD50;RAD9B;RBBP8;RAD51;PALB2;MLH1;KAT5;RFC5;MSH6
gsea,Molecules Associated With Elastic Fibres R-HSA-2129379,-0.23776469402588646,-0.7083000303256752,0.8980769230769231,0.9203270455084508,1.0,5/18,26.23%,VTN;ITGAV;EFEMP1;TGFB2;LTBP1
gsea,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.20128014086284454,-0.7068930209478106,0.8958742632612967,0.9204634033207578,1.0,9/30,30.62%,UBE2S;CDK4;ANAPC11;CDKN1B;CCND3;CDC26;CDC16;ANAPC15;ANAPC16
gsea,Miscellaneous Transport And Binding Events R-HSA-5223345,-0.22883279455877573,-0.6940388630484293,0.8990291262135922,0.9313198918536534,1.0,6/19,31.57%,ADD2;NIPAL3;NIPA1;TUSC3;CTNS;MRS2
gsea,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.2526164065216779,0.6870997660962861,0.8584558823529411,0.9986121516368863,1.0,6/16,25.39%,GPC3;VCAN;GPC5;DCN;CSPG4;NCAN
gsea,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.21587109248545167,-0.6852254030891641,0.915057915057915,0.9373809893910543,1.0,5/21,19.90%,SNW1;FABP7;HEY1;MAMLD1;PBX1
gsea,Signaling By PDGF R-HSA-186797,0.1870541647049267,0.6807060698370757,0.9151138716356108,0.9989603649458949,1.0,11/39,19.81%,SYNGAP1;THBS3;SOS1;PLAT;NCK2;PLCG1;COL4A1;COL9A2;COL4A4;COL4A2;PIK3CA
gsea,Myogenesis R-HSA-525793,0.2102896159687571,0.6760327719391082,0.9112426035502958,0.9975562145669381,1.0,6/25,15.79%,MAPK14;CDON;NEO1;MAPK12;MEF2D;MAPK11
gsea,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.1956590532636509,0.6759460565491692,0.91792656587473,0.9924439701449395,1.0,10/28,25.23%,TOPBP1;WRN;HUS1;ERCC4;RAD52;RAD17;RMI1;ABL1;ATM;RFC4
gsea,Keratinization R-HSA-6805567,0.21941333146000633,0.6672974173414981,0.9089026915113871,0.9938837124864754,1.0,5/18,18.09%,PKP4;PCSK6;PKP2;KRT12;CAPN1
gsea,Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.18060375386825758,0.6610000548725842,0.9534883720930233,0.9933654853517317,1.0,4/36,7.02%,CERS4;SPNS2;SGMS1;CERS6
gsea,Phosphorylation Of APC/C R-HSA-176412,-0.21543408881005355,-0.6488500065718402,0.9278557114228457,0.9618650543448553,1.0,8/16,37.58%,UBE2S;ANAPC11;CDC26;CDC16;ANAPC15;ANAPC16;UBE2E1;ANAPC2
gsea,G0 And Early G1 R-HSA-1538133,0.20941858418470755,0.6432323227868424,0.9254032258064516,0.9998249163810545,1.0,5/19,19.80%,HDAC1;MYBL2;LIN52;LIN54;RBBP4
gsea,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.20494443223986122,-0.6374526495734462,0.9571150097465887,0.9669996760958544,1.0,9/19,37.58%,UBE2S;ANAPC11;CDC26;CDC16;BUB3;ANAPC15;ANAPC16;UBE2E1;ANAPC2
gsea,Signaling By BMP R-HSA-201451,-0.20431622418741086,-0.6309636727021892,0.9364754098360656,0.9690436109098716,1.0,6/20,26.47%,SMAD7;BMPR2;BMPR1B;SMAD9;SMAD5;BMPR1A
gsea,Glycosphingolipid Metabolism R-HSA-1660662,0.17587953424643954,0.6271901409362807,0.9723404255319149,1.0,1.0,4/33,8.60%,HEXA;HEXB;ESYT3;ESYT2
gsea,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.19794036402691154,-0.6230572397176865,0.9386503067484663,0.9717178528088102,1.0,10/20,41.25%,OGN;CHST1;B4GALT6;LUM;CHST2;PRELP;ST3GAL1;B4GALT2;B4GALT3;B4GAT1
gsea,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.20159586936810536,-0.6201766952795748,0.9438877755511023,0.9718309973326688,1.0,7/22,34.26%,SLC38A2;SLC3A1;SLC38A5;SLC25A29;SLC7A10;SLC3A2;SLC16A10
gsea,RHOD GTPase Cycle R-HSA-9013405,-0.16165161727017574,-0.619707964762629,0.9784313725490196,0.970810679365842,1.0,6/45,15.69%,EFHD2;EMD;PIK3R1;LMAN1;PGRMC2;VAMP3
gsea,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.22487416290971196,0.6133454039118974,0.8963636363636364,1.0,1.0,6/16,25.39%,GPC3;VCAN;GPC5;DCN;CSPG4;NCAN
gsea,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.158929118136482,0.5995311352693137,0.9811715481171548,1.0,1.0,6/45,12.83%,SLC44A5;SLC6A1;SLC22A4;SLC5A3;SLC6A7;SLC44A2
gsea,Nicotinate Metabolism R-HSA-196807,-0.19332026023169374,-0.5962217951503744,0.9546279491833031,0.9788196460607277,1.0,6/21,25.48%,PARP16;NMNAT3;NAXD;PARP4;NAXE;CD38
gsea,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.18925588665879423,-0.5850262247285597,0.9650924024640657,0.9813144105996074,1.0,8/19,37.58%,UBE2S;ANAPC11;CDC26;CDC16;ANAPC15;ANAPC16;UBE2E1;ANAPC2
gsea,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.1529899006321126,0.5783525164710044,0.9933920704845814,1.0,1.0,8/39,17.56%,QTRT1;THADA;NSUN2;ALKBH8;CTU2;PUS7;TRMT11;TRMT13
gsea,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.20633407108050558,0.5575834199898877,0.9473684210526315,1.0,1.0,6/16,25.39%,GPC3;VCAN;GPC5;DCN;CSPG4;NCAN
gsea,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.18481779941585783,0.5565054759026106,0.9762376237623762,1.0,1.0,2/18,8.57%,CDC27;ANAPC5
gsea,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.18098422115772178,0.5192524218620903,0.9878542510121457,1.0,1.0,4/15,19.80%,HDAC1;LIN52;LIN54;RBBP4
gsea,Signaling By PDGFR In Disease R-HSA-9671555,-0.15997507471290517,-0.4770948585307549,0.9922330097087378,0.9973380484203164,1.0,5/18,29.10%,HRAS;PIK3R1;NRAS;PIK3CB;PIK3R2
gsea,HS-GAG Degradation R-HSA-2024096,0.16414193495797305,0.46896429490301833,0.994263862332696,1.0,1.0,4/16,22.18%,GPC3;NAGLU;GPC5;GLB1L
gsea,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.14657274451368185,0.4449378935162767,0.994,0.9988747574018252,1.0,18/18,85.36%,LARS2;NARS2;VARS2;SARS2;DARS2;RARS2;MARS2;TARS2;IARS2;AARS2;EARS2;CARS2;PARS2;YARS2;PPA2;DTD1;FARS2;WARS2
